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Summary 
The balance between stability and plasticity has to be regulated to maintain 
proper functionality of the brain and to promote learning and memory processes. 
In the adult, the extracellular matrix (ECM) that is formed by glia cells and 
neurons enwraps and stabilizes synapses and neuronal networks. ECM 
molecules as well as transmembrane proteins are cleaved by extracellular 
proteases and subsequently yield new signaling molecules that are important 
mediators of synaptic plasticity. The huge variety of ECM and transmembrane 
proteins and extracellular proteases lead to many unanswered questions about 
their involvement in the precise regulation of synapses throughout development 
and plasticity processes. In this thesis, the involvement of the hyaluronan based 
ECM on the regulation of postsynaptic NMDA receptors was investigated. 
Further, the signaling mechanism of the extracellular cleaved cadherin 
superfamily member Calsyntenin (Cst) is investigated. 
In late postsynaptic development when neuronal networks are established 
(roughly P70 in mice), a drop in structural plasticity can be observed. On the 
molecular level, neurotransmitter receptors are recruited and stabilized at 
synaptic contacts, which determine the mature properties of synaptic 
transmission. Key events are changes in the subunit composition of NMDA 
receptors from predominantly GluN1/GluN2B- to GluN1/GluN2A-NMDA 
receptors, which alters plasticity processes of the synapses. At the same time the 
hyaluronan-based ECM matures, stabilizes synaptic contacts and limits plasticity 
processes. Removal of the ECM induces an increased and juvenile form of 
plasticity. In this thesis I hypothesized a causal link between the two 
developmental changes, and thus an influence of the ECM on the characteristics 
of the GluN2B-NMDA receptors. Indeed I found that enzymatic digestion of the 
ECM by the glycosidase hyaluronidase (Hya) increased the surface expression 
and synaptic currents of GluN2B-NMDA receptors in mature cultured 
dissociated hippocampal neurons. This was due to an altered phosphorylation 
state of GluN2B upon ECM digestion which led to a lower endocytosis rate. 
Further experiments demonstrated that this effect was β1-integrin dependent. 
Finally lateral mobility of surface GluN2B was more confined after prolonged 
ECM removal. Taken together, these results suggest that ECM molecules regulate 
surface abundance of GluN2B-NMDA receptors and an increased surface 
abundance of GluN2B-NMDA receptors may mimic juvenile states. This may be 
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one mechanism underlying the observed increased neuronal plasticity after ECM 
removal.  
In the second part the cellular function and signaling of the postsynaptic, 
transmembrane protein Cst and especially of its shed ectodomain were 
investigated. In humans, the Cst gene is known to have strong influence on 
episodic memory. C. elegans lacking Cst show impaired associative learning, 
which can be rescued by application of the ectodomain of Cst. It was suggested 
that Cst-1 binds secreted frizzled related protein 1 (sFRP-1), a protein involved in 
wnt signaling (Leuthäuser et al., unpubl.). So far no effect of Cst-1 on canonical 
wnt signaling could be shown. Furthermore Cst-1 did not directly bind to 
Frizzled-1, which was tested due to the close homology between sFRP-1 and the 
extracellular domain of Frizzled-1. Wnt signaling affects presynaptic activity and 
therefore I tested whether Cst-1 has a potential influence in this context. 
Synaptotagmin antibody uptake experiments demonstrated that the ectodomain 
of Cst-1 increased neurotransmitter release in cortical neurons, which was 
prevented by either blocking wnt signaling or inhibiting α7-nAChRs that were 
shown to be involved in wnt signaling-dependent effects on presynaptic activity. 
Taken together the results suggest that the ectodomain acts as a trans-synaptic 
messenger, whose exact function needs to be further clarified.  
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Zusammenfassung  
Die Fähigkeit zu plastischen Veränderungen im Gehirn, sowohl struktureller als 
auch funktioneller Art, wandelt sich während der Entwicklung und wird als 
Reaktion auf Aktivitätsveränderungen oder Verletzungen angepasst. Die Balance 
zwischen Stabilität und Plastizität muss ein Leben lang reguliert werden, um die 
Gehirnfunktionen aufrecht zu erhalten, und Lern- und Gedächtnisprozesse zu 
ermöglichen. Im adulten Gehirn sind die Synapsen von einer extrazellulären 
Matrix (ECM) ummantelt und stabilisiert, die gemeinsam von Gliazellen und 
Neuronen produziert wird. Sowohl ECM-Moleküle, als auch transmembranale 
Proteine werden durch extrazelluläre Proteasen gespalten, was neue 
Signalmoleküle hervorbringt, die wichtige Mediatoren für plastische Prozesse an 
der Synapse sind. Die große Bandbreite an extrazellulären und 
transmembranalen Molekülen birgt viele offene Fragen über deren Einfluss in 
der präzisen Regulation von Synapsen während der Entwicklung und 
Plastizitätsprozessen im Gehirn.  
Diese Arbeit behandelt die Funktionen von zwei Komponenten der ECM. Zum 
einen wurde der Einfluss der Hyaluronsäure-basierten ECM auf die Regulation 
von postsynaptischen NMDA Rezeptoren untersucht. Andererseits wurde das 
Spaltungsprodukt des transmembranalen Proteins Calsyntenin (Cst), das 
Mitglied der Cadherin Superfamilie ist, auf dessen Signalweg sowie mögliche 
Rezeptoren erforscht.  
In der postnatalen Entwicklung, zu einem Zeitpunkt an dem neuronale 
Netzwerke gefestigt werden (in Mäusen ~P70), ist ein Abfall der strukturellen 
Plastizität zu beobachten. Auf molekularer Ebene werden 
Neurotransmitterrezeptoren an den Synapsen stabilisiert, die die adulten 
Eigenschaften einer Synapse mitbestimmen. Ein Rezeptor, dessen 
Zusammensetzung sich in juvenilen und adulten Synapsen unterscheidet, ist der 
NMDA Rezeptor. Postnatale Synapsen sind hauptsächlich von GluN2B-NMDA-
Rezeptoren dominiert, während adulte Synapsen vornehmlich GluN2A-NMDA-
Rezeptoren aufweisen. Ob ein NMDA-Rezeptor die GluN2A oder GluN2B 
Untereinheit enthält bestimmt maßgeblich dessen Eigenschaften und beeinflusst 
damit auch das Plastizitätspotential einer Synapse. Parallel zum Wechsel der 
NMDA-Rezeptorzusammensetzung bildet sich die adulte Form der ECM aus. 
Das Erscheinen dieser reifen ECM wird als Endpunkt für eine juvenile, 
hochplastische Phase im Gehirn betrachtet. Die ECM stabilisiert Synapsen und 
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verhindert bis zu einem gewissen Grad plastische Prozesse im Gehirn. Durch die 
Behandlung mit Enzymen, die die Struktur der Matrix zerstören, können 
juvenile, plastische Prozesse wieder induziert werden. Auf Grund der zeitlichen 
Überlappung dieser zwei beschriebenen, entwicklungsabhängigen Prozesse und 
des gemeinsamen Einwirkens auf die Plastizität neuronaler Netzwerke wurde 
ein möglicher Einfluss der ECM auf die Zusammensetzung von NMDA-
Rezeptoren postuliert. Das Enzym Hyaluronidase (Hya) spaltet das 
Hyaluronsäure-Rückgrat der ECM und zerstört so ihre dichte, netzwerkartige 
Struktur. Die Behandlung reifer, neuronaler Zellkulturen mit Hya erhöhte die 
Oberflächenexpression von GluN2B-NMDA-Rezeptoren, was zu erhöhten 
synaptischen Strömen durch diese Rezeptoren führte. Dieser Effekt wurde 
verhindert, indem β1-Integrine in ihrer Funktion inhibiert wurden. Die 
Gesamtmenge an GluN2B Proteinen war jedoch nicht verändert durch den ECM 
Verdau, was auf eine veränderte Endo- oder Exozytose hinweist. Durch den 
ECM Verdau wurde GluN2B vermehrt phosphoryliert, woraus eine verringerte 
Endozytose resultierte. Außerdem zeigte sich, dass GluN2B-NMDA-Rezeptoren 
nach der Hya Behandlung eine geringere laterale Mobilität in der Membran 
aufwiesen. Die erhöhte synaptische Oberflächenexpression von GluN2B-NMDA-
Rezeptoren nach der Hya-Behandlung, was einer juvenilen 
Rezeptorzusammensetzung entspricht, könnte ein molekularer Baustein sein, der 
eine erhöhte Plastizität nach EZM-Verdau begründet.  
Im zweiten Teil dieser Arbeit wurden die zelluläre Funktion und die zu Grunde 
liegenden Signalwege von Calsyntenin (Cst), einem transmembranalen Protein 
der Cadherin Superfamilie, untersucht. Das Protein wird von Proteasen 
geschnitten und dabei wird ein Proteinfragment, die Ectodomäne, in das 
extrazelluläre Milieu freigegeben. Es ist bekannt, dass das Cst-Gen in Menschen 
Einfluss auf das episodische Gedächtnis hat. In C. elegans Mutanten, denen das 
Cst-1-Gen fehlt, wurde ein verändertes assoziatives Lernen nachgewiesen, dass 
durch Zugabe der Ectodomäne wieder normalisiert wurde. Es gibt Hinweise, 
dass auch die Regulation von AMPA-Rezeptoren in diesen Tieren beeinflusst ist, 
jedoch ist der genaue Signalweg unbekannt. Unveröffentlichte Daten aus dem 
Labor von Prof. Sonderegger zeigen, dass Cst-1 secreted frizzled related protein 1 
(sFRP-1) bindet. sFRP-1 ist ein extrazelluläres Protein, das den Wnt-Signalweg 
inhibiert. Auf Grund dessen wurde in dieser Arbeit untersucht, ob Cst-1 einen 
Einfluss auf den „canonical“ Wnt-Signalweg hat. Dieser verändert die 
Genexpression und wird mit einem Reportersystem erforscht, in dem Luciferase 
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exprimiert wird, wenn der Wnt spezifische Promotor aktiviert ist. Cst-1 zeigte 
keinen Einfluss auf die Expression der Luciferase. Auf Grund struktureller 
Homologien von sFRP-1 und dem Frizzled-Rezeptor wurde postuliert, dass Cst-1 
auch an Frizzled bindet; dies konnte aber nicht nachgewiesen werden. Es ist 
bekannt, dass der Wnt Signalweg präsynaptische Aktivität regulieren kann, 
weshalb die Wirkung von Cst-1 auf die Präsynapse untersucht wurde. Anhand 
der Aufnahme eines Synaptotagmin-Antikörpers konnte gezeigt werden, dass 
die Ectodomäne von Cst-1 die präsynaptische Aktivität erhöht. Dieser Effekt 
konnte verhindert werden, indem entweder der Wnt Signalweg oder die α7-
nACh Rezeptoren inhibiert wurden, von denen bekannt ist, dass sie in Wnt 
abhängige Prozesse in der Präsynapse involviert sind. Zusammenfassend zeigen 
die Daten, dass die Ectodomäne von Cst-1 als transsynaptisches Signalmolekül 
fungiert, dessen genauer Einfluss weiter zu erforschen ist. 
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1 Introduction 
The proper function of the brain involves the precise orchestration of single 
synapses. The strengthening and weakening of synapses is an important process 
in this context and needs to be strictly regulated. For this general purpose there is 
a huge variety of regulatory proteins within the cells, which have been studied 
extensively. During my PhD I focused on the regulatory function of extracellular 
molecules at the synapse. Synapses are no isolated structures build up by the pre- 
and postsynapse; they are enwrapped by glia cells and the extracellular matrix 
(ECM). This arrangement is described as the quadripartite synapse (Sykova and 
Nicholson, 2008). Glia cells secrete proteins into the extracellular space which 
influence synaptic functions and form major constituents of the ECM. 
Thrombospondin for instance is a large ECM molecule, secreted by glia cells, 
which was shown to influences synaptogenesis in the hippocampus (Xu et al., 
2010). Proteolytic cleavage of extracellular molecules is another mechanism to 
affect synaptic properties, as it was demonstrated for the neurotrypsin-
dependent cleavage of agrin, which leads to filopodia formation in the 
hippocampus (Matsumoto-Miyai et al., 2009). The variety of extracellular 
proteins and transmembrane proteins influencing synaptic transmission is huge, 
which leads to several open questions.  
I divided my thesis into two parts, in which I investigated both the influence of 
the hyaluronan-based ECM on synaptic transmission and cellular effects of an 
extracellular cleaved protein. 
In the first part I describe my work on the hyaluronan-based ECM of the brain, 
which is known to influence the development of the brain and synaptic plasticity. 
The plasticity of glutamatergic synapses is mainly determined by their amount of 
AMPA and NMDA receptors. Therefore I studied the influence of the ECM on 
the expression pattern of NMDA receptors and underlying signaling 
mechanisms.  
The second part focus on a protein called calsyntenin (Cst), which is member of 
the cadherin superfamily. Especially its poorly described ectodomain, which is 
shed after extracellular proteolytic cleavage and its influence on cellular 
functions, was in focus of my work. Interestingly, in humans, the Cst gene was 
linked to episodic memory. C. elegans lacking Cst-1 show impaired associative 
learning, which can be rescued by application of the ectodomain. However, the 
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precise molecular function of Cst is poorly understood as well as its cellular 
receptor. The aim of this part was to elucidate potential receptors and cellular 
function of the ectodomain of Cst-1.  
1.1 The ECM of the brain 
1.1.1 Molecular composition of the ECM 
Neurons in the brain are surrounded by a complex, three dimensional 
hyaluronan-based ECM. Around most cells and in the neuropil the ECM has a 
diffuse appearance. Beside this, the it can form unique, dense netlike structures, 
called perineuronal nets (PNNs), which were first described by Camillo Golgi 
1893 (reviewed in Celio and Blumcke, 1994). During the past years more 
evidences were obtained that the ECM has both passive and active functions, 
which are important for the development and functionality of the brain.  
The basic constituents of the PNNs are hyaluronan, chondroitin sulfate 
proteoglycans (CSPGs), link proteins (HAPLNs) and tenascin-R (Dityatev et al., 
2010). Hyaluronan is a linear polysaccharide and builds the backbone of the 
ECM. In the brain it has been suggested to be anchored to the cell membrane by 
hyaluronan synthase (Kwok et al., 2010). Proteoglycans bind to hyaluronan, other 
ECM or cell-surface molecules and by that serve as organizational scaffolds. 
Lecticans, including aggrecan, versican, neurocan and brevican, are the most 
prominent proteoglycans in the brain (Yamaguchi, 2000). HAPLNs stabilize the 
interaction of hyaluronan and lecticans. Tenascin-R is the most prominent 
glycoprotein of the tenascin protein family in the adult brain. It builds trimers 
that can bind three other lecticans to stabilize the integrity of the PNN structure. 
All these components build up the netlike structure of the PNNs as described by 
Golgi.  
During development the ECM undergoes several changes. It develops during the 
first three postnatal weeks in rodents (Celio and Blumcke, 1994). The formation 
of PNNs is activity dependent and concurs with the closure of the critical period, 
in which neurons are highly input sensitive and plastic (Lander et al., 1997, 
Hensch, 2005). The individual components of the juvenile and adult matrix differ 
and the density of formed nets increases during the postnatal development 
(Milev et al., 1998, Rauch, 2004). In dissociated rat hippocampal cultures grown 
for 11 days in vitro (DIV 11) PNNs are only present at some single cells, mostly 
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inhibitory, parvalbumin positive interneurons (Frischknecht et al., 2009). After 
DIV 21 PNNs are visible on almost every cell but in different intensities. They 
reach their adult properties with the ending of synaptogenesis (Koppe et al., 
1997, John et al., 2006). At this time the synapses are fully wrapped by the ECM, 
apparently only the synaptic cleft is free of it. 
Although the three-dimensional meshwork of extracellular proteins seems to be a 
stable structure, it undergoes continuous rearrangements with regard to 
plasticity processes. There are three families of endogenous remodeling enzymes. 
One of those is the matrix metalloproteinases (MMPs) family (Puente et al., 2003). 
These proteins are zinc- and calcium-dependent endopeptidases that are mainly 
secreted into the extracellular space (Sbai et al., 2008). The other two families of 
ECM degrading proteases are the “A disintegrin and metalloproteases” (ADAM) 
and the “A disintegrin and metalloproteinase with thrombospondin motifs” 
(ADAMTS) families. The majority of ADAMs are type I transmembrane proteins, 
which allows juxtamembrane cleavage of other membrane-associated proteins 
(Edwards et al., 2008). In contrast ADAMTSs are secreted proteins (Porter et al., 
2005). All these proteases need to be highly regulated in their synthesis and/or 
activity by posttranslational modifications or release as inactive pro-enzymes. 
Additionally endogenous inhibitors like tissue inhibitors of metalloproteinases 
(TIMPs) control their activity state (Yong, 2005).  
However, not only proteases may modulate the ECM but also glycosidases, but 
their physiological role during plasticity processes in the brain remains elusive. 
They are mainly used as experimental tools to modulate the ECM. The most 
commonly used enzymes are Hyaluronidase (Hya) and Chondroitinase ABC 
(ChABC). Hya is an endogenous enzyme that cleaves predominantly hyaluronan 
but has an intrinsic chondroitinase function (Margolis et al., 1972, Stern and 
Jedrzejas, 2006). ChABC is a bacterial enzyme (from Proteus vulgaris) that 
removes chondroitin sulfate glycosaminoglycan side chains from molecules 
(Yamagata et al., 1968, Bukalo et al., 2001). Both of these enzymes have been 
extensively used to degrade the ECM in vitro and in vivo (Bukalo et al., 2001, 
Pizzorusso et al., 2002, Frischknecht et al., 2009, Kochlamazashvili et al., 2010, de 
Vivo et al., 2013, Happel et al., 2014).  
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1.1.2 ECM in neuronal plasticity 
The interconnection of the ECM with different kinds of plasticity processes in the 
brain is subject of plenty of studies. On one hand it was studied whether 
modulation of the ECM influences synaptic plasticity and on the other hand 
whether synaptic activity changes ECM integrity. 
ECM in long-term potentiation 
On a molecular level it was shown that enzymatic digestion of the ECM with Hya 
or ChABC increases lateral mobility of GluA1-AMPA receptors and by that the 
exchange of synaptic and extrasynaptic receptors in primary hippocampal 
cultures. That results in an enhancement of short term plasticity (Frischknecht et 
al., 2009). In hippocampal slices treated with Hya L-type voltage-dependent Ca2+ 
channel (L-VDCC)-driven currents were suppressed and an L-VDCC-mediated 
component of long-term potentiation (LTP) abolished (Kochlamazashvili et al., 
2010). Further indications for an influence of the ECM on LTP were given by 
experiments showing that mice lacking the CSPGs neurocan or brevican have 
deficits in LTP maintenance (Zhou et al., 2001, Brakebusch et al., 2002). MMP-9 
mutant mice show also impairments in the late phase of LTP (Nagy et al., 2006). 
Using the enzymatic digestion as ECM manipulation, ChABC treatment of 
hippocampal slices reduces LTP and long-term depression (LTD) (Bukalo et al., 
2001). However, in vivo ChABC treatment in the visual cortex supports LTP (de 
Vivo et al., 2013). The most obvious difference between these two studies is the 
experimental setup (in vitro vs. in vivo), which could be one explanation for the 
discrepancy. Additionally, the studies differ in their duration of ECM digestion. 
This suggests diverse short- or long-term effects of the ECM degradation. 
ECM in homeostatic plasticity 
Homeostatic plasticity describes the adjustment of synaptic transmission upon 
prolonged activity changes of the network. For example lesion of the entorhinal 
cortex results in chronic denervation of the dentate gyrus, which leads to 
increased levels of brevican and ADAMTS4-mediated brevican cleavage product 
after 2 days (Mayer et al., 2005). However, the injection of kainite that induces 
epileptic seizures, also upregulates ADAMTS4 expression and leads to a 
remodeling of the ECM (Yuan et al., 2002). This implication of the ECM in 
homeostatic adaptations could also be shown in neuronal cell cultures. A 
prolonged inactivation of primary hippocampal cultures leads to homeostatic 
Introduction     18 
plasticity which is paralleled by an increased cleavage of brevican by ADAMTS4 
(Valenzuela et al., 2014).  
ECM in structural plasticity 
On a structural level it has been shown that after spinal cord injury a CSPG-rich 
glial scar is formed that inhibits axonal growth. This inhibition is due to CSPGs 
since ChABC treatment stimulates axon outgrowth and the formation of new 
contacts after CNS or spinal cord injury (McKeon et al., 1999, Niederost et al., 
1999, Moon et al., 2001, Bradbury et al., 2002).  
The role of ECM in structural plasticity has been highlighted in the rat visual 
cortex. The so called critical period is a time frame of high plasticity during 
which topographic representations of sensory inputs are established in the 
cortex. Monocular deprivation during this critical period leads to a shift of ocular 
dominance of cortical neurons toward the open eye and in a loss of visual acuity 
for the deprived eye. Those cortical areas that were innervated by the deprived 
eye are now incurred by the open eye (Fagiolini et al., 1994). The ocular 
dominance shift is not seen any more if monocular deprivation is induced after 
the closure of the critical period. It was demonstrated that the critical period 
starts with the end of third postnatal week, peaks around the fourth week and 
begins to decline at the end of the fifth week. In 2002 Pizzorusso et al. presented 
that the development of the ECM overlaps with the critical period (Pizzorusso et 
al., 2002). The abundance of an adult ECM marks the end of the critical period. 
Dark rearing of animals from birth prolongs not only the critical period but also 
the development of the ECM, in particular of perineuronal nets. One-week 
exposure to a normal light/dark circle is enough to rapidly terminate ocular 
dominance plasticity and the formation of perineuronal nets. Enzymatic removal 
of the ECM in the visual cortex of adult rats can reactivate ocular dominance 
plasticity and therefore virtually rejuvenate the plasticity of the cortex 
(Pizzorusso et al., 2002). But the study does not provide any molecular 
mechanism. In addition it has been found that ECM digestion in the visual cortex 
in vivo increases structural and functional plasticity in terms of higher spine 
motility and higher responses to theta-burst stimulation (de Vivo et al., 2013). 
Thus, there seems to be a close relation between the ECM and the plasticity of the 
visual cortex.  
Another study that shows the critical role of the ECM in brain plasticity in vivo 
deals with the ability of Mongolian gerbils to relearn an auditory discrimination 
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task. Hya injection before the beginning of a reversal learning task increases the 
performance significantly without erasing the previously learned task (Happel et 
al., 2014). That proposes the modulation of the ECM as a potential tool to reopen 
a window of opportunities for plasticity processes in established neuronal 
networks.  
The precise molecular mechanisms are still not clear. Regarding neuronal 
plasticity on a molecular level the NMDA receptor is a prominent candidate to 
regulate those processes. Before going into details about the connection of 
NMDA receptors with plasticity and ECM some basal information about the 
NMDA receptor will be provided. 
1.2 The NMDA receptor 
At excitatory synapses of the vertebrate brain the most common neurotransmitter 
is glutamate. It is released from presynaptic terminals and activates glutamate 
receptors at the postsynapse. Ionotropic glutamate receptors are ligand-gated ion 
channels that depolarize the postsynaptic membrane by an influx of cations. 
Ionotropic glutamate receptors can be subdivided into three families: AMPA (α-
amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor), kainite and 
NMDA (N-Methyl-D-aspartic acid) receptors. AMPA receptors account for the 
fast postsynaptic response, but NMDA receptors exhibit a specialized role. Due 
to their diverse subunit composition, expression and association with 
intracellular signaling molecules they are essential for brain plasticity. They are 
also thought to transfer activity patterns into long-term changes in synapse 
structure and function (Traynelis et al., 2010). 
1.2.1 Functionality of the NMDA receptor 
NMDA receptors have unique properties that give them their special position 
among the ionotropic glutamate receptors. First, they are highly permeable for 
Ca2+ ions, which can activate intracellular signaling cascades (Mayer et al., 1987); 
second, their opening mechanism is more complex than the one of AMPA 
receptors. During resting membrane potential their pore is blocked by an 
extracellular Mg2+ block and the binding of glutamate does not lead to channel 
opening. It needs a preceding depolarization which removes the Mg2+ block to 
allow glutamate to open the pore (Lynch et al., 1983, Mayer et al., 1984, Nowak et 
al., 1984). This gives the receptor its special role as a coincidence detector for 
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synchronized pre- and postsynaptic activity. Additionally a co-agonist, glycine or 
D-serine is needed to activate the receptor (Johnson and Ascher, 1987). Third, 
they exhibit much slower kinetics then AMPA receptors due to slower glutamate 
unbinding (Vicini et al., 1998). Fourth, NMDA receptors have long intracellular 
tails that are docking stations for several signaling molecules and substrates for 
posttranslational modifications, i.e. phosphorylation (Kohr and Seeburg, 1996, 
Krupp et al., 1998). Therefore the NMDA receptor is of special interest for 
neuronal differentiation, synaptogenesis and synaptic plasticity. 
1.2.2 Subunit composition, characteristics and trafficking of NMDA receptors 
There are three families of NMDA receptor subunits: GluN1, GluN2 A-D and 
GluN3 A-B (Law et al., 2003). Functional receptors consist of hetero-tetramers 
with two obligatory GluN1 subunits and two GluN2 subunits. In some cases 
there is one GluN2 and one GluN3 subunit found (Cull-Candy and Leszkiewicz, 
2004). The two GluN2 subunits can be of the same isoform, called di-heteromeric 
receptors (i.e. GluN1/GluN2A or GluN1/GluN2B) or different isoforms, called tri-
heteromeric receptors (i.e. GluN1/GluN2A/GluN2B) (Sheng et al., 1994). The 
abundance of tri-heteromeric receptors was shown in many regions of the brain, 
particularly in the hippocampus and cortex, varying between 15 – 50% (Rauner 
and Kohr, 2011).  
NMDA receptors have slower kinetics than the fast responding AMPA receptors. 
The kinetics of the receptor are mainly determined by the GluN2 subunit 
(Dzubay and Jahr, 1996). GluN2B-containing NMDA receptors (GluN2B-NMDA 
receptors) have longer opening and closing constants than GluN2A-NMDA 
receptors (Monyer et al., 1994, Vicini et al., 1998, Erreger et al., 2005) (Figure 1, 
inset). Additionally, GluN2B-NMDA receptors have higher calcium permeability 
and provide more calcium per unit of current than GluN2A-NMDA receptors 
(Erreger et al., 2005, Sobczyk et al., 2005).  
Another molecular difference between GluN2A- and GluN2B-NMDA receptors 
is the association of the cytoplasmic C-terminus with intracellular signaling 
molecules. The most prominent signaling molecule which is linked to NMDA 
receptor is the Ca2+/Calmodulin-dependent protein kinase II (CaMKII). CaMKII is 
highly abundant at synapses (Erondu and Kennedy, 1985, Peng et al., 2004) and 
is crucial to induce LTP (Malinow et al., 1989, Otmakhov et al., 1997). GluN2B 
subunits have a high affinity for CaMKII whereas GluN2A shows only low 
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affinity (Strack and Colbran, 1998). This distinct binding affinity for CaMKII is 
thought to differentially regulate synaptic plasticity, which will be discussed in 
detail in sections 1.2.3 and 4.3.  
Interestingly the subunit composition of NMDA receptors undergoes a 
developmental switch (Figure 1). During embryonic and early postnatal periods 
there are predominantly GluN2B-NMDA receptors present throughout the brain. 
After the first three postnatal weeks the expression of GluN2A-NMDA receptors 
increases, whereas the expression of GluN2B-NMDA receptors declines (Monyer 
et al., 1994, Kirson and Yaari, 1996). That results in an increase of the synaptic 
GluN2A/GluN2B ratio (Sheng et al., 1994, Flint et al., 1997, Hoffmann et al., 2000). 
This process requires synaptic activity or sensory experience, exemplified in the 
visual cortex (Carmignoto and Vicini, 1992), however the precise molecular 
mechanisms leading to the subunit switch are still unknown.  
The trafficking and synaptic localization of NMDA receptors are regulated via 
the cytoplasmic tail of GluN2A and GluN2B. Members of the membrane-
associated guanylate kinase (MAGUK) family anchor NMDA receptors at the 
synapse (Kornau et al., 1995, Niethammer et al., 1996). Especially, the 
postsynaptic density protein 95 (PSD-95) and the synapse-associated protein 102 
(SAP-102) bind with their PDZ domains the PDZ-binding motifs of NMDA 
receptors. It was shown that mice lacking PSD-95 have a deficit in the GluN2 
switch (Beique et al., 2006). The binding efficacy and by that synaptic tethering is 
controlled via phosphorylation of the PDZ-binding motif of GluN2A or GluN2B. 
Casein kinase 2 (CK2) phosphorylates S1480 in the PDZ binding motif of GluN2B 
that inhibits further binding of MAGUKs and therefore destabilizes GluN2B-
NMDA receptors at the synapse (Chung et al., 2004, Sanz-Clemente et al., 2010). 
CK2 activity is also required for the acute activity-induced GluN2 switch. 
Another binding motif (YEKL) in the C-terminus of GluN2B provides the binding 
site for the clathrin adaptor protein 2 (AP-2) which is essential for the clathrin-
dependent endocytosis of the receptor. After phosphorylation of the tyrosine 
residue (Y1472) in the YEKL motif, AP-2 cannot bind the GluN2B-NMDA 
receptor anymore, which leads to receptor stabilization at the surface (Lavezzari 
et al., 2003). Sanz-Clemente et al. created a model in which the coordinated 
phosphorylation of these two residues of GluN2B regulates its trafficking: Early 
in development the association of GluN2B-NMDA receptors with MAGUKs 
(S1480 unphosphorylated) stabilizes the receptors at the membrane. This is 
supported by the phosphorylated Y1472 (no binding of AP-2). During the critical 
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period, NMDA receptor activation leads to phosphorylation of S1480 by CK2 
(disruption of MAGUKs). This disruption of the NMDA receptor from MAGUKs 
triggers the de-phosphorylation of Y1472 (AP-2 binding), which results in 
promoted GluN2B-NMDA receptor endocytosis. It was also shown that 
metabotropic glutamate receptors and the release of intracellular calcium are 
required for the GluN2 switch (Bellone et al., 2011, Matta et al., 2011). 
The subcellular localization of the different NMDA receptor subtypes is under 
ongoing debate. A simplified model suggests that in the adult forebrain di-
heteromeric GluN1/GluN2A- and tri-heteromeric GluN1/GluN2A/GluN2B-
NMDA receptors are found at synaptic sites with variable ratios due to plastic 
changes. Di-heteromeric GluN1/GluN2B-NMDA receptors are thought to be 
more prominent at extrasynaptic sites (Dalby and Mody, 2003, Townsend et al., 
2003, Rauner and Kohr, 2011). 
Figure 1: Developmental switch of NMDA receptors 
Neonatal synapses throughout the brain contain mostly GluN2B-NMDA receptors, which are sensitive to 
the selective inhibitor Ifenprodil. The developmental switch in the subunit composition is dependent on 
activity and/or experience and coincides with the development of the ECM. In juvenile synapses GluN2B-
NMDA receptors are more prominent. Those are sensitive to Ifenprodil (red current trace). In adult 
synapses GluN2A-NMDA receptors are dominating the synapse, which are not sensitive to Ifenprodil 
(blue current trace). The inset shows currents from either GluN2A- or GluN2B-NMDA receptors, 
demonstrating that GluN2B-NMDA receptors have much longer decay times which is an important feature 
for the coincidence detection of pre- and postsynaptic activity. This scheme is oversimplified as only 
diheteromeric receptors are presented, even though it is postulated that the majority of synaptic receptors 
is built by triheteromeric GluN2A/2B-NMDA receptors. Current traces are taken from Nature Review, 
Paoletto, Bellone and Zhou, 2013 
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1.2.3 The GluN2A/GluN2B ratio 
As mentioned before, the GluN2 subunit mainly determines kinetics and 
intracellular coupling of the receptor und therefore strongly influences the 
characteristics and plasticity of the synapse. The opening duration of NMDA 
receptors has critical influence on the coincidence detection of pre- and 
postsynaptic activity. The regulation of the GluN2A/GluN2B ratio contributes to 
define the threshold to induce synaptic plasticity. The change in the ability to 
induce subsequent synaptic plasticity was called metaplasticity in 1996 (Abraham 
and Bear, 1996).  
Many studies describe GluN2B as the driving force to elicit LTP, since it targets 
CaMKII to the synapse and synapses with lower GluN2A/GluN2B ratio need 
lower stimulation for LTP induction (Barria and Malinow, 2005, Lee et al., 2010). 
Thus the GluN2A/GluN2B ratio is an important regulator in terms of 
metaplasticity. Controversial publications present GluN2A-NMDA receptors as 
more important for LTP (Yang et al., 2012). In summary the question which 
NMDA receptor elicits LTP or LTD cannot be answered easily and depends 
mainly on the experimental design (Paoletti et al., 2013). Results differ for 
example depending whether the isolation of NMDA receptor subtypes was 
achieved by pharmacology or genetic disruption. For further details see section 
4.3. 
The expression of GluN2B-NMDA receptors correlates with the developmental 
periods of enhanced plasticity in vivo (Kleinschmidt et al., 1987, Fox et al., 1989). 
In the model of ocular dominance plasticity in the visual cortex, it was shown 
that the GluN2A/GluN2B ratio increases during the critical period (Erisir and 
Harris, 2003). Additionally, dark rearing of animals, which prolongs ocular 
dominance plasticity into adulthood, increases the abundance of GluN2B 
subunits as well. Also visual deprivation in adult animals increases GluN2B 
expression (He et al., 2006). Interestingly, the developmental GluN2 subunit 
switch occurs within the same time window as the formation of the ECM. As 
mentioned before, removal of the ECM can reactivate juvenile plasticity in the 
visual cortex of adult mice, but the molecular mechanisms are still not fully 
understood. Since removal of the ECM rejuvenates cortex plasticity, it is tempting 
to speculate that it could also “rejuvenate”, i.e. decrease the GluN2A/GluN2B 
ratio.  
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Along this line it has been shown that the integrity of the ECM affects cell surface 
molecules like members of the integrin family are in their activity (Wu et al., 
2002, Tan et al., 2011, Orlando et al., 2012). Integrins are coupled to intracellular 
signaling molecules and affect intracellular processes upon extracellular 
remodeling. As integrins are shown to affect NMDA receptor mediated synaptic 
currents (Lin et al., 2003, Bernard-Trifilo et al., 2005), they are prime candidates to 
be involved in ECM-dependent regulation of NMDA receptors.  
1.3 Integrins 
Integrins are transmembrane proteins that are responsible for cell-cell and cell-
ECM interactions. They play critical roles in a variety of biological processes such 
as cell motility, adhesion, synaptogenesis, proliferation, apoptosis, neural 
development and inflammation but also in axon guidance, neurite extension, 
synaptic plasticity and axon regeneration (Lemons and Condic, 2008).  
1.3.1 Subunit composition, ligand binding and intracellular signaling 
Integrins are obligate heterodimers containing two distinct chains, called α and β 
subunits, which are non-covalently associated. 24 different integrins are formed 
by combinations out of 8 β and 18 α subunits (Hynes, 2002). They are expressed 
in nearly every cell type in the body and a subset is expressed in the brain. In 
particular α3, α5, α8, αV, β1 and β3 subunits are enriched in neurons (Bernard-
Trifilo et al., 2005), whereas glia cells were shown to express α1, α2, α3, α6, αV 
and β1(Previtali et al., 1997). Both subunits span the plasma membrane and in 
general have short cytoplasmic but large extracellular domains, which recognize 
short peptides that contain a key constituent acidic amino acid. The ligand 
specificity is due to both subunits of the integrin heterodimer (Hynes, 2002). 
Integrin function is regulated by both intracellular (inside-out) and extracellular 
(outside-in) signals. The ‘inside-out’ signaling describes the change from a low 
ligand-binding affinity conformation (inactive) to a high affinity one (active) and 
is also termed ‘integrin activation’. The ‘outside-in’ signaling depicts intracellular 
activation of signaling cascades upon integrin-ligand binding (Takagi et al., 2002, 
Mould and Humphries, 2004).  
Many extracellular ligands like fibronectin, tenascins and thrombospondins 
contain an Arg-Gly-Asp (RGD) binding motif, originally identified as the 
sequence in fibronectin that binds to the α5β1-integrin (Pierschbacher and 
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Ruoslahti, 1984). Synthetic RGD peptides are common tools to experimentally 
affect integrins.  
With their short intracellular tail integrins are coupled to a multitude of signaling 
proteins like a variety of kinases i.e. Arg kinase, CaMKII, src family kinases (SFK) 
and focal adhesion kinase (FAK) (Yamaguchi, 2000, Bernard-Trifilo et al., 2005, 
Kwok et al., 2010). This broad spectrum of signaling cascades enables integrins to 
influence a wide range of cellular processes.  
1.3.2 Integrins in synaptic plasticity 
In my thesis I investigated putative plasticity changes after ECM removal the 
implementation of integrins in synaptic plasticity is of special interest. Several 
studies have shown that the blockage of integrins leads to impairments in LTP 
(Peng 1991; Staubli 1990). Theta burst stimulation in hippocampal slices regulates 
the activity pattern of β1-integrins by increasing their trafficking to the plasma 
membrane (Kaech and Banker, 2006). Further, genetic disruption of β1-integrins 
in mature excitatory neurons impairs LTP (Chan et al., 2006). To clarify the role of 
integrins in plasticity processes, many studies address the influence of integrins 
on NMDA receptors due to their potential to elicit LTP. Activation of β1-integrins 
affects the phosphorylation state of GluN2A and GluN2B subunits via increased 
SFK activity (Bernard-Trifilo et al., 2005). In line with that the application of the 
SFK inhibitor PP2 eliminated an RGD induced increase of NMDA receptor 
mediated currents (Lin et al., 2003).  
β3-integrins seem to be more important for the regulation of homeostatic 
plasticity, since this form of plasticity is abolished in β3 knockout mice, whereas 
LTP or LTD are still inducible in those mice (Ueda et al., 1994). Moreover surface 
levels of β3-integrins are increased after blockage of neuronal network activity 
and β3-integrins regulate GluA2-AMPA receptor trafficking, which is a key 
mechanism for synaptic scaling (Hedstrom et al., 2007, Bikkavilli and Malbon, 
2009). Collectively these data prove that integrins are involved in the regulation 
of synaptic plasticity.  
1.3.3 Regulation of integrins by ECM molecules 
How would ECM remodeling affect integrin signaling? The CSPGs aggrecan and 
versican interact with β1-integrins and either decrease or increase Y397 
phosphorylation of FAK, respectively (Wu et al., 2002, Tan et al., 2011). 
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Phosphorylation of FAK activates its kinase activity and subsequently further 
signaling cascades. As aggrecan and versican differ in their temporal and spatial 
expression (Yamaguchi, 2000, Popp et al., 2003) the opposed influence on β1-
integrins could be important in certain brain areas or developmental stages. 
Modulation of the ECM via proteases is also known to affect integrin signaling. 
MMPs cleave many ECM proteins which include integrin-ligands, such as 
laminin, N-cadherin, dystroglycans and proteoglycans (Lander et al., 1997). The 
application of purified MMP-9 leads to spine enlargement and increases 
postsynaptic currents, and both effects were dependent on β1-integrin 
functionality (Wang et al., 2008). Further MMP-9 affects lateral mobility of 
NMDA but not AMPA receptors in a β1-integrin-dependent manner (Michaluk et 
al., 2009). Degradation of the ECM in hippocampal slices by application of 
ChABC enhances β1-integrin activation as well as pY397 FAK level, which leads 
to increased spine motility and the appearance of spine head protrusions 
(Orlando et al., 2012). In line with that, the inhibitory effect of aggrecan on 
laminin-mediated axon growth by impairing integrin signaling could be 
removed by application of ChABC (Tan et al., 2011). This underlines an 
inhibitory effect of chondroitin sulfates on integrin signaling.  
Altogether, based on all these observations it is tempting to hypothesize that the 
ECM may regulate NMDA receptors in an integrin-dependent manner. This 
mechanism is a good candidate to transform the information about 
rearrangements of the ECM into intracellular, plasticity related signaling 
pathways.  
1.4 Calsyntenin 
Calsyntenin-1 (Cst-1) is the first identified member of a small protein family 
consisting of three members: Cst-1, -2, -3 (Vogt et al., 2001, Hintsch et al., 2002, 
Araki et al., 2003). They belong to the cadherin superfamily and are the only 
members showing sequence homology along the entire protein sequence in 
vertebrates and invertebrates. This indicates that the function of Cst is likely to be 
conserved throughout evolution. The protein was initially named calsyntenin 
due to its potential to bind synaptic Ca2+ (Vogt et al., 2001). Araki and colleagues 
termed this protein family alcadeins (Alzheimer-related cadherin-like protein) as 
they demonstrated a stabilizing function of alcadein for the amyloid precursor 
protein (APP) (Araki et al., 2003). In this thesis the term calsyntenin will be used.  
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1.4.1 Expression and structure of calsyntenin 
The Csts are expressed in the whole brain as components of the postsynaptic 
membranes, predominantly in excitatory synapses (Vogt et al., 2001, Hintsch et 
al., 2002). But each of the three family members displays a distinct neuronal 
mRNA expression pattern, which was described in detail by Hintsch et al. Cst-1 
is expressed in the majority of neurons with small variations in its expression 
level. In contrast to Cst-1, the expression of Cst-2 and Cst-3 is not uniform in 
neurons of the same neuronal subtypes. Pyramidal neurons of the CA2 and CA3 
region of the hippocampus for example express high amounts of all three Csts 
whereas pyramidal neurons of the CA1 show a high level of Cst-1, but low levels 
of Cst-2 and Cst-3. Highest expression of Cst-2 and Cst-3 but a low level of Cst-1 
is found in putative GABAergic neurons. Part of the cerebellar Purkinje cells 
express Cst-2 and Cst-3, but no Cst-1 (Hintsch et al., 2002). In summary, defined 
subpopulations of both excitatory and inhibitory neurons express different 
combinations of the three Csts. 
Csts are type-1 transmembrane proteins with a large extracellular N-terminal 
part, a transmembrane segment and a short cytoplasmic C-terminal tail (Figure 
1). The extracellular part contains two cadherin-like (CAD) repeats and a 
laminin-G domain (LamG). The intracellular part shows a conserved acidic 
region and kinesin light chain-binding motifs (Konecna et al., 2006). This part 
shows the largest sequence deviations between Cst-1, -2 and -3. The total number 
of acidic residues and the size of acidic clusters is the highest in Cst-1. Cst-2 is 
also rich in acidic residues however clusters are less abundant and smaller in 
comparison with Cst-1. The cytoplasmic segment of Cst-3 is markedly shorter, as 
it contains only one kinesin light chain-binding motif whereas Cst-1 and Cst-2 
contain two of those motifs (Hintsch et al., 2002). In contrast the proximal part of 
the intracellular tail is highly conserved even through different species. This part 
contains binding sites for interaction partners, which will be described later.  
1.4.2 Proteolytic cleavage of calsyntenin 
Csts undergo proteolytic cleavage at the cell membrane. Primary cleavage by α-
secretases (ADAM-10 and ADAM-17) takes place in the extracellular, 
juxtamembrane region. This cleavage releases the ectodomain (sCst) into the 
extracellular space. The release of an extracellular segment of a transmembrane 
protein is called ‘shedding’. Therefore enzymes acting in this way are termed 
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sheddases. α-secretase action triggers subsequent secondary cleavage in the 
transmembrane segment by a presenilin-dependent γ-secretase. A small peptide 
(p3-Cst) is released into the extracellular space (Araki et al., 2004, Hata et al., 
2009). The transmembrane stump is internalized. Initially it was postulated that it 
accumulates in the spine apparatus (Vogt et al., 2001). In 2004 Araki et al. 
demonstrated that this cytoplasmic fragment of Cst-1 binds to the adapter 
protein FE65 and translocates into the nucleus. This interaction was shown to 
suppress FE65 dependent gene transactivation induced by AICD, the cytoplasmic 
fragment of APP which is also produced by γ-secretase cleavage. The 
cytoplasmic fragment of Cst-1 alone with FE65 does not affect gene 
transactivation (Araki et al., 2004).  
Cst-1 has been proposed to compete as a substrate for cleavage with APP, which 
is a well-known substrate of α- and γ-secretase. Both Cst-1 and APP bind with 
Figure 2: Schematic illustration of Cst-1 and its proteolytic cleavage  
Csts undergo proteolytic cleavage by α- and γ-secretases, known from APP processing. The α-secretase 
cuts Cst within an extracellular, juxtamembrane region and releases the protein fragment sCst 
(corresponding to the soluble APP ectodomain sAPP) or ectodomain. This fragment was mainly 
investigated in this work. Subsequently the γ-secretase cleaves the protein within the transmembrane 
region and releases the small peptide p3-Cst (corresponding to the APP fragment, p3) into the 
extracellular milieu. The transmembrane stump is internalized and translocated to the nucleus by building 
a complex with FE65. 
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their intracellular segment to the same domain of X11-like Protein (X11L) (Araki 
et al., 2003). X11L is a neuron-specific adapter protein. Formation of this tripartite 
complex results in stabilization of APP’s metabolism and enhances the X11L 
dependent suppression of Aβ production (Araki et al., 2003). This complex does 
not only protect APP but also Cst-1 from γ-secretase cleavage (Araki et al., 2004). 
This suggests, that APP processing and the formation of its potentially pathologic 
cleavage product Aβ are in close relation with Cst-1 processing. Deregulation of 
one of the proteins thus inevitably affects the processing and subsequently the 
signaling of the other protein (Araki et al., 2003, Araki et al., 2004).  
1.4.3 Calsyntenin as an intracellular transport protein 
As mentioned previously Cst-1 contains two kinesin light chain 1 (KLC1) binding 
motives (KBS) in the intracellular segment. Cst-1 binds with these two conserved 
motives, KBS-1 and -2, the tetratricopeptide repeats (TPR) of KLC1, which are 
known to be responsible for the interaction with cargo proteins (Verhey et al., 
1998, Konecna et al., 2006, Araki et al., 2007). Kinesins are responsible for the fast 
anterograde axonal transport along microtubules. That awards Cst-1 a function 
in kinesin-dependent axonal vesicle transport as a cargo receptor protein. Hence 
it is plausible to assume that Cst-1 could have an impact on other proteins by 
influencing their transport dynamics. For instance the axonal transport of APP is 
influenced by Cst-1 as it mediates the trans-Golgi exit of APP in a kinesin 
dependent manner (Ludwig et al., 2009). By regulating the axonal transport of 
APP the production of Aβ is controlled as well (Araki et al., 2007, Steuble et al., 
2012, Vagnoni et al., 2012). Cst-1 is present in the trans-Golgi network and Cst-1 
positive vesicles are always found on plus end-directed trajectories, characteristic 
for vesicles that carry cargo intended for distal neuronal functions (Ludwig et al., 
2009). Another cargo that is dependent on Cst-1 is the NMDA receptor. In 
juvenile Cst-1 KO mice the postsynaptic level of GluN2B-NMDA receptors is 
increased which leads to an increased GluN2B-NMDA receptor dependent LTP 
(Ster et al., 2014). Adult Cst1-KO mice do not show altered synaptic transmission 
or plasticity anymore. That implies that the developmental switch of 
predominantly GluN2B- to GluN2A-NMDA receptors is delayed in the mutant 
mice. It was demonstrated that Cst-1 vesicles are loaded with both GluN2A and 
GluN2B subunits and delivered to the trans-Golgi network without any 
preference. As the expression of Cst-1 peaks at postnatal day 7 (Konecna et al., 
2006) they propose that Cst-1 drives the rapid implementation of the switch from 
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GluN2B to GluN2A subunits at synaptic level (Ster et al., 2014). When Cst-1 is 
absent the NMDA receptors still reach their destination in the postsynaptic 
membrane, even though delayed.  
1.4.4 Cellular functions of the ectodomain of calsyntenin 
Two human studies about hippocampus-dependent memory resulted in the 
identification of CLSTN2 (encoding Cst-2) as a memory related human gene 
(Papassotiropoulos et al., 2006, Jacobsen et al., 2009, Preuschhof et al., 2010). 
Carrier of a single nucleotide polymorphism (T→C) within CLSTN2 show better 
episodic memory performance than TT genotype carriers. Preuschof et al. could 
show that this positive effect of C allele carrier is not found in subjects being 
carrier of a C allele in the KIBRA gen, encoding a scaffolding protein. Further it 
has been shown that the Cst-1 orthologous CASY-1 is crucial for associative 
learning in Caenorhabditis elegans (C. elegans) (Ikeda et al., 2008, Hoerndli et al., 
2009). Phenotypes of casy-1 mutants are rescued by overexpressing the 
extracellular part, corresponding to the α-secretase cleavage product of CASY-1, 
suggesting a specific signaling function of this ectodomain. Additionally 
Hoerndli et.al showed that C. elegans lacking the AMPA-type glutamate receptor 
subunit GLR-1 (glr-1 mutants) exhibit similar defects as the casy-1 mutant. 
However, double loss-of-function mutants (casy-1 + glr-1 mutant) show no 
further reduction in learning performance. Further, increased levels of GLR-1 
could rescue the phenotype of casy-1 mutants. Thus CASY-1 very likely acts in a 
GLR-1 receptor-dependent pathway (Hoerndli et al., 2009). However, the cellular 
signaling mechanism and the receptor for the ectodomain of Cst-1 are unknown 
so far. 
Interesting in this context are preliminary data from a proteomic screen to 
identify extracellular ligands of Cst-1 performed by Kerstin Leuthäuser in Peter 
Sonderegger’s laboratory. Vitreous fluid from E14 chicken embryos was loaded 
on CNBr activated sepharose columns, which were coupled to his-tagged Cst-1 
fusion proteins. Data from this assay suggested Cst-1 to bind secreted frizzled 
related protein 1 (sFRP-1). This interaction occurs at the cysteine-rich domain 
(CRD) of sFRP-1, a domain that is highly conserved in the frizzled receptor, 
which is part of the wnt signaling pathway and contributes to a multitude of 
cellular processes. sFRP-1 is known to bind to wnt and/or frizzled and thereby 
antagonizes wnt signaling (Wang et al., 1997, Bafico et al., 1999). Importantly, it 
has been shown that the wnt pathway in C. elegans affects the abundance of GLR-
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1 receptors (Dreier et al., 2005). Taken together, this interaction may offer an 
explanation for the CASY-1 mutant phenotype in C  elegans. Based on these data 
the interaction of Cst-1 and sFRP-1 and the influence of Cst-1 on wnt signaling 
were investigated. 
1.5 Wnt signaling 
The wnt signaling pathways are highly conserved among species. They are 
essential and well characterized in developmental processes, including synaptic 
differentiation. In addition wnt signaling also plays part in synaptic maintenance 
and function, like modulation of synaptic vesicle cycle and trafficking of 
neurotransmitter receptors (Inestrosa and Arenas, 2010).  
The protein wnt was first discovered in Drosophila (Sharma and Chopra, 1976). 
Mutation caused loss of wings and halters which leads to the gene name wingless. 
Mutation of the gene in mice caused malignant transformation of mammary 
tissues which provided the name int. As wingless and int are homologs the name 
wnt was established as a combination of both names.  
Wnt signaling is divided into two major parts: canonical and non-canonical wnt 
signaling. The canonical wnt signaling has been extensively studied. The main 
regulator in this pathway is the transcriptional co-activator β-catenin (section 
1.5.1). Non-canonical wnt signaling pathways are highly diverse but they have in 
common to be β-catenin independent. An overview is provided in the work of 
Semenov (Semenov et al., 2007). There are at least two major non-canonical 
pathways: the planar cell polarity (PCP) pathway and the Ca2+ pathway. In the 
Wnt/PCP pathway activation of frizzled (Frzl) receptor leads to activation of the 
GTPases Rho and Rac which in turn stimulate ROCK and c-Jun N-terminal 
kinase (JNK), respectively. Therefore the Wnt/PCP pathway is also called 
Wnt/JNK pathway. The Wnt/Ca2+ signaling pathway is initiated by activation of 
phospholipase C (PLC) which produces inositol 1,4,5-triphosphate (IP3) and 1,2 
diacylglycerol (DAG). These products lead to an increase in cytosolic Ca2+ level, 
which subsequently activates several pathways, for example CaMKII that affects 
via phosphorylation of the cAMP response element-binding protein (CREB) 
transcription of wnt target genes (De, 2011). Non-canonical pathways will not be 
detailed here, as they are not investigated in this work. 
There are 19 Wnt genes and 12 Frzl receptors in vertebrates. It is hard to classify 
wnt ligands as ‘canonical’ or ‘non-canonical’. From a classical point of view wnt-
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1, wnt-3a, wnt-8 and wnt-8b act in the canonical and wnt-4 and wnt-5a play the 
major part in non-canonical wnt signaling (De, 2011). But this classification is 
highly controversial and further depends on the specific combination of a certain 
wnt ligand binding to a certain Frzl receptor.  
1.5.1 Canonical wnt signaling 
The wnt ligand is a secreted, lipid-modified glycoprotein (Kurayoshi et al., 2007) 
that binds to its cell surface receptor Frzl, which is a seven-transmembrane 
spanning G-protein coupled receptor (Schulte and Bryja, 2007). The extracellular 
N-terminus of Frzl contains a Cysteine-rich domain (CRD), which forms the wnt 
ligand binding motif. Stimulation of Frzl and its co-receptor, the low-density 
lipoprotein receptor related protein (LRP), activates the intracellular signaling 
machinery including the activation of disheveled protein (DVL). This results in 
the deactivation of a so-called destruction complex, which contains proteins like 
glycogen synthase kinase-3β (GSK-3β) and adenomatous polyposis coli (APC). 
Normally the destruction complex keeps cytosolic β-catenin phosphorylated, 
which tags β-catenin for proteasomal degradation. Non-phosphorylated β-
catenin accumulates in the cytosol and translocates into the nucleus. There it 
associates with the T-cell factor/lymphoid enhancer factor-1 (Tcf/Lef) family of 
transcription factors and initiates transcription of target genes (Oliva et al., 2013).  
1.5.2 Function of sFRPs 
There are several secreted antagonists of wnt signaling. Dickkopf-related 
protein 1 (Dkk-1) blocks the interaction of wnt with Frzl and LRPs (Mao et al., 
2001), the wnt inhibitory factor (WIF), sclerostin, cerebus, Wise/SOST and others 
(Cruciat and Niehrs, 2013). The most prominent antagonist of wnt signaling is the 
family of sFRPs (Finch et al., 1997, Rattner et al., 1997). The sFRP family consists 
of five members, sFRP-1-5. They all contain two major domains: the netrin-
related domain (NTR) and CRD. The C-terminal NTR domain is defined by 
segments of positively charged residues and by six cysteine residues (Uren et al., 
2000, Chong et al., 2002). The CRD contains 10 conserved cysteine residues which 
build disulfide bridges (Rehn et al., 1998, Chong et al., 2002). The CRDs of sFRPs 
display 30 – 50% sequence similarity with the CRDs of Frzl (Rehn et al., 1998). It 
is proposed that sFRPs inhibit wnt signaling by binding wnt ligands that 
prevents their binding to Frzl. It was demonstrated that the CRD domain of 
sFRP-1 is necessary and sufficient to bind wnt and to inhibit wnt signaling (Lin et 
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al., 1997). More recent studies open a new discussion as for instance a CRD-
lacking mutant of sFRP-1 still binds to wingless (Uren et al., 2000). In addition, 
optimal wnt inhibition is only achieved by both protein domains, CRD and NTR 
(Bhat et al., 2007). These contradictions imply that sFRPs have multiple wnt 
binding sites which could explain observed different affinities of certain sFRPs 
for different wnt ligands. Additionally the CRD shows the ability to dimerize 
(Dann et al., 2001) and to build homo- and heteromeric complexes of sFRPs and 
Frzl (Bafico et al., 1999, Rodriguez et al., 2005). 
As the CRD domain of sFRPs and Frzl is highly homolog, it is nearby to 
investigate if Cst-1, as it binds to the CRD of sFRP-1, binds to the CRD of Frzl.  
1.5.3 Wnt signaling at the mature neuronal synapse 
It was shown that wnt-4, -5a, -7a and -11 are present in hippocampal neurons of 
rat embryo and adult rat (Cerpa et al., 2008). Several studies demonstrate an 
influence of wnt signaling on the functionality of mature synapses (Ahmad-
Annuar et al., 2006, Cerpa et al., 2008, Farias et al., 2009, Cerpa et al., 2010).  
At presynaptic sites it was shown that wnt-7a fast and robustly stimulates the 
recycling of presynaptic vesicles, whereas wnt-3a shows only moderate effect. 
Wnt-1 and wnt-5a do not affect vesicle recycling (Cerpa et al., 2008). Application 
of wnt-7a further increases synaptic vesicle exocytosis at least temporally. Finally 
the number and size of synaptic vesicle recycling sites is increased by wnt-7a 
treatment, without affecting the protein level (Cerpa et al., 2008). In line with this 
a double-mutant mice lacking wnt-7a and Dvl exhibit decreased frequency in the 
release of neurotransmitter and altered synaptic protein localization (Ahmad-
Annuar et al., 2006). These data suggest that the presynaptic function of wnt-7a is 
driven by β-catenin-dependent signaling but without demanding gene 
transcription. Supporting evidence comes from studies showing that wnt-7a 
regulates trafficking of α7-nicotinic acetylcholine receptors (α7-nAChR) to the 
plasma membrane (Farias et al., 2007). Activation of α7-nAChR increases 
neurotransmitter release in hippocampal cells (Gray et al., 1996). The regulation 
of α7-nAChR by wnt-7a involves APC, which is highly expressed in hippocampal 
neurons (Brakeman et al., 1999) and builds a cytoplasmic complex with β-catenin 
(Rubinfeld et al., 1993). Wnt-7a induces the dissociation of β-catenin from APC, 
promoting the interaction of APC with α7-nAChR to induce its trafficking to the 
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plasma membrane (Farias et al., 2007). This represents an example of a β-catenin-
dependent signaling without affecting gene transcription.  
At postsynaptic sites it was shown that application of wnt-5a to rat hippocampal 
slices increases the amplitude of field EPSPs by modulation of NMDA- and 
AMPA receptor mediated currents (Cerpa et al., 2010). In line with this wnt-5a 
leads to rapid insertion of NMDA receptors into the postsynaptic membrane and 
increases the number of PSD-95 clusters (Farias et al., 2009, Cerpa et al., 2010). 
These effects are mediated via CaMKII and JNK phosphorylation indicating that 
wnt-5a acts via non-canonical signaling in the postsynapse.  
Since Cst-1 was shown to bind to sFRP-1, it is tempting to speculate that Cst-1 
may also influence synaptic properties via wnt signaling, which is addressed in 
the course of my PhD thesis.  
1.6 Aims 
There are two major parts in this thesis: 
 
I. The effect of the ECM on the expression and dynamics of GluN2B-NMDA 
receptors  
II. Cellular effects of Calsyntenin-1’s ectodomain 
 
Part I 
The ECM plays an important role in the development of the brain and in the 
regulation of synaptic function. It has been shown that removal of the ECM in the 
visual vortex after the critical period rejuvenates ocular dominance plasticity, but 
the underlying molecular mechanisms are not clear. It is known is that the 
GluN2A/GluN2B ratio of NMDA receptors at the synapse is crucial for the 
threshold to induce synaptic plasticity. This ratio is decreasing during the critical 
period. If removal of the ECM brings plasticity back into a juvenile stage, does it 
also rejuvenate the GluN2A/GluN2B ratio? Does the ECM removal increase the 
abundance of GluN2B-NMDA receptors that probably lead to increased 
plasticity? If so, what is the signaling mechanism that transfers the information of 
the ECM removal into the cell and changes the expression profile of NMDA 
receptors? The aims of this part are summarized here: 
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- Does the digestion of ECM alter NMDA receptor-driven synaptic 
currents? 
- Does the digestion of ECM influence expression levels of GluN2B-NMDA 
receptors? 
- Does the digestion of ECM alter surface abundance of GluN2B-NMDA 
receptors? Is the signaling mechanism integrin dependent? 
- Does the digestion of ECM change GluN2B phosphorylation? 
- Does the digestion of ECM change mobility of GluN2B-NMDA receptors? 
 
Part II 
The activity of extracellular proteases is known to yield new signaling molecules 
to affect synaptic transmission. The effect of ectodomain shedding of the 
cadherin superfamily member Cst is poorly described. Published data 
demonstrate a rescuing effect of this ectodomain in C. elegans Cst-1 mutants that 
show an impaired associative learning. But the involved signaling mechanisms 
are still not known. Unpublished data suggested that Cst-1 binds sFRP1, a 
protein related to wnt signaling. This binding needs the CRD of sFRP-1, which is 
homologous to the CRD of Frzl. These observations lead to the hypothesis that 
Cst-1 could also bind to Frzl, which would provide a possible receptor for the 
ectodomain of Cst-1. Further it was questioned if Cst-1 influences wnt signaling-
dependent gene transcription as it could affect the activity of the pathway by 
interacting with sFRP-1. Further, wnt signaling was shown to influence 
presynaptic activity which led to the investigation of the effect of Cst-1 on 
presynaptic activity. The aims of this part are summarized here: 
 
- Does Cst-1act on canonical wnt signaling activity? 
- Does Cst-1 bind Frzl? 
- Does Cst-1 influence presynaptic activity? 
 
Material and Methods     36 
2 Material and Methods 
Chemicals were purchased from Roth or the companies indicated. The quality of 
the reagents was of analytical grade. 
2.1 Neuronal cell cultures 
Rat hippocampal and cortical cultures were prepared by Heidi Wickborn, Anika 
Lenuweit, Bettina Kracht, Anita Heine and Kathrin Hartung. All media and 
solutions were warmed (37°C) before use. Dissociated hippocampal cultures 
were prepared as Banker type cultures as described from Kaech & Banker (Kaech 
and Banker, 2006).  
Table 1: Media and reagents for neuronal cell cultures 
Media and reagents  Ingredients/Company 
DMEM full 10 % FCS (Gibco);1 % Penicillin/Streptomycin 100× (Gibco); 2 mM L-Glutamine 100× (Gibco) in DMEM (Gibco) 
NB+ (Neurobasal)  
 
2 % B27 (Gibco); 2 mM L-glutamine (Gibco); 1 % 
Penicillin/Streptomycin 100× (Gibco) in Neurobasal (Gibco) 
Distilled Water   Gibco /Millipore 
HBSS+ (with Mg2+ and Ca2+) Gibco 
HBSS- Gibco 
AraC 1.5 mM   Calbiochem 
10× Trypsin   Gibco 
10× Trypsin + EDTA 0.5 % Gibco 
Paraffin   Paraplast embedding medium (Fischer) 
Freezing medium DMEM full, 10 % DMSO 
Poly-L-Lysin 100 mg/l poly-L-lysin in 100 mM boric acid, pH 8,5, sterile filtered 
Poly-D-Lysin 100 mg/l poly-D-lysin in 100 mM boric acid, pH 8,5, sterile filtered 
2.1.1 Glia cells 
Preparation: P0-P2 pups from Wistar rats were decapitated and both 
hemispheres were isolated and freed by the meninges in ice cold HBSS+. After 
three washing steps with ice cold HBSS- 10x trypsin was added and incubated 
for 20 min at 37 °C. The hemispheres were washed three times with HBSS- and 
dissociated in 1ml DMEM full by using 1 ml pipette. Cells were plated in 10 ml 
DMEM full in 75 cm2 flasks and kept in the incubator at 37 °C, 5 % CO2 and a 
humidity of 95 %. The media was changed the following day and then every 4-5 
days. After 10-14 days cells were confluent and split in a 1:4 ratio. After being 
confluent again cells were frozen. 
Freezing: The flasks were washed with HBSS-, 10x Trypsin + EDTA was added 
and incubated at 37 °C until all cells were detached. Cells were re-suspended in 
DMEM full and centrifuged for 5 min at 1000 x g followed by re-suspension in 
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1 ml freezing media. The aliquots were slowly frozen in “isopropanol containing 
boxes” at -80 °C and on the following day the frozen aliquots were transferred to 
-150 °C and stored until usage. 
Plating: Frozen aliquots were quickly thawed at 37 °C. Two aliquots were diluted 
in 48 ml DMEM full and plated into 10 Ø 6 cm plates with a final volume of 5 ml 
each.  
2.1.2 Preparation of glass coverslips 
18 mm glass coverslips for dissociated hippocampal cultures were incubated in 
69 % HNO3 in an end-over-end rotator overnight. The next day coverslips were 
neutralized by rinsing with ultra-pure water. Afterwards, coverslips were boiled 
three times in the microwave oven with exchanging water in between. 
Thereupon, coverslips were dried separately on a paper tissue and subsequently 
sterilized at 225 °C for 16 h. Paraffin puncta were applied and coverslips were 
coated with Poly-L-Lysin overnight at 37 °C and then washed three times with 
ultra-pure water. Finally, coverslips were stored for 3-4 days until the day of 
preparation. 
Coverslips used for dissociated cortical cultures were only sterilized without any 
previous washing procedure, coated with Poly-D-Lysin, washed with ultra-pure 
water und stored in HBSS- until day of preparation. 
2.1.3 Preparation of neuronal cultures 
E18-19 embryos of Wistar rats were decapitated and both hemispheres were 
isolated and freed by the meninges in ice cold HBSS+. The hippocampi were 
isolated from the cortex and both cortices and hippocampi were treated in the 
same way from now on. After three washing steps with HBSS- 10x trypsin was 
added and incubated for 20 min at 37 °C. Tissues were washed again with HBSS- 
and dissociated with two syringes of different diameter (first 0.9 mm, then 0.45 
mm). Using a cell mesh cells were further dissociated and diluted with DMEM 
full to different plating concentrations. Dissociated cortical cultures were plated 
in 24 or 6 well plates with a density of 50.000 or 500.000 cells per well, 
respectively. On the following day DMEM full was replaced by NB+. Dissociated 
hippocampal cultures were plated with a density of 30.000 cells per coverslip. 
After 1 h coverslips were placed into prepared Ø 6 cm plates containing the glia 
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feeding layer, cells facing down. At DIV 4 AraC was added to the hippocampal 
cultures. Cells were fed once a week. 
2.2 Stable HEK293-T cell line cultures 
Table 2: Media and reagents for stable HEK293-T cell line cultures 
Media and reagents  Ingredients/Company 
DMEM full 10 % FCS (Gibco);1 % Penicillin/Streptomycin 100× (Gibco); 2 mM L-Glutamine 100× (Gibco) in DMEM (Gibco) 
HBSS- Hank’s balanced salt solution, Ca2+ and Mg2+ free (Invitrogen)  
10× Trypsin + EDTA  Gibco 
1× Trypsin   10 % 10× Trypsin + EDTA (Gibco) in HBSS-  
Poly-D-Lysin 100 mg/l poly-D-lysin in 100 mM boric acid, pH 8,5, sterile filtered  
Human Embryonic Kidney Cells (HEK293-T) (ATCC) were mainly cultured by 
Kathrin Gruss and cultured in DMEM full. Cells were split twice a week until 
they reached passage P30 – P40. If cells were plated on glass coverslips those 
were treated with Poly-D-Lysin for 1 h and washed three times with ultra-pure 
water.  
2.3 Molecular Biology 
2.3.1 DNA constructs (commercially available) 
- pCI-SEP_Glu2B (Plasmid #23998) purchased from addgene. Depositing 
Laboratory: Robert Malinow (Kopec et al., 2006) 
- rat Frizzled-1-HA-pCD (Plasmid #16818) purchased from addgene. 
Depositing Laboratory: Randall Moon (Xenopus Expression Plasmids, 
unpublished) 
- Super 8x TOPFlash (Plasmid #12456) purchased from addgene. Depositing 
Laboratory: Randall Moon (Veeman et al., 2003) 
- Super 8x FOPFlash (Plasmid #12457) purchased from addgene. Depositing 
Laboratory: Randall Moon (Veeman et al., 2003) 
- 7-TGC (Plasmid #24304) purchased from addgene. Depositing Laboratory: 
Roel Nusse (Fuerer and Nusse, 2010) 
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2.3.2 DNA constructs (custom-made) 
Table 3: DNA constructs (custom made) 
Construct  Vector backbone Insert Source 
Cst1Clea-myc pcDNA3.1. (A+) Cst1 aa 1 - 822 (mouse) self-made 
Cst1Cad-myc pcDNA3.1. (A+) Cst1 aa 1 – 263 (mouse) self-made 
Cst1LamG-
myc pcDNA3.1. (A+) 
Cst1 aa 1 – 28 + 362 - 508 
(mouse) self-made 
Cst3Clea-myc pcDNA3.1. (A+) Cst1 aa 1 - 811 (mouse) self-made 
Wnt8a-myc pcDNA3.1. (A+) Wnt8a aa 1 – 68 (mouse) self-made 
GluN1-wt pRcCMV GluN1 (rat) gift from Dr. Paoletti (Bordeaux) 
Neurofascin 
186  Neurofascin 186 
gift from Dr. Dirk Montag 
(Magdeburg) 
Cst1 pcDNA3.1. (A+) Cst1 (mouse) Prof. Sonderegger (Zurich) 
Cst3 pcDNA3.1. (A+) Cst3 (mouse) Prof. Sonderegger (Zurich) 
2.3.3 Transfection of dissociated hippocampal neurons 
For Quantum Dot experiments dissociated hippocampal neurons grown on Ø 18 
mm coverslips were transfected by using Effectene Transfection Reagent 
(QIAGEN) following the protocol offered by the company. Cells were transfected 
at DIV 5 with two DNA constructs: pCI-SEP_GluN2B and GluN1-wt (0.75 µg 
each). DNA was diluted with Buffer EC and Enhancer solution was added and 
mixed. After incubation of 5 min at RT Effectene reagent was added and mixed. 
10 min of incubation at RT were followed by diluting the mix 1:1 with cell media. 
Coverslips were placed in a separate petri dish filled with NB+ with cells facing 
up. Transfection mix was distributed over each coverslips and incubated for 1 h 
at 37 °C. Afterwards cells were placed back into the former petri dish containing 
the glia feeding layer. 
2.3.4 Transfection of HEK293-T cells 
Table 4: Buffer for transfection of HEK293-T cells 
Buffer Composition 
Solution A 500 mM CaCl2 
Solution B 140 mM NaCl, 50 mM HEPES, 1.5 mM Na2PO4, pH 7.05 
Table 5: Quantities of buffers and DNA for transfection of HEK293-T cells 
plate / flask V of media (ml) DNA (µg) Sol A / Sol B (µl) 
24 well plate 0.5 1 25 
12 well plate 1 2 50 
25 cm2 flask 5 8 175 
75 cm2 flask 10 25 500 
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150 cm2 flask 30 75 1500 
HEK293-T cells were transfected with a CaPO4 method. Confluent cells were 
split the day before transfection in a 1:5 ratio. DNA was diluted in a certain 
amount (Table 5) in Solution A. Solution B was added and incubated for 1 min at 
RT. The mix was added to the cells and 4 – 10 h later the cell media was 
exchanged. In general cells were used for experiments after 48 h. 
2.3.5 PCR to amplify defined DNA fragments 
Table 6: Primer sequences for Cst constructs 
Construct Primer forward Primer reverse 
Cst1Clea-
myc 
Cst1full-fw 
5’ TTAAGCTTATGCTGCGCCGCC 3’ 
Cst1clea-rev 
5‘AAGAATTCGGCATGTTCCACGGGGTTGG 3‘ 
Cst1Cad-
myc 
Cst1Cad-fw 
5’AAGGATCCATGCTGCGCCGCCCT 3‘ 
Cst1Cad-rev 
5‘TTGAATTCGGGGCTGCAGGTGGGCTTGA 3‘ 
Cst1LamG-
myc 
Cst1LamG-fw 
5’AAGTTAACCATGACAGTGACCAGGTCTTT 3’ 
Cst1LamG-rev 
5‘TTGAATTCATACTCTTGCCAGCAAGCTC 3‘ 
Cst3Clea-
myc 
Cst3Cleafw_ms 
5’AAAAGCTTATGACCCTCCTGCTGGT 3‘ 
Cst3Clearev_ms 
5‘AACTCGAGACTGGGATGGGCCACC 3‘ 
Table 7: PCR protocol / Cycles 
Process Temperature and Time Cycles 
Initial denaturation 95 °C, 3 min 1 
Denaturation 95 °C, 20 sec 
30 - 40 Annealing 57 °C, 20 sec 
Extension 72 °C, 60 - 90 sec 
Final extension 72 °C, 5 min 1 
Table 8: Buffers for PCR 
To investigate cellular functions of the ectodomain of Cst three DNA constructs 
were produced: Cst1Clea-myc/his (Cst1Clea) or Cst3Clea-myc/his (Cst3Clea), 
containing both cadherin and LamG domains; Cst1Cad-myc/his (Cst1Cad), 
containing only two cadherin domains and Cst1LamG-myc/his (Cst1LamG), 
containing only the LamG domain. All constructs were tagged with an N-
terminal myc/his tag. Table 6 depicts the primers that were used for each 
Buffer / Item Composition / Company 
Taq Polymerase QIAGEN 
5x Phusion GC Buffer QIAGEN 
MgCl2 25 mM QIAGEN 
Q-Solution QIAGEN 
Deoxynucleotide Triphosphate Set (dNTPs) Fermentas 
DMSO QIAGEN 
Smart Ladder DNA Marker 200 – 10 kb Eurogentec 
GeneRulerTM 1 kb Plus DANN Ladder Life Technologies 
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construct. The template DNA was either Cst1 or Cst3 provided by Prof. 
Sonderegger (Table 3). 
When cDNA constructs were generated by PCR, specific primers were re-
suspended at a concentration of 100 pmol/µl and used in the amplification 
reaction at a final concentration of 10 pmol/µl. The final concentration of the PCR 
reagents were: template DNA 20 ng / 50 µl, 0.2 mM dNTPs, 0.02 units/µl of 
Phusion DNA Polymerase, 3 % DMSO in Phusion GC Buffer (5 x). The 
temperature profile used for PCR is highlighted in Table 7. 
2.3.6 DNA agarose gel electrophoresis 
Table 9: Buffers for DNA gel electrophoresis 
DNA fragments, e.g. PCR products were separated by one dimensional agarose 
gel electrophoresis according to their size. Agarose gels were prepared as 1 – 2 % 
w / v dependent on the fragment size. Agarose was melted in 1x TAE buffer by 
heating in a microwave. 5 – 10 µl ethidium bromide solution were added before 
polymerization to visualize the DNA at a later time. Gels were run in an 
electrophoresis chamber (Sub-Cell®, BioRad) with 60 – 100 V (depending on the 
size of the gel) in 1x TAE buffer until DNA fragments were separated properly. 
The DNA fragments were visualized under UV-light and photographed with an 
Eagle-Eye (Stratagene) using the gel documentation system Gel Doc (Biorad).  
To isolate the DNA out of the agarose Gel the PCR cleanup gel extraction kit 
(Macherey-Nagel) was used. 
2.3.7 DNA digestion by restriction enzymes and ligation of DNA fragments 
Table 10: Buffers for DNA digestion by restriction enzymes 
To ligate different DNA fragments with each other the DNA needs to have 
appropriate ends. Therefore the DNA gets digested by restriction enzymes that 
cut the DNA at specific sequences. That results in defined overhangs (sticky end) 
Buffer / Item Composition / Company 
Agarose Bio&SELL / BIOZYM 
50x TAE buffer 4.84 g Tris, 114.2 ml Acetic acid, 37,3 g EDTA 
Ethidium bromide  Roth (0.5 µg/ml working concentration) 
Buffer / Item Composition / Company 
Buffer 10x Fermentas / NEB 
Restriction enzymes Fermentas / NEB 
Ligation Buffer 10x Fermentas / NEB 
T4 DNA Ligase Fermentas / NEB 
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or blunt ends, which can be ligated with the suitable partner. In most of the cases 
a target vector and a smaller construct (insert) should be ligated and therefore 
need to be digested with the same enzymes. Depending on whether an analytic 
or a preparative digestion should be performed, the amounts of ingredients 
varied: 0.5 - 1 µg DNA, 0.5 – 2 µl restriction enzyme and Buffer (10x) were 
diluted in nuclease free water. The buffer and the concentration of enzymes 
varied upon different combinations of enzymes. 
To ligate the predigested vector and insert these two are mixed in a 1 : 7 ratio 
with T4 ligase in Ligation Buffer (10x). Reaction was performed at 16 – 20 °C for 
2 – 8 h. To select successful ligations, DNA constructs were transformed into E. coli 
XL10 Gold competent cells for subsequent DNA mini-prep isolation. 
2.3.8 Transformation of E. coli XL10 Gold competent cells 
Table 11: Items for bacteria transformation 
To transform DNA constructs into E. coli competent cells a heat shock protocol 
was used. DNA was incubated with 100 µl competent E. coli cells on ice. After 
heat shock at 42 °C for 30 sec cells were cooled down on ice for 2 min and diluted 
in 1 ml warm LB medium without antibiotics. Cells were gently shaken for 1 h at 
37 °C, subsequently centrifuged at 1000 x g for 1 min and re-suspended in 100 µl 
LB medium. The whole suspension was plated on an LB Agar plate containing 
the corresponding antibiotic and in case of a blue-white-screening X-Gal and 
IPTG. Plates were placed at 37 °C over night. 
2.3.9 Plasmid Isolation (Mini Preparation) 
Table 12: Buffers for plamisd isolation 
One colony from an agar plate was picked and transferred into a 2 ml LB 
medium overnight culture. Plasmids were isolated by an alkaline lysis. After 
Item Composition / Company 
E.coli XL10 Gold Bacteria  Stratagene 
LB medium 20 g LB Broth Base (Invitrogen) / 1000 ml H2O  
LB Agar 15 g Select Agar (Invitrogen) / 1000 ml LB-medium  
Antibiotics Roth 
X-Gal Roth 
IPTG Roth 
Buffer Composition 
P1  Buffer 50 mM Tris/HCl pH 8.0, 10 mM EDTA, 100 μg/ml RNase A (4 °C) 
P2 Buffer 200 mM NaOH, 1 % (w/v) SDS  
P3 Buffer 3 M potassium acetate, pH 5.5 (4 °C) 
Material and Methods     43 
centrifugation with 5500 rpm for 5 min cells were re-suspended in 300 µl P1 
buffer and 300 µl P2 buffer were added. Probes were gently pivoted and 
incubated at RT for 5 min. Ice cold P3 buffer was added, pivoted and incubated 
on ice for 5 min. After centrifugation with 14000 rpm for 10 min supernatants 
were transferred into a new reaction tube, 510 µl isopropanol were added and 
pivoted. After 5 min incubation at RT the plasmids were spun down with 
maximum speed for 10 min. Supernatants were removed and the pellets washed 
with 1 ml 70% Ethanol (v / v). Afterwards the pellets were centrifuged again and 
supernatants removed. After drying, the pellets were diluted in 50 µl dH2O each 
and stored at -20 °C. For mammalian cell transfection, DNA with high 
concentration and purity was prepared using the NucleoBond® Xtra Midi EF Kit 
(Macherey-Nagel). DNA concentration was measured with NanoDrop1000 
(peQLab). 
For sequencing the DNA constructs were sent to SeqLab (Sequence Laboratories 
Göttingen) 
2.4 Antibodies 
Table 13: List of primary antibodies, origin and working concentrations 
Primary antibody Species Company Cat-No. ICC dilution WB dilution 
α GluN2B rb Alomone labs AGC-003 1:400/ 1:25/ 1:1000  
α GluN2B N59/36 ms NeuroMab 75-101  1:500 
α pGluN2BY472 rb AAT Bioquest 8A0526  1:500 
α pGluN2BS133 rb Millipore 06-519  1:500 
α PSD-95 ms NeuroMab  1:1000  
α Map2 ms Sigma-Aldrich  1:2000  
α β3-tubulin ms Synaptic System   1:1000 
α GFP ms   1:1000  
α Synaptotagmin 1-550 
Oyster ms Synaptic System  1 : 750  
α β1-integrin (CD29) rat BD Pharmingen 555002 1:25  
α Brevican gp 
PD 
Seidenbecher / 
Dr. Frischknecht 
 1:1000  
α Neurofascin rb abcam ab31719 1:1000  
α myc ms abcam ab18185 1:1000  
α HA rat Roche 11867423001 1:500  
Species: rabbit (rb), mouse (ms), guinea pig (gp), rat. Fluorescently labelled 
secondary antibodies that were used for ICC were purchased from Invitrogen 
(Alexa Fluor 488, 568, 647 1:1000) or from Dianova (Cy3, Cy5 1:1000). 
Fluorescently labelled secondary antibodies that were used for quantitative 
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immunoblotting were purchased from Invitrogen (ms Alexa Fluor 680, 1:20.000) 
and from Rockland (rb IRDye 800 W, 1:20.000). 
Table 14: List of enzymes and drugs 
Drug Company Cat-No. ICC dilution 
Hyaluronidase (Hya) Millipore 38594 250 u / 500 µl 
Chondroitinase 
(ChABC) Sigma C3667 0.1 u / 500 µl 
PP2 Tocris 1407 1 – 10 µM 
2.5 Immunocytochemistry 
Table 15: Buffers for immunocytochemistry 
Buffer Composition 
4 % PFA (w / v) 4 % PFA in PBS pH 7.4 
Blocking Solution 10 % FCS in PBS, 0,1 % Glycin, 0,1 % Triton X-100 
1x PBS 2,7 mM KCl, 1,5 mM KH2PO4, 137 mM NaCl, 8 mM Na2HPO4, pH 7,4 
Mowiol (96 ml) 9.6 g Mowiol, 24 ml H2O, 24 g Glycerol  2 h stirring, 48 ml 0.2 M Tris pH 8.5  10 min 50 °C, 2.5 g DABCO 
Tyrode buffer 145 mM NaCl, 5 mM KCl, 10 mM glucose, 10 mM HEPES, 2 mM MgCl2, 2 mM CaCl2, pH 7.4, osmolarity 300 mosmol 
2.5.1 Immunostainings of dissociated neuronal cultures 
Rat cortical neurons were grown on Ø 12 mm coverslips in NB+ medium. If 
surface or extracellular proteins should be stained, antibodies were diluted in 
NB+ medium. A wet chamber was covered with Parafilm and drops of the 
antibody solution were pipetted on it. Coverslips were turned, cells facing down, 
on top of the drop and incubated at 37 °C for 20 min. After 5 min fixation with 
4 % PFA cells were incubated in Blocking Solution to block PFA reactivity and 
unspecific binding sites and to permeabilize the cells. Primary antibodies against 
intracellular proteins were diluted in Blocking Solution and dropped on Parafilm. 
Coverslips with cells facing down were incubated with primary antibodies for 90 
min at room temperature or overnight at 4 °C. Afterwards cells were washed 
three times with 1x PBS. Secondary antibodies were again diluted in Blocking 
Solution and incubated with the cells for 45 min at room temperature in 
darkness. Following three washing steps coverslips were mounted with Mowiol 
on object slides and stored at 4 °C until usage. 
If no surface or extracellular proteins were stained, the protocol started with the 
PFA fixation of the cells. 
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Synaptotagmin antibody uptake 
To investigate presynaptic activity an antibody against the luminal domain of 
synaptotagmin-1 coupled with a fluorophore was used in the same way as 
antibodies for surface expressed receptors. If synapses are active and fuse their 
neurotransmitter vesicles with the cell membrane the luminal part of 
synaptotagmin-1 gets exposed to the neuronal surface and the antibody can bind 
and is taken up when vesicular membranes are endocyted. In this way the 
fluorescence intensity of this antibody reflects the activity state of the single 
synapses.  
2.5.2 Binding Assay 
To investigate if extracellular proteins bind to surface expressed receptors a 
binding protocol was established. Cst1Clea, Cst3Clea and Cst1Cad were 
overexpressed in HEK293-T cells. The proteins were secreted into the 
supernatant which was collected. Alpex cells, constantly expressing brevican, 
secrete the protein and these supernatants were collected as well. HEK293-T cells 
were transfected with either Frzl-1-HA or neurofascin. After 48 h cells were 
plated on coated Ø 12 mm coverslips. When cells were settled down they were 
briefly washed with warmed HBSS+. The collected supernatants were diluted in 
FKS free DMEM full (1 : 2.5) and cells were incubated in these dilutions at 18 °C 
for 1 h. Afterwards cells were washed with HBSS+ and fixed with 4 % PFA. In 
this experiment the Blocking Solution did not contain Triton, since all the 
antibodies that were used should only label surface expressed or surface 
bounded proteins. Apart from that the immunostaining protocol followed the 
same procedure as described in section 2.5.1.  
2.5.3 Microscopy and image analysis 
Images were taken using a Zeiss Axioplan 2 epifluorescence microscope 
equipped with a camera (Cool Snap EZ camera; Visitron Systems, or Spot RT-KE; 
Diagnostic Instruments, Inc.) and MetaView software (MDS Analytical 
Technologies). Image processing and analysis were performed using ImageJ 
(MacBiophotonics ImageJ Version 1.41a) and OpenView (Version 1.5 from Noam 
Ziv) software. 
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2.5.4 Quantum Dot experiments 
Dissociated hippocampal neurons grown on Ø 18 mm coverslips and transfected 
at DIV 5 (see 2.3.3) were used for Quantum Dot (QD) experiments from DIV 21 – 
26. Some coverslips were treated with Hya overnight, some with Hya for 10 min. 
QDs (Life Technologies) were centrifuged before use for 10 min at 10.000 x g. 
0.5 µl GFP antibody were incubated with 1 µl QD-655 in 1x PBS for 10 min under 
gentle shaking. 1 µl Casein was added to reduce the formation of aggregates and 
the master mix was incubated for another 15 min. 1 µl of the master mix was 
diluted in 100 µl cell media and dropped on a petri dish covered with Parafilm 
(final concentration of antibody / QD-655: 1:2000 / 1:1000). The coverslip was 
incubated with cells facing down for 2 min at 37 °C. Subsequently cells were 
washed in Tyrode buffer containing 0.1 % BSA and fixed in an imaging-chamber 
(Low Profile Open Bath Chamber, Warner Instruments) and filled with warmed 
Tyrode buffer.  
Live imaging was performed at 37 °C using an inverted microscope (Observer. 
D1; Carl Zeiss, Inc.) in a heated imaging chamber TC-344B (Warner Instruments) 
and an EMCCD camera (Evolve 512; Photometrics) controlled by MetaMorph 
Imaging (MDS Analytical Technologies) and VisiView (Visitron Systems GmbH) 
software. Live streams were acquired every 30 ms (33 Hz) for 30 sec.  
Data analysis was performed with custom-made software (Groc et al., 2007). Two 
parameters were analyzed the Mean Square Displacement (MSD) and the 
Instantaneous Diffusion Coefficient (Dinst). The MSD is calculated by the distance 
that a QD moves in between two images, for example between the 1th and 2th 
picture and the 2th and 3th image. The second MSD is based on the covered 
distance between the 1th and 3th and the 2th and 4th image. The MSD provides 
information about the area a QD explores within a defined time window. The 
Dinst describes the velocity of a QD calculated out of the first 4 images of the 
stream.  
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2.6 Biochemistry 
Table 16: Buffers for biochemistry 
Buffer Composition 
4x SDS sample buffer 250 mM Tris, pH 6.8, 1 % (w/v) SDS, 40% (v/v), glycerol, 4 % β-mercaptoethanol, 0.02 % bromophenol blue 
Cell lysis buffer 
10 mM Tris, pH 7.4, 150 mM NaCl, 2 % SDS, 1 % deoxycholate, 1 % 
Triton X-100, Complete Protease Inhibitor Cocktail (Roche) 1 Tbl. per 10 ml, 
PhosSTOP Phosphatase Inhibitor Cocktail (Roche) 1 Tbl. per ml, 1 % NaVO3 
Electrophoresis buffer 192 mM glycine, 0.1 % (w/v) SDS, 25 mM Tris, pH 8.3 
Separation buffer 1.5 mM Tris pH 8.8 
Stacking buffer 0.5 M Tris pH 6.8 
Separation gel (20 %) 
8.25 ml separation buffer, 7.5 ml 87 % Glycerol, 16.5 ml 40 % Acrylamyde, 330 
µl EDTA (0.2 M), 22 µl TEMED, 120 µl 0.5 % Bromophenol blue and 75 µl 10 
% APS 
Separation gel (5 %) 8.25 ml separation buffer, 17.94 ml dH2O, 1.89 ml 87 % Glycerol, 4.12 ml 40 % Acrylamide, 330 µl EDTA (0.2 M), 22 µl TEMED and 118 µl APS 
Stacking gel (5%) 
6 ml stacking buffer, 7.95 ml dH2O, 5.52 ml 87% Glycerol, 3.90 ml 30 % 
Acrylamyde, 240 µl EDTA (0.2 M), 240 µl 10% SDS, 17.2 µl TEMED, 30 µl 
Phenol red and 137 µl 10% APS 
Coomassie brilliant 
blue staining solution 
1 mg/1000 ml Coommassie brilliant blue R-250, 60 % (v/v) methanol, 10 % 
(v/v) acetic acid  
Destaining solution 7 % (v/v) acetic acid, 5 % (v/v) methanol  
Blotting buffer 192 mM Glycine, 0,2 % (w/v) SDS, 18 % (v/v) methanol, 25 mM Tris pH 8,3 
1x TBS 50 mM Tris, 150 mM NaCl, pH 7.5 
1x TBS-T 50 mM Tris, 150 mM NaCl, 1 % Tween-20 pH 7.5 
ACSF 125 mM NaCl, 2,5 mM KCl, 1,25 mM NaH2PO4, 25 mM NaHCO3, 2 mM CaCl2, 1 mM MgCl2, 25 mM glucose 
2.6.1 Acute hippocampal slices 
Acute hippocampal slices were prepared with the help of Jeet Singh.  
10 weeks old Wistar rats were anesthetized with isufluran. After decapitation the 
brain was rapidly removed and immersed in oxygenated ice-cold ACSF. 
Hippocampi were isolated and transverse slices (350 µm) were produced using a 
Vibratome (The Vibratome Company). After recovery in ACSF (32 °C) the slices 
were treated with Hya (500 u / ml) for 3 h. Three slices were triturated with a 
pipette in 90 µl of cell lysis buffer supplemented with Complete Protease 
Inhibitor Cocktail (Roche), PhosSTOP Phosphatase Inhibitor Cocktail (Roche) and 
1 % NaVO3 before adding 4x SDS sample buffer. Samples were stored at -80 °C 
until they were used for SDS page. 
2.6.2 SDS-Page using Laemmli system 
Proteins were separated using a one-dimensional sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) under fully denaturating 
conditions. Gradient gels were used in which the separating gel had an 
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acrylamide concentration of 5 % on top and 20 % at the bottom. The stacking gel 
was covering the separating gel to focus the proteins. Gels were placed in an 
electrophoresis chamber (Mighty Small II MINI Vertical Electrophoresis Unit, 
Hoefer) and filled with electrophoresis buffer. Protein samples were diluted with 
4x SDS buffer and boiled at 95 °C for 5 min, centrifuged with full speed for 
10 min to load the supernatants on the gel. The gel run was performed with 
constant 8 mA within the stacking gel and 10 mA during the separation phase. 
After SDS-page gels were either used for Western Blotting or they were stained 
with Coomassie solution for 30 min. By incubation with destaining solution for 
2 h or overnight the proteins get visible. For quantification the gels were scanned 
by Odyssey Infrared Imaging System (LI-COR Bioscience). 
2.6.3 Western Blotting 
Proteins were electrotransfered from polyacrylamide gels to Millipore 
Immobilon-FL transfer membranes (polyvinylidene fluoride membrane; PVDF). 
The membrane was activated in methanol for 30 sec. The transfer was performed 
in a Western Blot chamber (Mighty Small Transfer Tank, Hoefer) filled with 
Blotting buffer at 4 °C for 1.45 h with 200 mA. After the transfer the membrane 
was rinsed again with methanol and air dried. 
2.6.4 Immunoblot detection 
The PVDF membrane was blocked in 5 % BSA containing TBS-T for 30 min at RT. 
Primary antibodies were diluted in 2 % BSA containing TBS-T and probed for 
90 min at RT or overnight at 4 °C. After three times washing with TBS-T 
secondary antibodies diluted in TBS-T were incubated for 45 min at RT. After 
further washing steps with TBS-T the final washing needs to be done with TBS, 
since Tween-20 interferes with the upcoming scanning procedure. 
Immunodetection was performed with an Odyssey Infrared Imaging Scanner (LI-
COR Bioscience). 
2.6.5 Purification of eukaryotic expressed fusion proteins 
Table 17: Buffer for protein purification 
Buffer Composition / Company 
Binding buffer 10x 200 mM sodium phosphate, 5 M NaCl, 200 mM imidazole, 0.45 µm filtered 
Binding buffer 1x 20 mM sodium phosphate, 0.5 M NaCl, 20 mM imidazole, pH 7.4, 0.45 µm filtered 
Elution buffer 1x 20 mM sodium phosphate, 0.5 M NaCl, 0.5 M imidazole, pH 7.4, 0.45 µm filtered 
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To investigate the functions of extracellular shed proteins I produced fusion 
proteins, which can be purified by affinity chromatography. The aim was to get 
purified proteins of the following constructs: Cst1Clea, Cst1Cad, Cst1LamG, 
Cst3Clea (see Table 3). All proteins produced by these constructs are secreted 
into the cell medium. The procedure was the same for all constructs, since they 
all contain a myc / his tag which was used for purification. 
As an expression system eukaryotic cells (HEK293-T cells) were chosen because 
all proteins needed posttranslational modifications such as N- or O-glycosylation 
that can only be produced in eukaryotic cells. Therefore HEK293-T cells were 
transfected with one of the constructs. After 48 h of protein expression cell 
medium was collected and fresh medium was added. After further 12 h the cell 
medium was collected again. Combined media were centrifuged to remove 
remaining cells or cell debris.  
The ÄKTAprimeTMPlus system (GE Healthcare) with the preinstalled “Histidine-
tagged protein purification, gradient elution” program was used to purify 
overexpressed proteins. HisTrap FF columns (GE Healthcare) were used, which 
are packed with precharged Ni2+ Sepharose 6 for preparative purification of 
histidine-tagged recombinant proteins by immobilized metal ion affinity 
chromatography (IMAC). The procedure was fully automatic, controlled and 
Figure 3: Plot of the UV absorption (A280 nm) during protein purification 
Throughout the whole purification procedure, the fluid that exits the column is controlled for its UV 
absorption.  
On the right side, the elution phase is enlarged with 37 fractions á 1 ml (first 9 are indicated). 
Surrounding fraction 7 a shoulder in the UV absorption is detectable, which represents the eluted fusion 
protein.  
 
 
Material and Methods     50 
visualized by the Software PrimeView 5.31 (GE Healthcare). Right after the 
column exit, fluids are tested for their potential to absorb UV 280nm (Figure 3), 
which provides information about the protein content in the fluid. 
Collected cell media were diluted with 10x binding buffer to adjust the sample to 
composition of 1x binding buffer. The pH was set to 7.4 and the solution was 
filled in a super-loop of appropriate size (150 ml). After equilibration of the 
column with 1x binding buffer the Sample was loaded on the column and 
subsequently washed with 1x binding buffer. Figure 3 shows the plot of the 280 
nm absorption (mAU) acquired during the purification of Cst1Clea as an 
example. The curve increases during the loading phase of the column, due to the 
large amount of proteins in the flow-through, originating from the cell culture 
medium. During the washing step the absorption decreases again. The gradient 
elution increases the concentration of imidazole containing elution buffer 
continuously over 20 min to 100 %. Imidazole replaces and thus elutes the 
protein of the column. Imidazole itself shows absorption at 280 nm therefore the 
absorption rises with increasing imidazole concentration. During elution 
fractions of 1 ml are collected. Elution is followed by a washing step with 100 % 
elution buffer. The fractions which include the desired fusion protein can be 
detected by a peak within the absorption plot, which starts in the plotted 
example in fraction 7 (Figure 3). Samples of those fractions were separated by 
SDS-Page and the gels were stained with Coomassie solution. The positive 
fractions needed to be dialyzed since they contain imidazol. Dialysis tubes with a 
filtering rate of 3.5 and a Molecular Weight Cut Off (MWCO) of 4.000 – 6.000 D 
were used to transfer the purified proteins into 1x PBS. Fractions were filled into 
the dialysis tubes and then incubated in 1x PBS for 3 - 4 hours in which PBS was 
always exchanged. Protein concentration was measured with NanoDrop1000 
(peQLab). Afterwards proteins were stored at -80 °C.  
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2.7 Electrophysiology 
Table 18: Buffers and drugs for electrophysiology 
Buffer Composition / Company 
Extracellular solution 145 mM NaCl, 5 mM KCl, 0 mM MgCl2, 1 mM / 2 mM CaCl2, 10 mM HEPES, 10 mM D-glucose, 15 µM Glycine pH 7.4 
Intracellular / Pipette 
solution 
140 mM potassium gluconate, 2 mM MgCl2, 4 mM NaATP, 0.1 mM EGTA, 
10 mM HEPES, 10 mM phosphocreatine, 0.4 mM GTP, 10 mM QX-314 pH 
7.25 
CNQX 5 µM (Tocris) 
Bicuculline (BCC) 10 µM (Tocris) 
APV 10 µM (Tocris) 
Ifenprodil (Ifen) 3 µM (Tocris) 
Tetrodotoxin (TTX) 0.5 µM (Tocris) 
For electrophysiological recordings dissociated hippocampal cultures (DIV 21-
26), grown on Ø 18 mm coverslips were used. Coverslips were fixed in an 
imaging-chamber (Low Profile Open Bath Chamber, Warner Instruments) and 
continuously perfused with warmed extracellular solution containing the desired 
drugs if needed (IsmatecTM Reglo tubing pump). Patch pipettes were prepared 
of borosilicate glass capillaries (major diameter: 1.5 mm, inner diameter: 0.86 mm, 
length: 100 mm) using a Flamming/Brown Micropipette Puller (Model P-97, 
Sutter Instruments). The resistance of the pipettes fluctuated between 2.5 – 5 MΩ. 
Under visual control using an inverse microscope (Zeiss Axio Observer A1) with 
a 63x objective the pipette was placed onto the cells working with a 
micromanipulator (SM-5 Manipulator, Luigs & Neumann). To measure synaptic 
currents a computer controlled patch clamp amplifier was used (HEKA EPC10, 
Software: PatchMaster 2.11 HEKA). The serial resistances of the patch pipettes 
were allowed to fluctuate between 5 and 11 MΩ. 
2.7.1 Miniature Excitatory Synaptic Currents (mEPSCs) 
mEPSCs were measured during my diploma thesis. The extracellular Solution 
contained TTX to block action potentials, BCC to inhibit GABAA receptors and 
2 mM CaCl2 to increase the release probability. The holding potential was 
clamped at -40 mV. To analyze the NMDA receptor component of the mEPSCs 
APV was applied and currents were compared to control currents. 
2.7.2 Spontaneous Excitatory Synaptic Currents (sEPSCs) 
In order to isolate NMDA receptor mediated synaptic currents I added the 
AMPA receptor blocking agent CNQX to the extracellular solution. Ca2+ 
Material and Methods     52 
concentration was reduced to 1 mM to decrease the release probability. The 
holding potential was clamped at -70 mV. In order to verify that measured 
currents are completely driven by NMDA receptor APV was added. Application 
of ifenprodil shows the amount of GluN2B-NMDA receptor-mediated currents. 
2.8 Wnt signaling reporter systems  
To investigate the influence of Cst-1 on canonical wnt signaling two reporter 
systems were used. The first one is based on a GFP expression (7-TGC) and the 
other one on luciferase expression (Super 8x TOP/FOPFlash) if canonical wnt 
signaling is active. In both cases the reporter gene is under control of the Tcf/Lef 
binding site that respond to β-catenin-mediated activation. For further 
information on the constructs see section 2.3.1 and the listed publications.  
2.8.1 Reportersystem based on GFP expression 
HEK293-T cells were plated on Ø 12 mm coated coverslips and transfected with 
the 7-TGC construct which is a reporter system for canonical wnt signaling based 
on GFP expression. In a first set of experiments additionally to the transfection 
with 7-TGC, cells were co-transfected with either cDNA for wnt-8a or Cst-1. Then 
cells were incubated for 48 h. Since it was not possible to estimate the 
concentration of the desired protein in the extracellular space I continued to work 
with purified proteins like Cst1Clea and wnt-3a to add specific amounts (which 
are stated in the results) for better comparability. Cells were incubated for 6 h. In 
both experimental approaches cells were fixed, stained with DAPI to visualize 
the nuclei and without any further immunostaining mounted with Mowiol. The 
7-TGC construct leads to a constitutively expressed mCherry protein to localize 
the transfected cells. Both mCherry and GFP signals were acquired. The intensity 
of the GFP signal was later normalized to the intensity of mCherry because it 
reflects the expression level of the construct in each cell. 
2.8.2 Reporter system based on luciferase expression 
HEK293-T cells were transfected in flasks with either the Super 8x TOPFlash or 
Super8x FOPFlash construct. The Super 8x TOPFlash construct reports the 
activity of the canonical wnt signaling by expressing luciferase under control of 
the Tcf/Lef promotor. The Super8x FOPFlash construct contains a mutated 
version of the Tcf/Lef promotor and serves as a control. After approximately 12 h 
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the cells were plated in a 96 well plate, containing 100 µl per well. Another 12 h 
later purified proteins such as Cst1Clea, Cst1Cad and wnt-3a were added to the 
HEK293-T cells expressing the reporter system and incubated for 6 h. The 
detection of luciferase expression was performed with the ONE-GloTM Luciferase 
Assay System (Promega). It is important to work at RT since luciferase has a 
temperature optimum of 22.5 °C (Ueda et al., 1994). Therefore the cells were 
cooled down to RT for 30 min after incubation at 37 °C and the ONE-Glo reaction 
buffer was thawed at RT. 100 µl ONE-Glo reaction buffer were added in each 
well and kept for 3 min at RT. Subsequently luminescence was measured with 
GENios (TECAN). The luminescence values of the Super 8x TOPFlash transfected 
cells were normalized to the values of corresponding cells transfected with Super 
8x FOPFlash, which contains a mutated version of the Tcf/Lef binding site. 
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3 Results 
The results of my thesis consist of two parts. The first part describes the effect of 
an ECM removal on surface expression of GluN2B-NMDA receptors, which was 
the main part of my thesis. The second part contains the results of a side project 
that was started within the last year of my PhD. This part is about a protein 
called calsyntenin and its role in cellular functions. This project is in a 
preliminary state, but provides hints for future research directions. 
Part I:  The effect of the ECM on the expression and dynamics of 
GluN2B-NMDA receptors 
The ECM of the brain is formed during the first postnatal weeks and coincides 
with a switch in brain plasticity and in NMDA-receptor subunit composition. 
NMDA receptors are essential modulators for synaptic plasticity, thus I was 
interested in whether these two developmental changes are in a causal 
relationship. In order to investigate the role of ECM on the composition of 
NMDA receptors, I digested the ECM by making use of the glycosidase 
hyaluronidase (Hya) as published in (Frischknecht et al., 2009). This enzyme 
dissolves the hyaluronic acid backbone of the ECM and destroys its dense net-
like structure surrounding the cells (see Figure 8). This work is based on 
preliminary data that I obtained during my diploma thesis. For a comprehensive 
description I will refer to some data from my diploma thesis, which will be 
clearly marked as such.  
3.1 Electrophysiological recordings after ECM removal 
To analyze basal synaptic activity measurements of miniature excitatory 
postsynaptic currents (mEPSCs) are an established method. During my diploma 
thesis I measured mEPSCs in dissociated hippocampal cultures (DIV 21-26) 
before and after overnight Hya treatment. mEPSCs were analyzed for their 
amplitude, frequency, rise- and decay-time. None of these characteristics were 
affected by the ECM digestion, which is in line with previously published data 
from our laboratory (Frischknecht et al., 2009). Further blockage of NMDA 
receptors by (2R)-amino-5-phosphonovaleric acid (APV) did not show any 
significant differences in all analyzed parameters. I concluded that under 
tetrodotoxin (TTX) treatment the majority of activated channels are AMPA 
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receptors in our neuronal cultures. Due to that it was essential to develop a 
protocol to measure isolated NMDA receptor-mediated synaptic currents. 
3.1.1 Isolation of NMDA receptor-mediated synaptic currents in dissociated 
cultures 
Using TTX, I was not able to isolate NMDA receptor-dependent currents, which 
might be due to insufficient activation under these conditions. Therefore I 
performed measurements without TTX and made use of the spontaneous, 
intrinsic activity present in these cultures. Spontaneous excitatory synaptic 
currents (sEPSCs) driven by AMPA and NMDA receptors showed clearly 
detectable single peaks in the current traces, which are above noise (filled stars, 
Figure 4A). Figure 4C shows the same current trace as Figure 4A but with a lower 
magnification. There are periods of high frequent events with high amplitudes 
Figure 4: Isolation of NMDA receptor mediated currents 
(A) sEPSCs under control conditions, driven by AMPARs and NMDA receptors. Single peaks (filled stars) 
are clearly above noise.  
(B) sEPSCs under CNQX treatment, driven only by NMDA receptors. The amplitudes of potential peaks 
are not clearly separable from the noise of the setup. Potential peaks are marked with blank stars.  
(C) sEPSCs under control conditions, driven by AMPARs and NMDA receptors. Note that the trace is 
displayed with lower magnification as in (A) and (B) (see scale bar). Besides smooth baseline, periods of 
high, burst-like activity are visible.  
(D) sEPSCs under CNQX treatment, driven only by NMDA receptors. Note that the trace is displayed with 
lower magnification as in (A) and (B) (see scale bar). Single peaks (filled stars) with large amplitudes are 
detectable. 
(E) sEPSCs under CNQX + APV treatment. Single peaks that were detected in (D) disappeared, which 
proves that those currents were driven by NMDA receptors 
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that varied between ~ 400-1600pA and lasted for ~ 1500ms. In between these 
burst-like events a “smooth” baseline is present, which includes the single events 
described in Figure 4A (filled stars). To separate NMDA receptor mediated 
synaptic currents the competitive inhibitor of AMPA receptors 6-cyano-7-
nitroquinoxaline-2,3-dione (CNQX) was added. Under high magnification the 
clearly detectable events from Figure 4A disappeared. Amplitudes of potential 
peaks were indistinguishable from the noise of the setup (blank stars, Figure 4B). 
These events could not be analyzed. Figure 4D shows this current trace with 
lower magnification to visualize again periods of high current amplitudes. 
Application of CNQX shrunk the high frequency periods observed under control 
conditions (Figure 4C) to individual, clearly detectable peaks (Figure 4D). These 
peaks disappeared after application of APV which demonstrates that these 
currents were exclusively driven by NMDA receptors (Figure 4E). With this 
protocol it was possible to measure isolated NMDA mediated synaptic currents 
before and after Hya treatment. 
3.1.2 Increased NMDA receptor-mediated sEPSCs after ECM removal 
I measured NMDA mediated sEPSCs in dissociated hippocampal cultures (DIV 
21-26), as described in 3.1.1. Neurons were treated with Hya overnight. I found 
no obvious changes in the current traces before or after Hya treatment (Figure 
5A). The amplitudes of single peaks were quantified and no significant difference 
between the two groups was observed (Figure 5B). To further separate the 
currents into GluN2A- and GluN2B-NMDA receptor-mediated portions 
ifenprodil (Ifen) was used to selectively block GluN2B-NMDA receptors. Again 
no difference was detectable in the amplitudes (Figure 5B), which are obviously 
driven by GluN2A-NMDA receptors. Further information about involved 
receptors is contained in the total charge transfer, which is transferred during one 
single event. Especially the decay-time is determined by the composition of 
activated receptors. Before analyzing the total charge transfer, the amplitudes 
were normalized to accentuate differences within the decay-times of the peaks, 
which represent the subunit composition of NMDA receptors. GluN2A-NMDA 
receptors have shorter decay-times compared to GluN2B-NMDA receptors and 
therefore, unlike the amplitude, the decay-time is dominated by the GluN2B-
NMDA receptor. The total charge transfer was calculated by the integral of the 
mean peak per cell. I found a 38 % increase in total charge transfer after ECM 
digestion (Figure 5C), which was erased after application of Ifen that blocks  
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Figure 5: ECM removal enhances GluN2B-NMDA receptor-mediated synaptic currents 
(A) Example traces of NMDA receptor-mediated sEPCSs before and after Hya treatment in dissociated 
hippocampal cultures (DIV21-26).  
(B) Amplitudes of single peaks showed no significant differences to Ctl neither after Hya treatment nor 
after Hya plus Ifen treatment. (Ctl, -905.5 ± 179.4, n = 10; Hya -776.2 ± 174.8, n = 10; Hya + Ifen, -758.2 ± 
161.7, n = 11; average ± SEM; One-way ANOVA, P = 0.7991).  
(C) Quantification of the area under the curve (AUC) which represents the total charge transfer. Peaks of 
the recorded sEPSCs were normalized by their amplitudes before AUC calculation. It revealed a bigger 
charge transfer after ECM removal that decreased to Ctl levels after blocking GluN2B-NMDA receptors 
with Ifen. (Ctl, 1 ± 0.02, n = 10; Hya, 1.38 ± 0.09, n = 10; Hya + Ifen, 0.98 ± 0.05, n = 11; average ± SEM; 
One-way ANOVA, P<0.0001, Dunnett’s Multiple Comparison Test, *** P < 0.05).  
(D) Average of single peaks before and after Hya treatment and after Ifen application. Normalization of the 
amplitude illustrates the increased decay-time after Hya treatment (red line) in comparison to Ctl (black 
line). This can be restored after Ifen application (green line). Ctl traces are identical. 
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GluN2B-NMDA receptor-mediated currents. After the block of GluN2B-NMDA 
receptors the charge transfer was indistinguishable from control (Ctl) conditions. 
Further comparison of mean traces before (black) and after Hya treatment (red) 
showed a clear increase in the decay-time of the currents after ECM removal, 
which could be blocked by application of Ifen (green) (Figure 5D). 
This clearly indicates that Hya treatment increases GluN2B-NMDA receptor-
mediated synaptic currents. Whether this increase is due to altered gene 
expression, trafficking or receptor modification was subject to following 
experiments.  
3.2 Unaffected GluN2B protein level after ECM removal  
Increased GluN2B-NMDA receptor-mediated synaptic currents may be due to an 
increased GluN2B protein level. During my diploma thesis I showed, using 
immunocytochemistry experiments on permeabilized dissociated cortical 
neurons (DIV 21-24), that the total level of GluN2B proteins is not affected by the 
Hya treatment, neither in dendrites nor at synapses. 
Here I investigated the GluN2B protein level by biochemical methods. Therefore 
western blot (WB) experiments of dissociated cortical neurons were performed to 
compare Hya and untreated cells. 6 well plates of cortical cultures were treated 
Figure 6: Total GluN2B protein level stays unaffected after ECM removal 
(A): Quantitative WB of cortical cultures lysates (DIV 21) pre-treated with Hya over night. Western blot 
was incubated with antibodies against GluN2B and β3-tubulin. 
(B) Quantification of WB showed no significant change in GluN2B immunoreactivity after normalizing to 
the loading control β3-tubulin (Ctl 1 ± 0.08, n=9; Hya 1.1 ± 0.18, average ± SEM; n=9, P = 0.6282, 
unpaired t-test).   
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with Hya overnight and subsequently lysed in 1x SDS buffer. Probes were 
subjected to SDS Page and WB and the membranes were probed with antibodies 
against GluN2B and β3-tubulin as a loading control (Figure 6A). There was no 
difference in the total expression level of GluN2B between treated and untreated 
cells (Figure 6B). Taken together, these results suggest that ECM removal results 
in increased GluN2B-NMDA receptor mediated charge transfer without affecting 
the total amount of GluN2B.  
3.3 GluN2B surface expression is increased after ECM removal in 
a β1-integrin-dependent manner 
Since the protein level of GluN2B is not affected by the ECM removal I followed 
the line of an altered balance of intracellular and surface expressed GluN2B-
NMDA receptors. During my diploma thesis I obtained preliminary data 
regarding the surface expression of GluN2B-NMDA receptors after ECM removal 
using immunocytochemistry. In order to verify that enhanced GluN2B-NMDA 
receptor-mediated currents are due to an increased abundance of these receptors 
at the cell surface, immunocytochemistry experiments were performed on living, 
non- permeabilized hippocampal neurons (DIV 21-24). Surface GluN2B were 
labeled with an antibody raised against their extracellular N-terminus. 
Subsequently cells were fixed, permeabilized and synapses were labeled with an 
antibody against the postsynaptic protein PSD-95 (Figure 7A). Fluorescence 
intensity analyzes revealed an increase of about 25 % in surface expressed 
synaptic GluN2B after Hya treatment (Figure 7B). Measuring surface expression 
of GluN2B on whole dendrites, using a Map-2 mask, exhibited an increase of 
about 78 % in surface GluN2B after ECM removal (Figure 7C). This indicates that 
increased surface expression of GluN2B is not synapse specific but affects also the 
extrasynaptic population of GluN2B-NMDA receptors. These data demonstrate 
that the increased GluN2B-NMDA receptor mediated synaptic currents after 
ECM removal are due to an increased surface abundance of these receptors.  
Next I wondered about signaling mechanisms that sense changes in the ECM and 
trigger molecular changes at the synapse like altered receptor expression. Most 
promising candidates are integrins, which are known to interact with several 
ECM molecules and have been reported to modulate NMDA receptor abundance 
at the neuronal cell surface (Lin et al., 2003, Bernard-Trifilo et al., 2005). Further, 
chondroitin sulfates within the ECM have been suggested to inhibit integrin  
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Figure 7: ECM removal increases surface expression of GluN2B in a β1-integrin dependent manner  
(A) Dissociated hippocampal cultures (DIV 21-24) were treated with Hya over night and stained against 
surface GluN2B (nonpermeabilisied) (magenta) and the synaptic marker PSD-95 (permeabilised) (green). 
GluN2B intensities at the synapses were quantified using ImageJ and OpenView (scalebars, 20 µm, inset: 
5 µm).  
(B, C) The GluN2B surface expression at synapses and dendrites increased after ECM degradation and 
could be restored by simultaneous application of the β1-integrin function-blocking antibody CD29 ((B) 
Synapses: Ctl 1.0 ± 0.05, n = 68; Hya 1.3 ± 0.05, n = 70; Hya +CD29 0.7 ± 0.03, n = 51; (C) Dendrites: Ctl 
1.00 ± 0.04, n = 36; Hya 1.78 ± 0.11, n = 35; Hya+CD29 0.96 ± 0.03, n = 34; average ± SEM; One-way 
ANOVA, P<0.0001, Dunnett’s Multiple Comparison Test, *** P < 0.001). 
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signaling (Tan et al., 2011). I tested whether the increased surface expression of 
GluN2B after Hya treatment could be prevented by blockage of integrin 
signaling. For this purpose I added in parallel to Hya a function-blocking β1-
integrin antibody (CD29) to neuronal cultures. On the next day GluN2B surface 
staining was performed as described above. In both, synapses and dendrites the 
observed increased GluN2B surface expression was abolished after application of 
CD29 (Figure 7B, C). This suggests that removal of the ECM via Hya treatment 
increases β1-integrin signaling, which in turn regulates surface abundance of 
GluN2B-NMDA receptors.  
3.4 ChABC treatment increases surface expression of GluN2B-
NMDA receptors  
Both ChABC and Hya are ECM-degrading enzymes cleaving glycosaminoglycan 
chains. Hya degrades preferentially hyaluronic acid whereas ChABC favors 
chondroitin sulfate chains. However, Hya has an intrinsic chondroitinase activity 
while ChABC endows hyaluronidase activity. Many studies concerning the 
influence of the ECM on plasticity or integrin function used ChABC in their 
experiments (Orlando et al., 2012, de Vivo et al., 2013). In order to better compare 
my data with other work in the field and to exclude unspecific effects caused by 
Hya I repeated the experiments using ChABC.  
In a parallel approach using dissociated cortical cultures (DIV 21-24) I treated 
cells either with Hya or ChABC overnight and stained for surface expressed 
GluN2B receptors. For quantification I focused on synaptically expressed 
receptors by co-staining with Homer-1. Figure 8A shows the immunostaining for 
brevican under control, Hya and ChABC conditions. Brevican 
immunofluorescence was brighter and more compact under control compared to 
the ECM degrading conditions. What is more important, the brevican 
immunostaining was comparable under Hya and ChABC treatment. 
Quantification of surface expressed GluN2B-NMDA receptors revealed that Hya 
as well as ChABC treatment increased GluN2B surface abundance by 28 % and 
23 %, respectively (Figure 8B), which demonstrates that the increased surface 
expression of GluN2B is no artificial effect of Hya treatment.  
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3.5 Hya treatment does not alter GluN2B expression in DIV 11 
neurons 
To verify that the observed effect of Hya treatment on the surface expression of 
GluN2B-NMDA receptors was due to the degradation of the hyaluronan-based 
matrix the analysis of surface expressed GluN2B after Hya was performed in DIV 
11 cultures. Previous experiments were all performed in DIV 21-24 dissociated 
neuronal cultures because the hyaluronan-based ECM is fully developed at this 
age, whereas it is not yet established in younger neurons (John et al., 2006). 
Figure 9A shows comparative immunostaining against brevican before and after 
Hya treatment in DIV 11 and DIV 21 neurons. Neurons at DIV 11 do not show 
the intense brevican staining as found in DIV 21 neurons. Hence Hya treatment 
Figure 8: ChABC shows the same effect as Hya 
(A) Immunostaining of dissociated cortical cultures (DIV21-24) that 
were treated with either Hya or ChABC overnight and stained for 
brevican. Yellow arrows indicate the axon initial segment (AIS) 
which shows a bright brevican signal under ctl conditions. This 
intense staining of the AIS persits even after ECM digestion. The 
brevican-based ECM at the AIS is assembled and linked by 
neurofascin-186 to the intracellular skeleton (Hedstrom et al., 
2007) and due to that not affected by Hya or ChABC treatment. 
(Scale bar 20 µm) 
(B) Quantification of GluN2B surface staining (nonpermeabilisied) 
at synapses, marked by Homer-1 staining (permeabilised). 
GluN2B intensities at the synapses were quantified using ImageJ 
and OpenView. Both enzymes Hya and ChABC increased surface 
expression of GluN2B at synapses. (Ctl 1.00 ± 0.03, n = 39; Hya 
1.28 ± 0.06, n = 38; ChABC 1.23 ± 0.08, n = 37; average ± SEM; 
One-way ANOVA, P = 0.0039, Dunnett’s Multiple Comparison 
Test, *** P < 0.001). 
  
Results     63 
showed much stronger effect in DIV 21 neurons compared to DIV 11 neurons. 
Figure 9B shows that Hya treatment did not affect the surface expression of 
GluN2B-NMDA receptors neither at dendrites nor at synapses. These data 
diminish the possibility of unspecific side effects of the enzyme that could cause 
the observed effect on GluN2B-NMDA receptors. It gives evidence that the 
rearrangement of the matrix after Hya manipulation indeed is responsible for the 
increased surface abundance of GluN2B.  
3.6 ECM digestion increases phosphorylation of GluN2B and 
decreases its endocytosis  
I have shown that ECM removal increased surface expression of GluN2B in a β1-
integrin-dependent manner. During my diploma thesis I developed a protocol to 
measure the amount of endocytosed receptors within a defined time window. 
Figure 9: Surface expression of GluN2B-NMDA receptors was unaffected by Hya treatment in DIV 
11 neurons 
(A) Primary cortical cultures (DIV 21 or DIV 11) were treated with Hya over night and stained against 
brevican. At DIV 21 a well-developed ECM surrounds neurons under Ctl conditions. After Hya treatment 
the net-like structure is abolished, remaining just at the axon initial segment. In DIV 11 neurons no 
developed ECM can be visualized. (Scalebars, 20 µm)  
(B) Hya treatment in DIV 11 neurons did not affect the surface expression of GluN2B neither at dendrites 
(Map-2 mask) nor at synapses (PSD-95 mask). (Synapses: Ctl 1.0 ± 0.04, n = 25; Hya 0.98 ± 0.02, n = 
24; average ± SE, unpaired t-test, P = 0.7341; Dendrites: Ctl 1.00 ± 0.03, n = 39; Hya 0.99 ± 0.05, n = 40; 
average ± SEM; unpaired t-test, P = 0.9488) 
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Indeed treatment with Hya diminished the endocytosis rate of GluN2B-NMDA 
receptors to 90% of control conditions. It was suggested that the endocytosis of 
GluN2B-NMDA receptors is regulated via phosphorylation of a tyrosin (Y1472) 
within the YEKL motif, which builds the binding site for the adaptor protein 
AP-2. If Y1472 is phosphorylated AP-2 cannot bind the subunit and the receptor 
is stabilized at the surface. Therefore I investigated whether the phosphorylation 
state of Y1472-GluN2B after ECM removal was altered.  
In a first set of experiments high density cortical cultures (DIV 21) were treated 
with Hya overnight. On the next day cell lysates were prepared, separated by 
SDS page and blotted on PVDF membranes. By using an antibody against 
pY1472-GluN2B and an antibody against pan-GluN2B (Figure 10A) it was 
possible to analyze the ratio of pY1472-GluN2B to the entire population of 
GluN2B proteins. Figure 10A shows a WB of acute hippocampal slices to 
illustrate the signal of both antibodies against pan-GluN2B and pY1472-GluN2B. 
The signals at the predicted molecular weight are co-localizing (arrows) in both 
channels. As the other visible bands do not co-localize, they can be assumed to be 
unspecific. Figure 10A shows that the ratio of pY1472/GluN2B was increased 
after Hya treatment of dissociated cortical cultures. In a parallel approach, the 
Figure 10: Hya increases phosphorylation of GluN2B and decreases its endocytosis 
(A) Quantitative Western Blots of acute hippocampal cultures under Ctl and Hya conditions. Antibodies: 
α pGluN2B pY1472 (AP2 binding site) and α GluN2B 
(B) Quantification of Western Blots of cortical cultures (DIV 21-24) and acute hippocampal cultures. In 
both cases the amount of phosphorylated GluN2B, normalized to the total amount of GluN2B, was 
increasing after Hya treatment (overnight for cultures; 3h for slices). (Culture: Ctl 1.00 ± 0.07, n = 5; Hya 
1.24 ± 0.06, n = 5, average ± SEM Unpaired t-test, * P = 0.0296; Slices Ctl 1.00 ± 0.01, n = 2; Hya 1.31 ± 
0.1, n = 2, average ± SEM Unpaired t-test, P = 0.0794   
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phosphorylation state of GluN2B was analyzed in acute hippocampal slices from 
10 weeks old rats. Acute hippocampal slices were treated with Hya for 3 h and 
subsequently triturated and lysed. Immunodetection of pY1472-GluN2B and 
GluN2B revealed higher ratio of phosphorylated vs. total GluN2B after ECM 
removal and thus confirmed the data obtained from dissociated cultures (Figure 
10A).  
3.7 Mobility of GluN2B-NMDA receptors 
In previous studies from my laboratory it was shown that digestion of the ECM 
with Hya increases lateral mobility of GluA1-AMPA receptors (Frischknecht et 
al., 2009). In contrast GluN2A-NMDA receptors were found unaffected in their 
mobility, and GluN2B-NMDA receptors had not been tested. Since GluN2B-
NMDA receptors have to move out of the synapse to be endocytosed and I found 
decreased endocytosis upon ECM removal, it is tempting to speculate that their 
lateral mobility is also affected by ECM removal.  
Dissociated hippocampal cultures were co-transfected with GluN1 and GluN2B-
subunit fused to an extracellular superecliptic pHluorin (SEP). SEP is a mutant of 
the Aequorea green fluorescent protein, which is pH-sensitive with a pK of 7.1 
(Sankaranarayanan et al., 2000). Only surface-expressed GluN2B subunits are 
visible by the fluorescent signal of the SEP tag as the extracellular milieu has a 
pH of 7.4 that overlaps with the pH optimum of SEP. Intracellular vesicles are 
more acidic (pH 5.6), which quenches the fluorescence signal of SEP. 
Overexpression of SEP-GluN2B + GluN1 revealed both a diffuse expression 
within dendrites and accumulated expression at spots, most probably 
representing synapses (Figure 11B). The maximum projections of QD traces are 
presented in red in Figure 11B. Some QDs were sticking to the glass, as they did 
not co-localize with neurons, which were visualized in a differential interference 
contrast (DIC) image. The other QDs co-localized with the SEP-GluN2B signals.  
Cells were treated with Hya either overnight or for 10 minutes. Frischknecht et al. 
showed that the lateral mobility of AMPA receptors is increased after an acute 
ECM digestion with Hya (Frischknecht et al., 2009). Based on this observation, I 
included an acute ECM digestion in the mobility experiments. The receptors 
were labeled with an antibody against GFP pre-coupled with a QD (Figure 11A). 
Mobility was acquired every 30 ms (33 Hz) for 30 sec. The trajectories were 
analyzed for the Instantaneous Diffusion Coefficient (Dinst) and the Mean Square 
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Displacement (MSD) that represent the velocity and the confinement of the 
receptors, respectively. Quantification revealed that the Dinst was not affected by 
ECM digestion, meaning that the velocity of the receptors stayed the same 
(Figure 11C). The MSD illustrated that the receptors were less confined after 10 
min of ECM removal, but in contrast more restricted after overnight incubation 
with Hya (Figure 11D). To sum up, after 10 min of Hya action the GluN2B-
NMDA receptors explore a bigger area but are not increased in their surface 
Figure 11: Prolonged ECM digestion increased confinement of GluN2B-NMDA receptors 
(A) Schematic presentation of the overexpressed constructs: GluN1 wt and SEP-GluN2B. QDs were 
coupled to an antibody against GFP. Image is not drawn to scale. 
(B) Dissociated hippocampal cultures (DIV 21-24) were treated with Hya either for 10 min or overnight. 
QDs were coupled with the GFP antibody and living cells were labeled. The maximum projection of QD 
trajectories is presented in red and GluN2B overexpressed channels are presented in green. (scalebar 
20µm) 
(C) The Dinst did not reveal any differences between controls or Hya treated cells. The velocity of GluN2B-
NMDA receptors was not affected by ECM digestion. (Ctl 0.0023, Hya 10 min 0.2214, Hya overnight 
0.0019) 
(D) The mean square displacement (MSD) showed that GluN2B-NMDA receptors were less confined in 
their explored surface area after 10 min of ECM digestion. In contrast, a prolonged overnight Hya 
treatment increased their confinement. 
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expression. After an overnight incubation with Hya GluN2B-NMDA receptors 
are more abundant at the surface and additionally more confined in their 
mobility. 
Part II:  Cellular effects of Calsyntenin-1’s ectodomain 
Cellular functions of the ectodomain of Cst-1 are poorly described. The only 
published data are coming from a C. elegans study in which Cst-1 mutants were 
shown to have an impaired associative learning performance, which could be 
rescued by expressing the ectodomain of Cst-1 (Hoerndli et al., 2009). Neither 
surface receptors nor signaling pathways are known, which lead to cellular 
changes upon Cst-1 shedding.  
3.8 Purification of proteins 
First, in order to perform cell biological assays and to test for biochemical 
interactions of Cst with potential ligands, I designed DNA constructs for 
different protein fragments of Cst-1 and Cst-3 and produced them in eukaryotic 
expression systems (all tagged with a his / myc tag). Figure 12A shows the 
scheme of the domain structure for two fusion protein constructs. The first one is 
Cst1Clea-myc/his (Cst1Clea), which starts at the N-terminus with two cadherin 
domains (CAD), followed by the laminin-G domain (LamG) and is terminated 
exactly upstream of the α-secretase cleavage site, which is substituted by the 
myc/his tag. A similar construct was produced for Cst-3. The second construct 
Cst1Cad-myc/his (Cst1Cad) contains only the two CAD domains fused to the 
myc/his tag. Proteins were expressed in HEK293-T cells and purified as described 
in section 2.6.5. Elution fractions that contain the purified proteins were 
visualized by coomassie brilliant blue stained SDS pages and WBs that were 
incubated with an anti his antibody (Figure 12 B-E). Additionally to the elution 
fractions, the unpurified HEK293-T cell supernatant (input) and the flow-through 
were loaded. In Figure 12 B, C the coomassie gel (B) and the WB (C) of Cst1Clea 
purification are shown. Cst1Clea has a calculated size of 94 kD without the signal 
peptide. Both the coomassie gel and the WB show a signal within the purification 
fractions at ~120 kD. This discrepancy in molecular weight is potentially due to 
posttranslational modifications and the intrinsic charge of the protein that 
influences its behavior in SDS page (Rath et al., 2009, Shi et al., 2012). Further the 
observed apparent molecular weight is in line with previous publications (Vogt 
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et al., 2001). The signal of the WB proves that the protein of ~120 kD in fraction 4 
– 11 is his tagged and therefore the desired Cst1Clea fusion protein. As expected 
this signal is present in the input, but not in the flow-through. Figure 12 D, E 
shows the coomassie gel (D) and the WB (E) of the Cst1Cad purification. As 
expected from the calculated size of Cst1Cad (30 kD) both detection methods 
yield a signal at ~35 kD, which is present in the input, but not in the flow-
through. The WB shows a second his tag positive band significantly smaller than 
25 kD. The size of this protein argues for the isolated his/myc tag.  
Figure 12: Purification of fusion proteins  
(A) Scheme of fusion protein constructs. Both constructs are tagged with a myc/his tag. Cst1Clea 
contains two CAD domains and one LamG domain, whereas Cst1Cad lacks the LamG domain. 
(C, D) Coomassie gel (C) and WB (D) treated with an antibody against his-tag of the Cst1Clea fusion 
protein.  
(E, F) Coomassie gel (E) and WB (F) treated with an antibody against his-tag of the Cst1Cad fusion 
protein.  
Results     69 
The two coomassie gels show a second signal (~200 kD) above the his tag-positive 
band, but this band is not his tag-positive and it is further visible in the 
supernatant. The signal is present in both Cst1Clea and Cst1Cad purifications, 
which points this band out to represent a protein which is part of HEK cell 
supernatants and unspecifically bound to the Ni2+ sepharose. This possibility 
could be investigated by loading HEK293-T cell supernatants from untransfected 
cells on the Ni2+ sepharose columns. If the band is not visible in this control 
experiment the protein could be a co-purified binding partner of Cst-1.  
3.9 Cst-1 in canonical wnt signaling: GFP reporter system 
Unpublished data from Kerstin Leuthäuser suggested that Cst-1 binds sFRP-1, 
which is an antagonist for wnt signaling. This proposed interaction with sFRP-1 
suggests that Cst-1might affect wnt signaling. To elucidate this question a genetic 
reporter system was used in which GFP is expressed upon activation of the 
Tcf/Lef promotor which is the target promotor of canonical wnt signaling. 
HEK293-T cells were transfected with the reporter system. Figure 13A shows the 
GFP expression, which indicates the activity of the canonical wnt signaling. The 
constitutive expression of mCherry allows the localization of transfected cells and 
the DAPI staining is used to visualize nuclei of the cells. In the course of 
quantification I noticed a positive linear relationship between the intensities of 
the GFP signal and the mCherry signal (Figure 13B). That means that the GFP 
signal is partially dependent on the expression level of the DNA construct in each 
cell. Therefore GFP values were normalized to mCherry values. In a first set of 
experiments (Figure 13C) the reporter system was co-expressed with cDNA for 
wnt-8a and Cst-1 and incubated for 48 h. Wnt-8a was chosen because it is highly 
expressed in the brain (www.brain-map.org). Unfortunately, expression of wnt-
8a did not increase the activity of the canonical wnt signaling. Expression of Cst-1 
only slightly increased GFP expression (Figure 13C). This experimental setup did 
not include a control of the expression efficacy of wnt-8a and Cst-1. Too low 
expression levels of wnt-8a could be the reason why Cst-1 co-expression 
increased canonical wnt signaling while wnt-8a did not. For that reason a new 
experimental setup was chosen based on HEK293-T cells, which were only 
transfected with the reporter system and wnt and Cst1Clea were added as 
purified proteins in defined amounts. Here, wnt-3a was used instead of wnt-8a, 
as wnt-3a is the most commonly used activator of canonical wnt signaling in the 
field (von Marschall and Fisher, 2010, Ring et al., 2011, Ring et al., 2014).Wnt-3a 
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was commercially available whereas Cst1Clea was purified as described in 
section 2.6.5 and represents the extracellular cleavage product of Cst-1 after α-
secretase cleavage (Figure 12A). Figure 13D shows that both wnt-3a and Cst1Clea 
could increase canonical wnt signaling in higher doses (300ng/ml) but not in 
lower concentration (100ng/ml). To survey these results I used a more sensitive 
reporter system for canonical wnt signaling. The most accepted one is the so 
called Super 8x TOP/FOPFlash system which is based on the expression of 
luciferase upon Tcf/Lef promotor activation.  
 
Figure 13: GFP based reporter system to analyze the influence of Cst1 on canonical wnt signaling 
(A) HEK293-T cells were transfected with the GFP based reporter system of Tcf/Lef activity. Constitutive 
expression of mCherry visualizes transfected cells and the GFP signal represents the activation of Tcf/Lef 
promotor. DAPI staining visualizes the nuclei of plated cells.  
(B) Plot of GFP intensities per cell with the corresponding mCherry signal. Calculation of the Pearson 
correlation value r = 0.7745 revealed an increasing linear relationship of both signals. For further 
quantifications GFP signal was normalized to mCherry intensity. 
(C) HEK293-T cells were co-transfected with the GFP reportersystem and either wnt-8a or Cst-1 (48 h). 
Cst-1 but not wnt-8a increased GFP intensity (Ctl 1.00 ± 0.06, n = 23; wnt-8a 1.09 ± 0.03, n = 8; Cst-1 
1.31 ± 0.09, n = 12, average ± SEM; One-way ANOVA, P = 0.0065, Dunnett’s Multiple Comparison Test, 
* P < 0.05). 
(D) HEK293-T cells were transfected with the GFP reporter system and defined amounts of purified 
proteins wnt-3a and Cst1Clea were added (6h). Both proteins increased GFP expression when added 
with 300ng/ml but not with 100ng/ml. (Ctl 1.00 ± 0.04, n = 21; wnt-3a 100ng/ml 1.06 ± 0.05, n = 20; wnt-3a 
300ng/ml 1.16 ± 0.05, n = 21; Cst1 100ng/ml 1.12 ± 0.04, n = 22; Cst1 300ng/ml 1.19 ± 0.05, n = 21, 
average ± SEM; One-way ANOVA, P = 0.0192, Dunnett’s Multiple Comparison Test, * P < 0.05). 
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3.10 Cst-1 in canonical wnt signaling: luciferase reporter system 
Similar to previous experiments HEK293-T cells were transfected either with the 
Super 8x TOPFlash or Super 8x FOPFlash constructs. Cells were plated in 96 well 
plates and treated with purified wnt-3a at different concentrations overnight. 
Figure 14A shows the results of this assay after normalization of the Super 8x 
TOPFlash to Super8x FOPFlash signal. With increasing amounts of wnt-3a (4 – 16 
pmol/ml) canonical wnt signaling was activated. 16 pmol/ml wnt-3a protein led 
to an almost 10 fold increase in luciferase activity. In the next experiment 16 
pmol/ml wnt-3a were used as a positive control and different amounts of 
Cst1Clea or Cst1Cad were applied overnight (Figure 14B). None of the used 
concentration of Cst1Clea or Cst1Cad changed luciferase activity. In order to 
Figure 14: Cst-1 does not affect canonical wnt signaling / Tcf/Lef promotor activation 
(A) HEK293-T cells were transfected with the luciferase reporter system and treated with defined amounts 
of purified wnt-3a (overnight). 4 pmol/ml and 8 pmol/ml wnt-3a slightly increased luciferase activity, 
whereas 16 pmol/ml wnt-3a significantly enhanced luciferase activity. (Ctl 1.00 ± 0.03, n = 18; wnt-3a: 4 
pmol/ml 2.06 ± 0.26, n = 12; 8 pmol/ml 3.00 ± 0.43, n = 12; 16 pmol/ml 9.01 ± 0.43, n = 18; average ± 
SEM; One-way ANOVA, P < 0.0001, Dunnett’s Multiple Comparison Test, *** P < 0.0001). 
(B) HEK293-T cells were transfected with the luciferase reporter system and treated with defined amounts 
of purified wnt-3a, Cst1Clea or Cst1Cad (overnight). Only 16 pmol/ml wnt-3a increased luciferase activity 
significantly. Simultaneous application of equal amounts of wnt-3a and Cst1Clea had the same effect as 
wnt-3a alone. (Ctl 1.00 ± 0.05, n = 8; wnt-3a 16 pmol/ml 11.86 ± 1.34, n = 8; Cst1Clea: 1 pmol/ml 1.15 ± 
0.08, n = 8, 2 pmol/ml 1.23 ± 0.1, n = 8, 4 pmol/ml 1.02 ± 0.09, n = 8, 8 pmol/ml 1.00 ± 0.11, n = 8, 16 
pmol/ml 1.14 ± 0.11, n = 8; wnt-3a + Cst1Clea 16pmol/ml 12.27 ± 0.73, n = 8; Cst1Cad: 2 pmol/ml 1.26 ± 
0.15, n = 8, 4 pmol/ml 0.96 ± 0.07, n = 8, 8 pmol/ml 0.83 ± 0.05, n = 8; average ± SEM; One-way ANOVA, 
P < 0.0001, Dunnett’s Multiple Comparison Test, *** P < 0.0001). 
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clarify whether wnt-3a and Cst1Clea show any competitive behavior, wnt-3a and 
Cst1Clea were added together in equal amounts. Nevertheless the results did not 
change compared to the case where only wnt-3a was added. These data suggest 
that Cst-1 has no influence on canonical wnt signaling.  
3.11 Binding assay: Cst1Clea and Frizzled-1 
Even though I could not show an influence of Cst-1 on canonical wnt signaling-
dependent gene expression, an influence of Cst-1 on other wnt signaling 
pathways cannot be excluded. After identifying Cst-1 as a binding partner of 
sFRP-1 different deletion mutants were created to localize the binding region 
within sFRP-1. It was shown that the CRD of sFRP-1 is essential for Cst-1binding 
(Leuthäuser et al., unpubl.). CRDs are conserved between sFRPs and Frzl. 
Therefore it was feasible to test whether Cst-1 could also bind to Frzl. For that 
reason HEK293-T cells were transfected with an extracellular HA-tagged Frzl-1. 
Frzl-1 was chosen because it is highly expressed in hippocampal synapses 
Figure 15: Neither Cst1Clea nor Cst3Clea bind to Frzl-1  
(A) HEK293-T cells were transfected with HA tagged Frzl-1 and treated with supernatants from either 
Cst1Clea-myc or Cst3Clea-myc expressing HEK293-T cells. Living cells were stained for HA and myc 
tags. Neither Cst1Clea nor Cst3Clea bound to the Frzl-1-transfected cells. (scalebar 20µm) 
(B) To verify the experimental setup the binding assay was performed with a known interacting protein. 
HEK293-T cells were transfected with neurofascin and supernatants from HEK293-T cells expressing 
brevican were added. Living cells were stained against neurofascin and brevican. The brevican staining 
co-localized with the neurofascin staining, underlying the binding of these proteins. (scalebar 20µm) 
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(Varela-Nallar et al., 2009). Supernatants of Cst1Clea- or Cst3Clea-expressing 
HEK293-T cells were added to the cells. Figure 15A presents microscopic images 
that show surface staining for HA tag (Frzl-1-HA) and myc tag (Cst1Clea-myc / 
Cst3Clea-myc). None of these proteins bound Frzl-1. The supernatant of non-
transfected HEK293-T cells (Ctl supernatant) was used as a negative control and 
it shows the same result. As a positive control for the experimental design I chose 
brevican that interacts with neurofascin and is recruited to neurofascin 
overexpressing COS-7 cells (Hedstrom et al., 2007). Figure 15B shows clear 
recruitment of brevican to transfected cells. The application of control 
supernatants shows no signal of the brevican antibody that confirms its 
specificity. In the end these experiments show that under these conditions neither 
Cst1Clea nor Cst3Clea bind to Frzl-1.  
3.12 Cst-1 in presynaptic activity 
To date, a potential role of Cst-1 in wnt signaling remains to be clarified. Of note, 
wnt signaling is more diverse than the classical canonical and non-canonical 
pathways. It increases for example recycling of presynaptic vesicles (Ahmad-
Annuar et al., 2006, Cerpa et al., 2008) and is involved in targeting α7-nAChR to 
the plasma membrane, whose activation affects neurotransmitter release (Farias 
et al., 2007). Due to these phenomena a role for Cst-1 in presynaptic activity was 
considered. To investigate this, a well-established protocol was chosen to 
measure presynaptic activity: synaptotagmin-1 antibody uptake. Figure 16A 
shows a schematic illustration of this method. Dissociated rat cortical neurons 
(DIV 14-17) were incubated with different purified proteins for 1 h. In case of 
additional application of channel blockers like Bungarotoxin (BgTx) those were 
applied 30 min before addition of purified proteins to ensure that the channel 
cannot be activated upon protein application. Cells were then incubated with an 
antibody against the luminal domain of synaptotagmin-1. With every fusion 
event of a synaptic vesicle, the antibody is taken up. The higher the fluorescent 
signal the higher is the presynaptic activity. Application of Cst1Clea increased 
the fluorescence intensity (Figure 16B). This demonstrates that the average 
activity of presynapses is increased. Neither Cst1Cad nor Cst3Clea changed 
presynaptic activity significantly, indicating specificity of the effect for the full-
length ectodomain of Cst-1. The question arose which signaling pathway enables 
Cst1Clea to act on the presynapse. So far, I did not find a proof for the interaction 
of Cst-1 and Frzl-1, but the suggested interaction of Cst-1 and sFRP-1 made me to 
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test if the effect of Cst-1 on presynaptic activity can be prevented by inhibition of 
wnt signaling. A tool to inhibit wnt signaling at the presynapse is a soluble Frzl-1 
CRD (Varela-Nallar et al., 2009). I added simultaneously Frzl-1 CRD and 
Cst1Clea to the cells and prevented the activating influence of Cst1Clea alone 
(Figure 16B). Further, α7-nAChRs are one target of wnt signaling within the 
presynapse (Farias et al., 2007). By treatment with Cst1Clea and BgTx, an 
inhibitor of α7-nAChRs, the positive effect of Cst1Clea on presynaptic activity 
was inhibited (Figure 16B). BgTx alone did not change presynaptic activity.  
Figure 16: Cst1Clea increased presynaptic activity 
(A) Scheme to illustrate synaptotagmin-1 antibody uptake. Fluorescently labeled antibodies against 
synaptotagmin-1 were added to the cell media of dissociated cortical cultures (DIV 14-17). The antibody 
was taken up when a neurotransmitter vesicle was fused to the membrane and recycled. In this way 
presynaptic activity is visualized by the intensity of the uptaken antibodies.   
(B) Cst1Clea, but not Cst1Cad or Cst3Clea increased presynaptic activity. The effect of Cst1Clea could 
be inhibited by simultaneous application of soluble Frzl-1 CRD or by preincubation with BgTx to block 
α7-nAChRs. BgTx alone did not affect presynaptic activity. (Ctl 1.00 ± 0.04, n = 113; Cst1Clea 1.23 ± 
0.05, n = 124; Cst1Cad 1.10 ± 0.05, n = 78; Cst3Clea 0.95 ± 0.07, n = 53; Cst1Clea + Frzl-1 CRD 0.91 ± 
0.06, n = 26; Cst1Clea + BgTx 0.99 ± 0.06, n = 38; BgTx 1.11 ± 0.07, n = 38; average ± SEM; One-way 
ANOVA, P = 0.0002, Dunnett’s Multiple Comparison Test, *** P < 0.0001). 
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4 Discussion 
The aim of my thesis was to investigate the influence of the hyaluronan-based 
ECM and the extracellular cleaved molecule Cst-1 on synaptic transmission. I 
could show in the main project that enzymatic remodeling of the ECM leads to 
an enhanced surface expression of GluN2B-NMDA receptors in a β1-integrin-
dependent manner. In the side project I demonstrated that the ectodomain of Cst-
1, which originates upon ectodomain shedding, enhances presynaptic activity. 
Cellular consequences, potential signaling mechanisms and the impact of these 
observations will be discussed in the following.  
4.1 Regulation of surface expression of GluN2B-NMDA receptors 
The regulation of NMDA receptors is an important feature in terms of plasticity 
processes. Due to their Ca2+ permeability, coincident detection of pre- and 
postsynaptic activity and their intracellular coupling to signaling cascades 
NMDA receptors are attractive modulators for plasticity. In particular GluN2B-
NMDA receptors undergo activity-dependent changes in their surface 
abundance (Carmignoto and Vicini, 1992). It has previously been suggested that 
surface expression and endocytosis of GluN2B are regulated by phosphorylation 
of Y1472 within the YEKL-motif of GluN2B. This phosphorylation prevents the 
binding of the adapter protein AP-2 and subsequently inhibits the endocytosis of 
GluN2B-NMDA receptors (Nakazawa et al., 2001, Roche et al., 2001, Lavezzari et 
al., 2003, Prybylowski et al., 2005). Indeed, the presented data provide evidence 
that ECM digestion by Hya increased pY1472 of GluN2B and consequently 
decreased endocytosis of the receptor. However, it remains elusive which kinase 
phosphorylates GluN2B upon ECM degradation and this will be discussed.  
4.1.1 Src and Fyn kinase phosphorylate GluN2B-NMDA receptors 
Two kinases have been suggested to phosphorylate GluN2B at Y1472, namely the 
src kinase family (SFK) members Fyn and Src (Nakazawa et al., 2001, Zhang et 
al., 2008a). Nakazawa et al. showed that in HEK293-T cells Fyn phosphorylates 
GluN2B subunits at seven residues, including Y1472. Further, the 
phosphorylation was greatly reduced but not abolished in Fyn-mutant mice 
(Nakazawa et al., 2001). Zhang et al. suggested Src to phosphorylate GluN2B at 
Y1472 in a Cdk5-dependent manner, whereas phosphorylation by Fyn seems to 
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be Cdk5 independent. They propose Src to be responsible for the residual 
phosphorylation of Y1472 in Fyn mutant mice (Zhang et al., 2008a). There are 
further evidences in the study that the responsible kinase is member of the SFK. 
Interestingly, it was shown that application of integrin-ligand peptides evokes 
rapid increase in tyrosine phosphorylation by SFKs. This was followed by 
elevated NMDA receptor-mediated synaptic responses (Lin et al., 2003, Bernard-
Trifilo et al., 2005). However, it remains open whether increased NMDA currents 
were due to direct effects on the channel properties or were caused indirectly, by 
affecting the membrane trafficking of the receptor. Indeed phosphorylation of 
Y1472 of GluN2B regulates surface trafficking of the receptor (Lavezzari et al., 
2003). The YEKL motif, which includes Y1472, is the binding site for AP-2 that 
mediates clathrin-dependent endocytosis of the NMDA receptor. When Y1472 is 
phosphorylated AP-2 cannot bind anymore which results in stabilization of 
GluN2B-NMDA receptors at the surface. Based on that it was interesting to 
investigate whether the increased NMDA receptor mediated currents after 
application of integrin ligand peptides are due to an increased surface expression 
of GluN2B-NMDA receptors. The data in this study support this idea since it was 
shown that β1-integrin-dependent signaling increased surface expression of 
GluN2B which was paralleled by higher phosphorylation of Y1472 (Figure 17). 
My attempts to confirm SFKs as responsible enzymes using PP2 as an selective 
inhibitor (see Table 14) did not reveal explicit results. Thus, based on the 
described literature the kinase mechanism needs to be unraveled in this 
experimental setup using other kinase inhibitors. 
4.1.2 Lateral mobility of GluN2B-NMDA receptors 
Endocytosis of GluN2B takes place at perisynaptic sites were the endocytotic pits 
are localized (Blanpied et al., 2002) and starts with a CKII dependent 
phosphorylation of S1480 within the MAGUK/PDZ binding motif (Sanz-
Clemente et al., 2010). This motif binds to MAGUKs like PSD-95 or SAP-102 to 
tether the receptors within the post synaptic density. Phosphorylation of S1480 
leads to a disruption of the interaction of MAGUKs with GluN2B as well as to 
lateral movement of GluN2B to extrasynaptic sites where the endocytotic zones 
are localized (Clapp et al., 2010, Chen et al., 2012). In fact, after ECM digestion 
there was increased pY1472 and decreased endocytosis found. However, my 
attempts to quantify pS1480 failed due to poor detection with corresponding 
antibody (see Table 13). Thus, it remains to be investigated if the phosphorylation 
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state of S1480 is also affected, which would argue for a coordinated extra- and 
intracellular mobilization of the receptors.  
An indicator for altered association to the postsynaptic density is provided by the 
results of the mobility experiments presented here. Overnight treatment with 
Hya did not affect the velocity of surface expressed GluN2B-NMDA receptors 
but it decreased the explored surface area of the receptor. This could imply that 
GluN2B-NMDA receptors are more stabilized at synaptic sites, which is achieved 
by a higher binding to MAGUKs. Therefore it is tempting to speculate that long-
term ECM digestion decreases phosphorylation of S1480 to promote association 
of GluN2B with MAGUKs (Figure 17).  
Unfortunately the mobility experiments did not distinguish between synaptic 
and extrasynaptic receptors and thereby give no information about the exchange 
rate of those receptors. As my immunocytochemistry experiments revealed an 
increase in both synaptic and dendritic (extrasynaptic) receptors, one may 
speculate that both populations become more confined. Stabilization of GluN2B-
NMDA receptors at extrasynaptic sites could be a cellular mechanism to react 
faster on upcoming network changes that provoke molecular adjustments of the 
synapse. Having more receptors available at the surface, the regulation of 
synaptic receptor abundance can be carried out much faster as well. In addition, 
enhanced abundance of GluN2B-NMDA receptors at extrasynaptic sites itself can 
influence the fate of neurons as extrasynaptic NMDA receptor-mediated 
signaling differs from synaptic NMDA receptor-mediated signaling (Gladding 
and Raymond, 2011). Extrasynaptic NMDA receptors are likely to be activated 
upon glutamate spill-over during high-frequency repetitive activity or by 
glutamate release from other sources like surrounding glia (Rusakov and 
Kullmann, 1998, Le Meur et al., 2007, Chalifoux and Carter, 2011). Ca2+ transients 
mediated by synaptic NMDA receptors were shown to activate CREB and 
subsequently enhance transcription of pro-survival genes, whereas extrasynaptic 
NMDA receptors inactivate CREB, thus dominating the activating effect of 
synaptic ones (Hardingham et al., 2002). The question whether GluN2B-NMDA 
receptors lead to cell death and GluN2A-NMDA receptor to cell survival remains 
contradictory (Liu et al., 2007, von Engelhardt et al., 2007, Martel et al., 2009). 
However, as both compartments, synaptic and extrasynaptic sites, show higher 
abundance of GluN2B-NMDA receptors the ratio of activated synaptic versus 
extrasynaptic receptors remains probably the same and may not drive the 
neurons into a CREB-inactive status.  
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Acute Hya treatment increases lateral mobility of GluA1-AMPA receptors and by 
that enhances short-term plasticity (Frischknecht et al., 2009). In line with that, 
acute ECM digestion increased the explored area of GluN2B-NMDA receptors. It 
is proposed that the ECM forms surface compartments with varying size that 
operate as lateral diffusion barriers for surface molecules. Short-term Hya 
treatment supports this idea also for GluN2B-NMDA receptors. By regulating the 
lateral diffusion of receptors from one compartment to the other may allow 
synapse specific adjustments of receptors without producing global effects. 
Another advantage of a decreased confinement of GluN2B-NMDA receptors 
after acute ECM digestion could be that extrasynaptic receptors can move easily 
into the synapse. In contrast, overnight treatment with Hya led to a decreased 
mobility of GluN2B-NMDA receptors. This may be due to stimulation of 
intracellular signaling mechanism including activation of kinases and 
phosphatases that lead to the association of the NMDA receptors with MAGUKs 
that anchor the receptors at synapses. The increased anchoring at synaptic sites is 
visualized by the decreased lateral mobility (Clapp et al., 2010, Chen et al., 2012).  
4.1.3 Integrins regulate NMDA receptors 
As already mentioned integrin-ligand peptides are known to influence NMDA 
receptor currents and properties (Lin et al., 2003, Bernard-Trifilo et al., 2005, 
Watson et al., 2007). In this thesis it was demonstrated that a function-blocking 
β1-integrin antibody could inhibit ECM digestion-elicited increase of surface 
abundance of GluN2B (Figure 17). Increased NMDA receptor-mediated currents 
upon enhanced activation of β1-integrins are in line with previously published 
data. Activation of integrins with RGD peptides affect the phosphorylation state 
of GluN2A and GluN2B NMDA receptor subunits via increased SFK activity 
(Bernard-Trifilo et al., 2005). This could be blocked by a function-blocking 
antibody against β1-integrins. In line, application of the SFK inhibitor PP2 
eliminated an RGD-induced increase of NMDA receptor-mediated currents in 
acute hippocampal slices (Lin et al., 2003). Supporting evidence came from 
calcium imaging experiments that showed higher intracellular calcium levels 
after RGD-induced integrin activation. Interestingly, this increase was blocked by 
the GluN2B specific inhibitor ifenprodil and the SFK inhibitor PP2 (Watson et al., 
2007), suggesting that indeed GluN2B and SFKs were responsible for the 
increased Ca2+ transients after integrin activation. 
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4.2 ECM influences cellular properties via integrin signaling 
Several studies showed that ECM molecules interact with integrins and change 
their intracellular signaling. β1-integrins were shown to bind to the C-terminal 
domain of the CSPG versican and thereby activate the focal adhesion kinase 
(FAK) (Wu et al., 2002). Interestingly the peptide that is sufficient for this 
interaction does not contain the RGD consensus-binding motif, thus 
implementing a new binding mechanism. Another CSPG, which was shown to 
bind β1-integrins, is aggrecan. It inhibits axon growth on laminin-coated 
substrata by impairing integrin signaling, which results in decreasing pY397 FAK 
and pY418Src level (Tan et al., 2011). These phosphorylation steps lead to 
enhanced kinase activity. Treatment with ChABC prevented the axon growth 
inhibition by aggrecan (Tan et al., 2011). Additionally manganese, a potent 
integrin activator that keeps integrins in a high ligand binding affinity 
conformation, was able to abolish the inhibitory effect of aggrecan, raising the 
hypothesis that aggrecan keeps integrins in an inactive conformation and thereby 
decreases integrin signaling. Supporting data came from Orlando et al. who 
showed that ChABC treatment of organotypic hippocampal slices induced 
activation of β1-integrins and increased pY397 FAK levels (Orlando et al., 2012). 
Accordingly, structural changes were observed like enhanced spine motility and 
the formation of spine head protrusions. They propose CSPGs to “play a 
fundamental role in unmasking a cryptic binding motif that activates integrins 
and initiates both functional and structural plasticity”.  
The application of ChABC does not represent an endogenous remodeling of the 
ECM, as ChABC is a bacterial enzyme (Yamagata et al., 1968). Thus the search for 
neural ECM remodeling mechanisms leads to experiments that focused on the 
effect of proteolytic activity on integrins. Indeed, application of recombinant 
MMP-9 was shown to potentiate synaptic responses in an integrin-dependent 
manner (Wang et al., 2008). The authors speculate that latent RGD recognition 
sequences in target proteins of MMP-9 could get exposed after cleavage and 
thereby activate integrins. Alternatively, they suggest that MMP-9 may directly 
bind to integrins (Wang et al., 2003). 
In this thesis it was shown that both Hya and ChABC increase surface expression 
of GluN2B. Since Hya has an intrinsic chondroitinase function as well it is very 
likely that both enzymes decrease the inactivation of integrins due to degradation 
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of chondroitin sulfates. Thereby integrins are more activated and subsequently 
kinase activity is affected which leads to altered GluN2B phosphorylation.  
4.2.1 Reelin regulates NMDA receptor properties 
Several studies investigate the ECM protein reelin, which is involved in the 
developmental switch of NMDA receptor subunit composition, their mobility 
and physiological properties (Beffert et al., 2005, Qiu et al., 2006, Groc et al., 
2007). Reelin, a secreted glycoprotein is well known for its crucial role in the 
development of laminar structure of the cortex (D'Arcangelo and Curran, 1998).  
Blocking the function of reelin prevents the developmental subunit switch of 
NMDA receptors in a β1-integrin-dependent manner. Further, it decreases lateral 
mobility of GluN2B-NMDA receptors but increases their synaptic dwell time. In 
contrast, application of recombinant reelin accelerates the switch of subunits and 
reduces the synaptic dwell time of the receptors. (Groc et al., 2007). 
Figure 17: Schematic presentation of the putative signaling mechanism that increases GluN2B-
NMDA receptor surface expression upon ECM removal 
Adult synapses are surrounded by a dense ECM, which partially inhibits integrin signaling. The NMDA 
receptors are dominated by GluN2A-NMDA receptors, as the driving force for GluN2B-NMDA receptors is 
higher in comparison. The cytoplasmic tail of GluN2B contains two motifs, which are involved in the 
regulation of their trafficking. The ESDV motif is phosphorylated at this stage, which destabilizes the 
association to MAGUKs and allows the receptor to diffuse out of the synapse to the endocytotic pits. The 
YEKL motif is un-phosphorylated, which allows binding of AP-2 and results in endocytosis of the GluN2B-
NMDA receptor.  
In this thesis it is proposed that ECM digestion by Hya or ChABC leads to an increased surface 
expression of GluN2B-NMDA receptors. The proposed signaling mechanism starts with an enhanced 
activation of β1-integrins, which leads to an increased phosphorylation of the YEKL motif. This prevents 
binding of AP-2 and results in a decreased endocytosis and a stabilization of the receptors at the surface. 
The question marks highlight ambiguity that needs to be clarified by further experiments. Elucidating the 
exact way of enhanced integrin activation, the responsible kinase to phosphorylate GluN2B (most likely 
Fyn or Src) and the phosphorylation state of the ESDV motif would help to understand the whole signaling 
mechanism. 
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A well-established receptor for reelin is the Apolipoprotein E receptor 2 (Apoer2) 
which forms functional complexes with the NMDA receptor in the postsynaptic 
density (Beffert et al., 2005). Application of exogenous recombinant reelin leads 
to enhanced LTP, AMPA- and NMDA receptor-mediated postsynaptic currents 
and an enhanced tyrosine phosphorylation of NMDA receptors (Beffert et al., 
2005, Qiu et al., 2006). Further, Qiu et al. showed that the enhanced synaptic 
NMDA currents were abolished by the SFK inhibitor PP1. But they also 
demonstrated that surface expression of NMDA receptor subunits is unchanged 
after reelin application.  
There are parallels as well as differences between the studies mentioned above 
and the data of my thesis. The commonalities are that modulation of the ECM 
influences NMDA receptor subunit properties, by affecting the phosphorylation 
of the GluN2B subunit, partially stated to be β1-integrin-dependent. Simulating 
an immature reelin function decreases receptor mobility, which is in line with the 
observation of a decreased mobility after prolonged Hya treatment. Strikingly, 
the modulation of reelin does not change NMDA receptor surface expression, 
whereas Hya treatment increased GluN2B-NMDA receptor surface expression. 
To date, no data are available that describe in which way reelin is influenced by 
Hya or ChABC treatment. Thus it remains elusive, if the regulative mechanisms 
by reelin or Hya/ChABC influencing NMDA receptors interfere with each other 
or if they are separated. It can be stated that different strategies to remodel the 
ECM influence NMDA receptor properties in different ways by using partially 
the same singling molecules. Therefore, the guided use of ECM remodeling 
strategies provides a tool to selectively affect synaptic properties.  
4.3 Cellular consequences of an altered GluN2A/GluN2B ratio 
upon ECM remodeling 
The subunit composition, in particular the abundance of GluN2A and/or GluN2B 
subunits, determines the kinetics of the receptors and the activated signaling 
cascades as they have diverse intracellular tails (section 1.2.2). This thesis 
demonstrates that removal of the ECM in adult neurons increases surface 
expression of GluN2B-NMDA receptors, which are predominantly expressed in 
juvenile synapses. Therefore, the question arises about the functional 
consequences of a decreased GluN2A/GluN2B ratio.  
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4.3.1 Tri-heteromeric NMDA receptors 
In order to approach questions about cellular consequences of an altered 
GluN2A/GluN2B ratio, it is necessary to discuss the abundance of tri-heteromeric 
NMDA receptors. Most studies about NMDA receptor subunit composition focus 
on di-heteromeric receptors although 15 – 50% of the total receptor population 
are tri-heteromeric receptors (Sheng et al., 1994, Luo et al., 1997, Al-Hallaq et al., 
2007, Rauner and Kohr, 2011, Tovar et al., 2013). In early studies it was shown by 
immunoprecipitation that the dominant NMDA receptor complex in adult rat 
cortex contains three different subunits (Sheng et al., 1994, Luo et al., 1997). 
Several studies evidenced that tri-heteromeric NMDA receptors exist at the 
synapse and have intermediate kinetics compared to di-heteromeric receptors. 3 
µM ifenprodil inhibit 80 % of di-heteromeric GluN2B-NMDA receptors, but has 
no effect on GluN2A-NMDA receptors (Tovar and Westbrook, 1999). This was 
shown in a heterologous expression system (HEK293-T cells). Gray et al. 
confirmed this finding in neurons by deleting either GluN2A or GluN2B and 
compared their sensitivity for ifenprodil with WT neurons. 3 µM ifenprodil were 
demonstrated to exert an intermediate effect in WT neurons compared to 
GluN2A- or GluN2B-deficient neurons (Gray et al., 2011). Moreover, 
intermediate inactivation kinetics were shown by comparing neuronal cultures 
and acute slices of either GluN2A- or GluN2B knock-out mice with those from 
WT mice (Rauner and Kohr, 2011, Tovar et al., 2013). 
In my experiments neuronal cultures of WT rats were used, implicating a 
dominant abundance of tri-heteromeric NMDA receptors at synapses. After Hya 
treatment the NMDA receptor mediated sEPSCs were increased by 38 %. This 
increase was completely blocked by application of 3 µM ifenprodil. That suggests 
that those NMDA receptors that get stabilized at the surface are most probably 
di-heteromeric GluN2B-NMDA receptors. This result was confirmed by surface 
immunostainings of GluN2B subunits, which yielded 30 % more GluN2B-NMDA 
receptors at synapses after Hya treatment. Quantification of the surface GluN2B 
expression in the entire dendrite revealed an increase of 78 %. As only currents of 
synaptic NMDA receptors were measured in the sEPSCs experiments it stays 
ambiguous if the stabilized dendritic receptors are di- or tri-heteromeric 
receptors.  
Most of the studies addressing consequences of an altered GluN2A/GluN2B ratio 
exclude to a certain degree the abundance of tri-heteromeric NMDA receptors. In 
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terms of plasticity processes synaptic NMDA receptors are the main actors. Since 
Hya treatment leads to an increase of di-heteromeric GluN2B-NMDA receptors 
at synapses in my experiments tri-heteromeres can be excluded for further 
discussions of my results.  
4.3.2 Regulation of LTP by NMDA receptors and the ECM 
The influence of NMDA receptors on LTP 
Several partially controversial studies have shown that the GluN2A/GluN2B 
ratio critically affects various forms of synaptic plasticity such as LTP, LTD and 
metaplasticity (Paoletti et al., 2013, Shipton and Paulsen, 2014). The controversy 
whether GluN2A- or GluN2B-NMDA receptors were of higher importance to 
elicit LTP was studied during the last decades. The contradictions are often based 
on different experimental models (in vivo / in vitro / modeling), different protocols 
to induce LTP and different experimental setups (pharmacological / long-term or 
short-term genetic manipulation). Pharmacological studies suggested that 
inhibition of GluN2A-NMDA receptors prevented tetanus- and pairing-induced 
LTP but inhibition of GluN2B-NMDA receptors does not, but instead blocks LTD 
induction (Liu et al., 2004). That the frequency of stimulation can be crucial was 
shown as inhibition of GluN2B-NMDA receptors blocked the induction of spike-
timing-dependent LTP (low-frequency paradigm) but it did not impair tetanus-
induced LTP (Zhang et al., 2008b, Kohl et al., 2011). These different emphases of 
NMDA receptor subunits in responding to diverse stimulation frequencies can be 
important since network activity is changing upon behavior or molecular 
rearrangements. Overall, the pharmacological data do not provide a convincing 
evidence for a highly selective role of either subunit in LTP induction.  
If the intracellular tail of the NMDA receptor subunit and thereby their coupling 
to signaling cascades influences the preference for any kind of plasticity cannot 
easily be deduced from receptor blocking studies. In 1998 it was demonstrated 
that the C-terminal tail of GluN2B but not GluN2A or GluN1 shows high affinity 
to bind CaMKII (Strack and Colbran, 1998). The expression of mutated GluN2B 
subunits that show a reduced association with CaMKII prevented LTP (Barria 
and Malinow, 2005). Strikingly, it was sufficient to express mutated GluN2A 
subunits with a higher CaMKII affinity to rescue LTP. That states that the 
intracellular tail of GluN2B is essential for LTP as it keeps CaMKII within the 
proximity of synaptic activity. This observation brings a new perspective into 
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pharmacological experiments. In 2010 it was shown that pairing-induced LTP 
was not impaired by the block of GluN2B-NMDA receptors, but it was impaired 
by RNAi knock-down of GluN2B (Foster et al., 2010). That provides the GluN2B-
NMDA receptor a special role at the synapse, additional to its function as an ion 
channel.  
Based on the available data, both GluN2A- and GluN2B-NMDA receptors 
support the essential Ca2+ influx, depending on the stimulation protocol and 
developmental stage. Additionally GluN2B-NMDA receptors carry a unique role 
to target CaMKII to the proximity of Ca2+ influx at the PSD. Thus, the decreased 
GluN2A/2B ratio, as was found after Hya treatment may enhance the probability 
of eliciting LTP by given stimuli. Concerning LTD the data are even more 
inconclusive since neither GluN2A nor GluN2B seem to have a dominant role in 
this process. 
The influence of the ECM on LTP 
Several studies have shown that the ECM influences different kinds of synaptic 
plasticity. However, depending on the form of plasticity and experimental 
system the outcomes of the experiments vary.  
Prolonged ChABC treatment (3 days) in the visual cortex increased potentiation 
upon 3xTBS in vivo (de Vivo et al., 2013). Further the authors could show that 
chemical LTP combined with ChABC treatment potentiates visual responses. 
That provides a hint that prolonged ECM digestion can indeed increase 
functional plasticity, without providing precise molecular mechanisms yet. 
However, the authors speculate that this could be due to changes in receptor and 
channel surface localization, which would be in line with the altered 
GluN2A/GluN2B ratio after Hya or ChABC treatment in my experiments.  
In contrast, 2h Hya treatment of hippocampal slices did not influence single TBS-
induced LTP (Kochlamazashvili et al., 2010). However, the acute Hya treatment 
of hippocampal slices caused an impaired 5xTBS induced LTP, which was shown 
to be due to inhibited L-type Ca2+-channel currents. The application of exogenous 
hyaluronic acid restored the calcium transients and LTP. These data argue 
against an effect of Hya treatment on the NMDA receptor-dependent machinery 
of LTP induction. This discrepancy to the observed effect of Hya in my thesis 
could be due to the shorter duration of ECM digestion that was used by 
Kochlamazashvili et al. The increased mobility upon short-term Hya treatment 
and the decreased mobility upon overnight treatment, which I observed in my 
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thesis, supports the idea that different durations of ECM digestion cause diverse 
effects.  
Rearrangements of the ECM occur naturally by the action of proteases like MMP-
9 for example. MMP-9 level and proteolytic activity are rapidly increased by 
stimuli that induce late-phase LTP (L-LTP) in an NMDA receptor dependent 
manner (Nagy et al., 2006). Nagy et al. could show that pharmacological 
inhibition of MMP-9 selectively prevents the induction of L-LTP. The same holds 
true for MMP-9 mutant mice (Nagy et al., 2006). Brief application of active MMP-
9 leads to a potentiation in hippocampal area CA1, which could be erased by 
either echistatin, RGD peptides or integrin function-blocking antibodies 
suggesting that this potentiation is mediated by RGD-binding receptors (Nagy et 
al., 2006, Wang et al., 2008). These studies support findings of the present thesis 
unraveling a β1-integrin-dependent mechanism how ECM remodeling can 
influence cellular properties. In which way MMP-9 activity or ECM remodeling 
in general activate integrin signaling stays elusive. The most favorable 
mechanism is the exposure of latent recognition sequences by proteolytic 
cleavage, which then activate cell-surface integrins. Enhanced exposure of 
recognition sites to cellular receptors like integrins is also a conceivable 
mechanism to occur upon Hya or ChABC treatment. 
In studies that used either neurocan (Zhou et al., 2001) or brevican (Brakebusch et 
al., 2002) knock-out mice an impairment in the maintenance of LTP was detected, 
whereas no changes in the basal transmission or induction of LTP were observed. 
In addition Brakebusch et al. could show that application of an antibody against 
brevican mimicked the effect of the brevican KO animals. That presents again 
another effect of altered ECM composition on synaptic plasticity, as studies 
described before only observed effects in the induction of LTP. Tenascin-R 
deficient mice were shown to have a two-fold reduction in LTP (5xTBS), and 
short-term depression evoked by low-frequency stimulation was found reduced 
as well (Bukalo et al., 2001). In the same year a second study supported those 
data by showing an impaired NMDA receptor-dependent LTP (10xTBS) in 
tenascin-R deficient mice (Saghatelyan et al., 2001). Both studies showed that the 
basal NMDA receptor component was unaffected. Saghatelyan et al. state that 
amplitudes of NMDA receptor currents are normal, which is in line with my 
data. But they did not quantify decay times of the NMDA receptor-mediated 
currents, which could give more information about the subunit composition of 
NMDA receptors.  
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4.3.3 Regulation of metaplasticity by NMDA receptors and the ECM 
Since it is not possible to determine fixed roles for either NMDA subunit to 
induce either LTP or LTD, the idea of metaplasticity (Abraham and Bear, 1996) 
was brought into focus of research. Metaplasticity describes the mechanisms that 
regulate the basal state of synapses which determines the threshold to induce 
plasticity. The subunit composition of NMDA receptors is known to be activity-
dependent (Carmignoto and Vicini, 1992). Xu et al. demonstrated that the 
GluN2A/GluN2B ratio in acute hippocampal slices of 2-3 weeks old rats was 
decreased after high-frequency priming, which subsequently increased the 
magnitude of LTP but decreased LTD expression (Xu et al., 2009). For a higher 
GluN2A/GluN2B ratio they found an inverse relationship. Further, a plasticity 
protocol that induces no changes in ‘naive’ slices was able to induce LTP or LTD 
depending upon the previous priming protocol, as priming influences the 
GluN2A/GluN2B ratio to promote either LTP or LTD. In line, on a single synaptic 
level silencing led to enhanced GluN2B-NMDA receptor currents in comparison 
to naive synapses (Lee et al., 2010). Subsequently, the previously silenced 
synapses needed less intense protocols to elicit LTP and spine growth than 
previously active ones.  
So far it clearly shows that the GluN2A/GluN2B ratio influences the fate of 
neurons in terms of their future plasticity processes. That supports my 
hypothesis that a decreased GluN2A/GluN2B ratio after ECM removal enhances 
the probability to induce plasticity as it is enhanced in juvenile networks. One 
may suggests that the ECM digestion in my experiments is analogous to the 
priming procedure used in other studies to alter the GluN2A/GluN2B ratio. 
In line, tenascin-R-deficient mice were shown to exhibit elevated basal excitatory 
synaptic transmission and reduced perisomatic GABAergic inhibition, which 
could lead to metaplastic changes due to altered synaptic activity (Saghatelyan et 
al., 2001). Indeed, Bukalo et al. found the threshold to induce LTP to be increased 
in tenascin-R-mutant mice, which is the key factor in metaplasticity (Bukalo et al., 
2007). In turn a stimulation protocol that leads to LTP in WT mice induced LTD 
in tenascin-R-deficient mice. After several rescue experiments they proposed a 
chain of events including altered activity of GABAB and GABAA receptors, L-type 
Ca2+ channels and protein phosphatases, which all result in the metaplastic 
increase of LTP threshold in tenascin-R-deficient mice. This model does not 
consider NMDA receptor-mediated effects but the molecular mechanisms that 
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lead to metaplastic changes in mutant mice might be different than those after an 
enzymatic degradation of the ECM. Although individual components of the ECM 
may not be present in mutant mice, an alternative form of the mature ECM is 
formed and neurons may have established other compensatory mechanism than 
upon an acute ECM digestion. 
Comparable to the controversy about LTP dependence on the GluN2A/GluN2B 
ratio, the data related to its involvement in metaplasticity are not completely 
consistent. In 2012, Yang et al. presented a study in which they altered the 
GluN2A/GluN2B ratio by activating G-protein-coupled receptors (GPCRs) such 
as pituitary adenylate cyclase activating peptide 1 receptors (PAC1Rs) or 
dopamine 1 receptors (D1 receptors) (Yang et al., 2012). Depending on the 
activated GPCR they found a lower LTP threshold upon enhanced GluN2A-
NMDA receptor-mediated currents and a higher LTP threshold in case of 
enhanced GluN2B-NMDA receptor-mediated currents. These results are 
contradictory to the previously described effects of altered GluN2A/GluN2B ratio 
(Xu et al., 2009, Lee et al., 2010). It needs to be mentioned that Yang et al. used a 
unique method, in which they isolated single CA1 neurons out of acute 
hippocampal slices of two weeks old rats. This is a very artificial and isolated 
system and provides a lot of stress to the neurons. This could be one reason why 
results differ from other studies. Further they used another protocol to affect the 
GluN2A/GluN2B ratio. To change the ratio by altering network activity induces 
many more changes than only affecting the NMDA receptor; the same holds true 
for the activation of GPCRs. But both treatments have diverse side effects that 
could influence metaplasticity in different ways.  
Based on the controversy regarding the effects of GluN2A/GluN2B ratio it has to 
be clarified in which direction the neurons are primed by ECM digestion-induced 
increased GluN2B-NMDA receptor surface expression. Regardless the direction 
of plasticity changes, the community agrees that the subunit composition of 
NMDA receptors is an important modulator of several plasticity phenomena. 
ECM remodeling that alters the GluN2A/GluN2B ratio describes an additional 
cellular mechanism to influence plasticity potential of neurons. 
4.3.4 Regulation of structural plasticity by NMDA receptors and the ECM 
It is well described that persistent changes during late-phase LTP and LTD 
involve structural changes (Carlisle and Kennedy, 2005). Structural plasticity in 
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the brain includes the ability to build new synapses, change their size, 
morphology and motility or degrade established ones. Similar to the involvement 
of NMDA receptors and ECM in functional plasticity, their role in structural 
plasticity was also shown in several studies.  
Early expression of GluN2A in organotypic hippocampal slices reduces the 
number of synapses and dynamics of spines (Gambrill and Barria, 2011). In 
contrast the expression of GluN2B did not change synapse number but leads to 
increased spine motility and higher rates of spine additions and retractions. In 
line, knockdown of GluN2B decreased synapse number and spine motility. A 
study that supports this finding was performed in corticostriatal slices in which 
GluN2A-NMDA receptors were blocked, which resulted in an increase of spine 
head width (Vastagh et al., 2012). As in a metaplasticity study mentioned above 
(Yang et al., 2012) Vastagh et al. activated D1 receptors that decreased GluN2A-
NMDA receptors at synaptic sites and increased spine head width. This effect 
could be blocked by application of ifenprodil. Whether increased spine volume is 
a direct effect of the decreased GluN2A/GluN2B ratio remains elusive as the 
prolonged treatment with D1 receptor agonists not only decreased the 
GluN2A/GluN2B ratio but also increased insertion of AMPA receptors into the 
synapse. Spine volume has been positively correlated with strength of AMPA 
receptor-mediated currents (Matsuzaki et al., 2001). These studies propose a 
mechanism in which decreased GluN2A/GluN2B ratio supports potentiation of 
present synapses and an increase in both AMPA receptor content and spine 
volume. This close relationship of induction of LTP and structural plasticity was 
also shown at single synaptic level (Lee et al., 2010), described already in section 
4.3.3. Previously silenced synapses showed enhanced GluN2B-NMDA receptor 
mediated currents and needed lower stimulation to elicit LTP and spine growth 
(Lee et al., 2010).  
MMP-9 was also shown to influence dendritic spine enlargement, beside its effect 
on LTP (Wang et al., 2008). On one hand, they could show that TBS induced 
maintenance of spine enlargement and potentiation is dependent on the activity 
of MMP-9. On the other hand, the authors proved that MMP-9 application itself 
is already sufficient to induce potentiation and spine enlargement. Finally they 
stated that these effects are β1-integrin-dependent. In line ChABC treatment of 
organotypic hippocampal slices induced the appearance of spine head 
protrusions and enhanced the motility of dendritic spines in a β1-integrind-
dependent manner (Orlando et al., 2012). But the authors stated that this effect is 
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glutamate receptor independent, which would imply other underlying molecular 
mechanism than an altered GluN2A/GluN2B ratio. This could be due to shorter 
duration of ECM digestion in this study (4h) versus an overnight Hya/ChABC 
incubation in my work. A prolonged treatment in vivo with ChABC was shown 
to increase spine motility (de Vivo et al., 2013), without providing any molecular 
mechanism yet. The authors only speculate that the observed effects could be due 
to changes in receptor surface localization. As described previously, GluN2B-
NMDA receptor activity seems to influence structural spine plasticity, thus the 
observations from de Vivo et al. could be explained by altered GluN2A/GluN2B 
ratio upon ECM remodeling. It would be interesting to analyze if the increased 
spine motility could be blocked via ifenprodil, or if the level of pY1472-GluN2B is 
altered in these animals used by de Vivo et al.  
4.4 In vivo application of ECM digestion 
A number of studies have demonstrated altered plasticity in adult animals after 
ECM digestion using ChABC or Hya in vivo (Bradbury et al., 2002, Pizzorusso et 
al., 2002, Gogolla et al., 2009, Kochlamazashvili et al., 2010, de Vivo et al., 2013, 
Happel et al., 2014). 
4.4.1 ECM removal in the visual cortex and the role of NMDA receptors 
In particular studies in the visual cortex improved the knowledge about the 
influence of the ECM on plasticity. Monocular deprivation leads to a rapid 
depression of the deprived-eye inputs and a delayed strengthening of the open-
eye inputs (Frenkel and Bear, 2004). This adaption leads to an ocular dominance 
shift and is called ocular dominance plasticity. This shift can only be induced 
during the critical period of development and is not inducible in adults. 
However, enzymatic removal of the ECM in the visual cortex of adult rats can 
reactivate ocular dominance plasticity and therefore virtually rejuvenate the 
plasticity of the cortex (Pizzorusso et al., 2002). The molecular basis for this 
restoration is unknown to date. Several mechanisms are discussed, for example 
the GABA-mediated control of the critical period as preventing the maturation of 
GABA-transmission delayed the onset of the critical period (Hensch et al., 1998, 
Fagiolini and Hensch, 2000, Iwai et al., 2003). But Pizzorusso et al. state that 
treatment with ChABC does not lead to those alterations of visual cortical 
neurons that are observed after pharmacological treatments with GABA 
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antagonist (Pizzorusso et al., 2002). Therefore they exclude a general disinhibition 
to be the mechanism by that ChABC restores ocular dominance plasticity. 
Interestingly, the NMDA receptor subunit composition switches from mainly 
GluN2B- to GluN2A-NMDA receptors during the critical period in an 
experience-dependent manner (Carmignoto and Vicini, 1992, Quinlan et al., 
1999a, Quinlan et al., 1999b). Pizzorusso et al. described that dark rearing of 
animals prolongs the critical period and slows down the development of the 
ECM. One-week exposure to a normal light/dark circle was enough to rapidly 
terminate ocular dominance plasticity and the formation of perineuronal nets 
(Pizzorusso et al., 2002). As I propose a connection between ECM digestion and 
the abundance of GluN2B-NMDA receptors it is interesting to mention that dark 
rearing of rats from birth onwards attenuated the developmental increase in 
GluN2A-NMDA receptors and increased the proportion of GluN2B-NMDA 
receptors. Visual experience exerted an opposite effect (Quinlan et al., 1999a, 
Philpot et al., 2001). In 2007 Chen et al. added the observation that visual 
deprivation changes NMDA receptor subunit composition by initially increasing 
GluN2B and later by decreasing GluN2A protein levels (Chen and Bear, 2007). 
But does this change in subunit composition affect functional properties of the 
visual cortex? The influential Bienenstock, Cooper and Munro (BCM) theory 
describes that reduction in overall cortical activity by closing the contralateral eye 
decreases the modification threshold and thereby facilitating potentiation of 
inputs (Bienenstock et al., 1982). This sliding threshold builds the basis of 
metaplastic changes. As described in section 4.3.3, NMDA receptor subunit 
composition plays a critical role in metaplastic changes and indeed those changes 
were found in the visual cortex. Already in 1996 it was shown that light-deprived 
rats show enhanced LTP and diminished LTD over a range of stimulation 
frequencies, which was reversible by two days of light exposure (Kirkwood et al., 
1996). Further, dark reared animals showed a decreased LTD in response to 1 Hz 
stimulation, which is normally the optimal frequency for LTD, but an increased 
LTD in response to 0.5 Hz stimulation (Philpot et al., 2003). In line with the 
previous studies, brief dark exposure extended the integration temporal window 
for the induction of both spike-timing dependent LTP and LTD (Guo et al., 2012). 
This is based on the incorporation of GluN2B-NMDA receptors that prolongs the 
NMDA receptor mediated response and by that extends the window of 
coincidence detection of pre- and postsynaptic activity. This supports the idea 
that a sliding threshold to induce LTP/LTD is crucial for ocular dominance 
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plasticity. These results can be connected to the observed subunit changes of 
NMDA receptor upon light deprivation and light-exposure (Quinlan et al., 1999a, 
Philpot et al., 2001, Chen and Bear, 2007), supporting my proposed model of an 
altered GluN2A/GluN2B ratio upon ECM remodeling. 
In summary, the importance of the plastic changes of the GluN2A/GluN2B ratio 
to induce ocular dominance plasticity is extensively demonstrated. Further, 
permissive effects of the ECM on ocular dominance plasticity are described as 
well. But there are no studies available yet that focus on a possible connection 
between ECM remodeling, the resulting increase in plasticity and changes in the 
GluN2A/GluN2B ratio. My thesis demonstrates that digestion of the ECM with 
Hya can, at least in neuronal cultures, decrease the GluN2A/GluN2B ratio. Based 
on the described literature it is justified to speculate about a putative signaling 
pathway in which the ECM removal increases ocular dominance plasticity by 
affecting the GluN2A/GluN2B ratio probably in a β1-integrin-dependent manner 
as shown in my study. However this model needs further support. Clarifying 
experiments would include the blocking of β1-integrins simultaneously to ECM 
digestion and to test for ocular dominance plasticity under these conditions. 
Further, pY1472-GluN2B levels could be analyzed in these animals. 
Electrophysiological recordings including selective inhibitors for either GluN2A- 
or GluN2B-NMDA receptors could elucidate the question about an altered 
subunit ratio in the visual cortex upon ECM remodeling. 
4.4.2 Homeostatic plasticity as a model involved in ocular dominance 
plasticity 
An alternative mechanism involved in ocular dominance plasticity is synaptic 
scaling. It was first described in rat cortical cultures in which activity was blocked 
with TTX resulting in an increase in mEPSCs reflecting a global upscaling of 
synaptic weights (Turrigiano et al., 1998). This phenomenon was also found in 
the visual cortex where visual deprivation increased amplitudes of mEPSCs 
measured in cortical slices (Desai et al., 2002, Goel et al., 2006). That supports the 
hypothesis that besides plasticity processes like LTP/LTD and metaplasticity 
homeostatic plasticity occurs in the visual cortex as well to balance visual 
deprivation. The interconnection of these different kinds of plasticity processes is 
strong and some processes are discussed to be the preceding step to allow or 
change upcoming plasticity processes. The GluN2A/GluN2B ratio was also 
shown to be decreased in synaptic scaling experiments upon chronic inactivation 
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with TTX (Ehlers, 2003). In adult animals the induction of ocular dominance 
plasticity is only possible via a preceding period (10 days) of visual deprivation 
(He et al., 2006). During these 10 days of deprivation it was shown that, besides 
other molecular changes, the GluN2A/GluN2B ratio is decreased. Given that a 
decreased GluN2A/GluN2B ratio is necessary for ocular dominance plasticity 
and that visual deprivation elicits a chronic inactivation, it is tempting to 
speculate that synaptic scaling mechanisms lead to the altered GluN2A/GluN2B 
ratio which results in a sliding threshold for plasticity. If Hya or ChABC 
treatment in the visual cortex would also lead to a decreased GluN2A/GluN2B 
ratio, as proposed in my theses, digestion of the ECM would be an alternative to 
network silencing for reactivating ocular dominance plasticity in adults, as both 
would target the same molecular changes.  
Homeostatic plasticity occurring in the visual cortex provides another link to the 
ECM. Our group demonstrated that chronic deactivation of primary cortical 
cultures with TTX leads to an increased cleavage of brevican by ADAMTS4 at 
synaptic sites (Valenzuela et al., 2014). Subcellular fractionation suggested that 
the C-terminal fragment of brevican, which contains the chondroitin sulfate side 
chains, is enriched in the soluble fraction. The other fragment of brevican is more 
associated with cellular membranes. Consequently cleavage of brevican removes 
inhibiting chondroitin sulfate chains from synapses. Brevican is not the only 
substrate for ADAMTS4 since it also cleaves other lecticans like aggrecan, which 
is the main CSPG in the adult brain (Giamanco et al., 2010). Thus it is very 
intriguing that increased activity of ADAMTS4 leads to removal of permissive 
chondroitin sulfate side chains from the synapse. As described before removal of 
inhibiting chondroitin sulfate chains leads to increased structural plasticity and, 
as shown in my thesis, to a decreased GluN2A/GluN2B ratio. Based on these data 
it would be worth to investigate if a prolonged visual deprivation of adult 
animals (He et al., 2006) also affects the structural properties of the ECM (e.g. 
decreased abundance of chondroitin sulfates) and by that influences the 
GluN2A/GluN2B ratio. If this holds true, ECM digestion is not an alternative to 
network silencing to allow ocular dominance plasticity in adults (as suggested 
before), but ECM remodeling would be a direct effect of network silencing which 
then leads to further molecular changes. 
As mentioned before for MMP-9, the activity of proteases is thought to expose 
hidden binding sites for integrins (Michaluk et al., 2009). Consequently the 
increased activity of ADAMTS4 upon network inactivation could also promote 
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the abundance of new signaling molecules or binding sites to induce further 
plasticity processes. It could be tested if TTX treatment leads also to enhanced 
integrin signaling, proposing another signaling mechanism by that prolonged 
inactivation could lead to altered GluN2A/GluN2B ratio.  
Still, the complex molecular mechanisms underlying ocular dominance plasticity 
are partially controversial or not known. There are links between regaining 
plasticity in adults after ECM removal or prolonged visual deprivation. Further, 
the GluN2A/GluN2B ratio is a prominent candidate to regulate plasticity in the 
visual cortex. The work of my thesis provides a link between the ECM and the 
GluN2A/GluN2B ratio and by that proposes a mechanism by which ECM 
remodeling could influence plasticity. 
4.4.3 ECM removal in memory processes 
ECM digestion was not only investigated in terms of ocular dominance plasticity, 
a form of developmental plasticity necessary to establish and refine sensory input 
but it was also shown to influence learning processes (Happel et al., 2014) or the 
extinction of fear memories in the adult (Gogolla et al., 2009). For instance, 
Happel et al. could show that ECM digestion in the auditory cortex enhances 
cognitive flexibility, as treated animals developed better performance in a 
reversal learning task than untreated animals (Happel et al., 2014). Thus this 
study provides evidence that ECM modulation could be a potential target for 
guided neuroplasticity with therapeutic potential.  
In terms of fear memory it was shown that ChABC injection into the amygdala of 
adult animals reopens the possibility to erase fear memories by extinction 
(Gogolla et al., 2009), a process that is only observed in juvenile animals and gets 
lost during adulthood (Bouton et al., 2006, Quirk, 2006, Myers and Davis, 2007). 
This demonstrated, comparable to the observations in the visual cortex, that 
plasticity mechanisms that drive juvenile plasticity are not completely lost in 
adults, but need some support to be reactivated. A recent study showed erasure 
of fear memories by extinction in adult reelin-haploinsufficient heterozygous 
reeler mice, like it is normally found in juvenile animals (Iafrati et al., 2014). In 
addition, it was suggested that the activity of GluN2B-NMDA receptors was 
crucial to erase fear memory. It is already well established that application of 
D-cycloserine, a partial NMDA agonist that binds to the glycine binding site, 
facilitates extinction and prevents the recovery of memories in rats, mice and 
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humans both before and after extinction training (Guastella et al., 2007, Otto et 
al., 2007, Weber et al., 2007, Matsuda et al., 2010).  
Thus, in summary one may speculate that underlying mechanism of ChABC 
induced erasure of fear memory may also depend on GluN2B-NMDA receptor 
expression, like I showed in neuronal cultures. Therefore experiments as 
described in my thesis may help to understand molecular changes based on an 
ECM remodeling and to identify endogenous signaling pathways, which may 
promote similar changes in plasticity. These pathways may be good targets to 
replace the invasive treatment using glycosidases with more specific ones to 
avoid potential side effects, which becomes of particular interest for translational 
approaches. Especially, in terms of fear memory it could help to find potential 
therapies to prevent the development of extinction-resistant pathological fear and 
anxiety like it is the case in post-traumatic stress disorder (PTSD). The enhanced 
flexibility, the increased ability of relearning and of synaptic rearrangements after 
an ECM remodeling could be helpful for instance after the implantation of 
auditory prostheses to achieve long-lasting successful treatment (Lim et al., 2007, 
Deliano et al., 2009).  
4.5 Cst-1 in wnt signaling 
To date, the cellular function of Cst-1 and especially of Cst-1’s ectodomain 
remains elusive. Cst-1 lacking C. elegans mutants show an impaired associative 
memory, which could be rescued by expression of the ectodomain of Cst-1 (Ikeda 
et al., 2008, Hoerndli et al., 2009). These data suggest that the ectodomain is 
sufficient to induce cellular changes, but the signaling pathway or surface 
receptors are not known. It was suggested that Cst-1 binds the wnt signaling 
antagonist sFRP-1 and that a specific protein domain, the CRD of sFRP-1 is 
sufficient for this interaction (Leuthäuser et al., unpubl.). The CRD is also 
involved in binding wnt ligands; therefore it is likely that binding of Cst-1 to the 
CRD interferes with the sFRP-1/wnt binding. Further, Frzl also contains a CRD 
where wnt ligands bind to activate intracellular signaling cascades. Cst-1 could 
influence the binding properties at this site of action as well. That led to the idea 
to investigate the role of Cst-1 in wnt signaling. 
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4.5.1 Does Cst-1 bind Frzl? 
The aim was to investigate if Cst-1 shows binding potential to Frzl. Searching in 
the Allen Brain Atlas (www.brain-map.org), a database for mRNA localization by 
in situ hybridization on adult mouse brain, revealed that Frzl-1 is the most 
abundant member of the Frzl family. In addition it was shown that Frz-1 is 
highly expressed at presynaptic sites in hippocampal cultures (Varela-Nallar et 
al., 2009). Therefore binding of Cst1Clea to Frzl-1 was tested. But no binding 
could be observed in our test system. The binding specificity of Frzl family 
members and their ligands is complex. In 2014 an overview about known 
interactions of wnt ligands and Frzl was published (Dijksterhuis et al., 2014), 
demonstrating that the majority of wnt ligands binds to Frzl-1, or at least 
activates Frz-1-dependent signaling. Nevertheless, not all wnt ligands interact 
with Frzl-1. Thus it stays elusive if Cst1Clea interacts with another Frzl. Although 
under experimental conditions the CRD of sFRP-1 was sufficient to bind Cst-1 
(Leuthäuser et al., unpubl.), it may well be that the NTR domain supports 
binding in vivo. Probably Cst1Clea cannot bind Frzl as it only contains the CRD 
and not the supporting NTR domain. Another possibility could be that an 
isolated, overexpressed CRD construct is able to bind Cst-1, as shown previously, 
but a CRD which is integrated into the N-terminal part of Frzl might exhibit 
another conformation that does not allow proper binding, at least not in my 
experimental design. Similar contradictions are observed in the binding 
properties of sFRPs to wnt ligands. First it was described that the CRD of sFRPs 
is sufficient to bind wnt ligands (Lin et al., 1997) but later studies describe that a 
CRD-lacking mutant of sFRP-1 still binds to wingless (Uren et al., 2000) and that 
optimal wnt inhibition is achieved only by combination of both protein domains, 
CRD and NTR (Bhat et al., 2007). Even though it is possible that Cst1Clea does 
not bind at all Frzl itself, it may influences wnt signaling activity by interacting 
with sFRP-1. 
4.5.2 Does Cst-1 influence canonical wnt signaling? 
The canonical wnt pathway leads to the activation of the Tcf/Lef promotor to 
induce transcription of wnt target genes. Therefore the experimental setups to 
investigate canonical wnt signaling are based on genetic reporter systems. A 
reporter gene, in this cases either GFP or luciferase, gets expressed upon Tcf/Lef 
activation. In the wnt signaling field the reporter system of choice is based on 
luciferase expression. Indeed, application of wnt-3a decupled the luciferase 
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signals, confirming the feasibility of the assay. In comparison Cst1Clea did not 
have any effect on the activity of the Tcf/Lef promotor, regardless of protein 
concentration or if Cst1Clea and wnt-3a were applied at the same time. These 
results suggest that Cst1Clea does not have any effect on the canonical wnt 
signaling, at least not in the regulation of Tcf/Lef activation. It is still plausible to 
assume that Cst1Clea acts on β-catenin-dependent wnt signaling that does not 
result in gene transcription changes. This was shown for instance for the 
signaling of wnt-7a in the presynapse, which regulates surface abundance of 
α7-nAChR in a transcription-independent manner (Farias et al., 2007). Therefore 
it would be interesting to investigate whether Cst1Clea influences downstream 
molecules of the canonical wnt signaling like DVL and β-catenin which are 
upstream of gene transcription. To further stress possible effects of an interaction 
of Cst-1 with sFRP-1 it could help to apply exogenous sFRP-1 alone or in 
combination with Cst-1 to cell assays like the luciferase reporter system. Recently 
a study demonstrated that sFRP-1 acts dose-dependently on canonical wnt 
signaling. Nanomolar concentrations of sFRP-1 increased wnt-3a induced 
luciferase expression in HEK293-T cells whereas higher concentrations blocked it 
(Xavier et al., 2014). Therefore it could be interesting to investigate if there is any 
dose-dependent influence of Cst-1 on sFRP-1, or if Cst-1 changes the dose-
dependency of the inhibitory effect of sFRP-1. 
4.6 Cst1 increases presynaptic activity 
Uptake of a fluorescently labeled antibody against the luminal domain of 
synaptotagmin-1 is an established cell biological measurement of presynaptic 
activity. The application of Cst1Clea increased the intensity of synaptotagmin-1 
antibody uptake, which demonstrates that presynapses release more 
neurotransmitter vesicles within the observed time window. In contrast the 
treatment with Cst1Cad or Cst3Clea did not alter presynaptic activity. As 
Cst1Clea but not Cst1Cad increases presynaptic activity it implies that the LamG 
domain of the Cst-1 ectodomain is important to induce this effect. Application of 
the purified LamG domain may proof this assumption. 
The principle of ectodomain shedding to generate signaling molecules is well 
known and Cst-1 is not the only transmembrane protein that is proposed to 
influence synaptic properties after ectodomain shedding (Ethell et al., 2002, 
Hinkle et al., 2006, Peixoto et al., 2012, Toth et al., 2013). For example Aβ, the 
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shedding product of APP, exerts activity-regulating functions at the presynapse 
(Abramov et al., 2009). Aβ binds selectively with picomolar affinity to α7-nAChR 
(Wang et al., 2000) and subsequently increases presynaptic Ca2+ levels, which was 
blocked by the α7-nAChR inhibitor BgTx (Dougherty et al., 2003). As Aβ is 
released from presynaptic sites but also from dendrites it functions as a trans-
synaptic signal (Haass et al., 2012). The same holds true for Cst-1 as it is found in 
the postsynapse and its shedding product Cst1Clea acts on the presynapse. This 
trans-synaptic signaling is an important mechanism by which postsynaptic 
modifications lead to precisely coordinated changes in presynaptic structure and 
function. Along this line, enhanced neuronal activity leads to cleavage of the 
postsynaptic protein neuroligin-1 by MMP-9. This results in rapid destabilization 
of its presynaptic binding partner neurexin-1β and subsequent in a decreased 
presynaptic release probability (Peixoto et al., 2012). An increased ectodomain 
shedding upon elevated activity was also shown for the α-secretase (Sakry et al., 
2014), the same enzyme that sheds Cst1Clea from Cst-1 at postsynaptic sites. 
Activity-dependent α-secretase activity could lead to altered Cst-1 cleavage and 
which subsequently would influence presynaptic activity as a trans-synaptic 
regulator. This could be a new mechanism by which presynaptic activity can be 
adjusted upon altered network activity. 
The signaling mechanism underlying Cst1Clea affecting presynaptic release 
probability remains elusive. It was shown that wnt signaling influences 
presynaptic function in several ways (Ahmad-Annuar et al., 2006, Farias et al., 
2007, Cerpa et al., 2008, Farias et al., 2009, Cerpa et al., 2010). To investigate if the 
presynaptic effect of Cst1Clea application depends on wnt signaling a soluble 
Frzl-1 CRD was simultaneously added and abolished the effect of Cst1Clea on 
the presynapse. This soluble Frzl-1 CRD was shown to inhibit wnt-3a-induced 
changes at the presynapse (Varela-Nallar et al., 2009). Acute treatment of 
hippocampal cultures with wnt-3a leads to an increase in the number of bassoon 
and vGlut1 clusters and in the number of functional recycling sites. All these 
effects were inhibited by the application of Frzl-1 CRD. Furthermore wnt-3a 
treatment increases the intensity of FM dye puncta and speeds up unloading 
kinetics. Increased uptake and unloading represent higher efficacy of 
neurotransmitter release upon stimulation. The uptake of FM dye is analogous to 
the uptake of synaptotagmin-1 antibody. Therefore increasing effect of Cst1Clea 
on presynaptic activity can be compared with the effect of wnt-3a. Even though, 
the antibody uptake was performed under unstimulated conditions and not upon 
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a certain stimulus like KCl application, both, wnt-3a and Cst1Clea increased 
synaptic vesicle release and in both cases soluble Frzl-1 CRDs abolished this 
effect. It seems contradictory that the binding assay revealed no binding of 
Cst1Clea to Frzl-1 and here the Frzl-1 CRD abolishes an effect mediated by 
Cst1Clea. sFRP-1, which is proposed to bind Cst-1, was shown to inhibit wnt-3a 
induced β-catenin accumulation at least in L-cells (Galli et al., 2006). In 
hippocampal neurons sFRP-1 inhibits effects of wnt-7a at the presynapse, which 
are comparable with those changes wnt-3a induces (Cerpa et al., 2008). Therefore 
sFRP-1 might also inhibit wnt-3a activity at the presynapse, leading to a 
hypothetical mechanism that could explain the results from the synaptotagmin-1 
antibody uptake experiment (Figure 18): applied Cst1Clea molecules may bind 
sFRP-1 and assuming that this binding detains sFRP-1 to inhibit wnt-3a, 
enhanced levels of free wnt-3a can stimulate presynaptic activity. In case of 
simultaneous application of Cst1Clea and Frzl-1 CRD enhanced levels of free 
wnt-3a bind to the soluble Frzl-1 CRD and by that do not activate presynaptic 
activity anymore. The most speculative assumption is that interaction of Cst1Clea 
and sFRP-1 prevents binding of wnt ligands to sFRP-1. Additionally, if this 
hypothesis holds true, one can conclude that the cadherin domain of Cst-1alone 
is not able to bind sFRP-1, as Cst1Cad did not increase presynaptic activity. The 
interplay between these molecules needs to be further investigated. It would be 
possible to investigate binding properties of all three proteins, wnt, sFRP and Cst 
using the Biacore Plasmon Resonance system. This would clarify if the 
interaction of Cst-1 with sFRP-1 influences binding preferences of wnt ligands 
and sFRP-1. 
Another way to inhibit the enhancing effect of Cst1Clea on presynaptic activity 
was to block α7-nAChR before adding Cst1Clea. α7-nAChR are highly Ca2+ 
permeable (Vernino et al., 1992) and enhance neurotransmitter release upon 
activation with nicotine (Gray et al., 1996). The question arises if α7-nAChRs are 
activated in my primary cortical cultures, as the mayor cholinergic projections to 
the cerebral cortex and hippocampus are coming from the basal forebrain 
cholinergic complex. But the media I used for the cell cultures (Table 1) contains 
choline chloride, which was shown to be an agonist for α7-nAChR (Mandelzys et 
al., 1995, Papke et al., 1996). Therefore I can assume that α7-nAChRs are activated, 
which is supported by the observation that BgTx blocks the effect of Cst1Clea, 
implementing that α7-nAChRs were active before. 
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It was shown that acute wnt-7a application increases the amount of α7-nAChR on 
the surface of presynaptic sites (Farias et al., 2007). This effect was dependent on 
β-catenin as it dissociates from APC, which then induces enhanced trafficking of 
α7-nAChR to the plasma membrane. But β-catenin dependent gene expression 
was not altered, at least not in short-term treatment. Farias et al. did not show 
that the enhanced surface abundance of α7-nAChR leads to enhanced vesicle 
release. But wnt-7a was later shown to enhance the frequency of mEPSCs in 
hippocampal slices (Cerpa et al., 2008); the same effect is observed when 
activating α7-nAChR with nicotine (Gray et al., 1996). Acute application of 
Cst1Clea enhanced presynaptic activity, which is inhibited by blocking 
α7-nAChR with BgTx. Thus it is feasible to speculate that Cst1Clea leads to 
increased wnt signaling activity via binding to sFRP-1 resulting in enhanced 
Figure 18: Scheme of potential signaling mechanisms involved in the stimulating effect of 
Cst1Clea on presynapses 
In this thesis it was shown that Cst1Clea increases release probability at presynaptic sites. As α-secretase 
sheds it from the postsynapse, it is proposed to act as a trans-synaptic messenger protein. Two signaling 
mechanisms can be proposed: The first one includes an interaction of Cst1Clea with sFRP-1, which 
prevents binding of wnt ligands to sFRP-1. That would result in increased amount of free wnt ligands, 
which activate Frzl and result in a dissociation of β-catenin from APC. APC then stimulates trafficking of 
α7-nAChR to the plasma membrane, which ends up in an increased release probability. This putative 
signaling mechanism is supported by two observations. The first one was that the effect of Cst1Clea can 
be prevented by application of soluble Frzl-1 CRD, which binds the enhanced level of free wnt ligands and 
therefore prevents increased activation of Frzl. The second was that the effect of Cst1Clea was inhibited 
by application of BgTx, which inhibits the increased signaling of α7-nAChR. It cannot be excluded that 
Cst1Clea acts directly on α7-nAChR, like Aβ does for example.  
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α7-nAChR surface expression. Their activation triggers vesicle release, and 
application of BgTx prevents this effect. As shown before, Cst1Clea did not affect 
canonical wnt signaling in a luciferase-based reporter system. That seems to be 
contradictory to the proposed mechanism by which it alters presynaptic function 
via a β-catenin-dependent pathway. But the results from the reporter system 
experiment only show that Cst1Clea does not alter β-catenin-dependent gene 
expression. It is well possible that application of Cst1Clea affects β-catenin 
properties, for example its preference to build a complex with APC (Rubinfeld et 
al., 1993). 
In summary, Cst1Clea was shown to influence presynaptic activity. Based on 
these data I raise the hypothesis that it acts via binding to sFRP-1, but not Frzl, 
thus influencing wnt signaling activity at the synapse. The prevention of its effect 
by application of either soluble Frzl-1 CRD or BgTx is both connected to wnt 
signaling effects but acts at two different steps in the proposed signaling 
mechanism (Figure 18). These signaling mechanisms for Cst-1 are yet highly 
speculative and need to be further investigated by targeting downstream 
molecules like β-catenin, DVL or APC as these were described to be involved in 
the wnt dependent regulation of presynaptic efficacy. Further it cannot be 
excluded that Cst-1 in addition acts via other mechanisms, i.e. in coordination 
with other extracellular proteins or directly on the α7-nAChR, as the Aβ peptide 
binds the receptor (Wang et al., 2000). As the metabolisms of Cst-1 and APP are 
closely related (see 1.4.2) and Cst1Clea and Aβ seem to have similar effects on 
presynaptic activity, it is worth to investigate possible interactions of their 
signaling, by adding both proteins simultaneously to the cultures and measure 
presynaptic activity. With respect to Alzheimer’s disease, it would be beneficial 
to get a better understanding of physiological and pathological effects of Aβ and 
of putative interactions with other molecules, like for example Cst-1.  
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